<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Med Res Methodol</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Med Res Methodol</journal-id>
    <journal-title-group>
      <journal-title>BMC Medical Research Methodology</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2288</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10668366</article-id>
    <article-id pub-id-type="publisher-id">2097</article-id>
    <article-id pub-id-type="doi">10.1186/s12874-023-02097-y</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Software</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>baymedr: an R package and web application for the calculation of Bayes factors for superiority, equivalence, and non-inferiority designs</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8421-090X</contrib-id>
        <name>
          <surname>Linde</surname>
          <given-names>Maximilian</given-names>
        </name>
        <address>
          <email>maximilian.linde@gesis.org</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5030-4091</contrib-id>
        <name>
          <surname>van Ravenzwaaij</surname>
          <given-names>Don</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/018afyw53</institution-id><institution-id institution-id-type="GRID">grid.425053.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 1013 1176</institution-id><institution>GESIS - Leibniz Institute for the Social Sciences, </institution></institution-wrap>Cologne, Germany </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/012p63287</institution-id><institution-id institution-id-type="GRID">grid.4830.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0407 1981</institution-id><institution>University of Groningen, </institution></institution-wrap>Groningen, The Netherlands </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>24</day>
      <month>11</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>24</day>
      <month>11</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <volume>23</volume>
    <elocation-id>279</elocation-id>
    <history>
      <date date-type="received">
        <day>14</day>
        <month>9</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>3</day>
        <month>11</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">Clinical trials often seek to determine the superiority, equivalence, or non-inferiority of an experimental condition (e.g., a new drug) compared to a control condition (e.g., a placebo or an already existing drug). The use of frequentist statistical methods to analyze data for these types of designs is ubiquitous even though they have several limitations. Bayesian inference remedies many of these shortcomings and allows for intuitive interpretations, but are currently difficult to implement for the applied researcher.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">We outline the frequentist conceptualization of superiority, equivalence, and non-inferiority designs and discuss its disadvantages. Subsequently, we explain how Bayes factors can be used to compare the relative plausibility of competing hypotheses. We present baymedr, an R package and web application, that provides user-friendly tools for the computation of Bayes factors for superiority, equivalence, and non-inferiority designs. Instructions on how to use baymedr are provided and an example illustrates how existing results can be reanalyzed with baymedr.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">Our baymedr R package and web application enable researchers to conduct Bayesian superiority, equivalence, and non-inferiority tests. baymedr is characterized by a user-friendly implementation, making it convenient for researchers who are not statistical experts. Using baymedr, it is possible to calculate Bayes factors based on raw data and summary statistics.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Bayes factor</kwd>
      <kwd>baymedr</kwd>
      <kwd>Equivalence</kwd>
      <kwd>Non-inferiority</kwd>
      <kwd>Superiority</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003246</institution-id>
            <institution>Nederlandse Organisatie voor Wetenschappelijk Onderzoek</institution>
          </institution-wrap>
        </funding-source>
        <award-id>016.Vidi.188.001</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>GESIS – Leibniz-Institut für Sozialwissenschaften e.V. (3447)</institution>
        </funding-source>
      </award-group>
      <open-access>
        <p>Open Access funding enabled and organized by Projekt DEAL.</p>
      </open-access>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© BioMed Central Ltd., part of Springer Nature 2023</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par9">Researchers generally agree that the clinical trial is the best method to determine and compare the effects of medications and treatments [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Although clinical trials are often similar in design, different statistical procedures need to be employed depending on the nature of the research question. Commonly, clinical trials seek to determine the superiority, equivalence, or non-inferiority of an experimental condition (e.g., subjects receiving a new medication) compared to a control condition (e.g., subjects receiving a placebo or an already existing medication; [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]). For these goals, statistical inference is often conducted in the form of testing.</p>
    <p id="Par10">Usually, the frequentist approach to statistical testing forms the framework in which data for these research designs are analyzed [<xref ref-type="bibr" rid="CR5">5</xref>]. In particular, researchers often rely on null hypothesis significance testing (NHST), which quantifies evidence through a <italic>p</italic>-value. This <italic>p</italic>-value represents the probability of obtaining a test statistic (e.g., a <italic>t</italic>-value) at least as extreme as the one observed, assuming that the null hypothesis is true. In other words, the <italic>p</italic>-value is an indicator of the unusualness of the obtained test statistic under the null hypothesis, forming a “proof by contradiction” ([<xref ref-type="bibr" rid="CR6">6</xref>], p. 123). If the <italic>p</italic>-value is smaller than a predefined Type I error rate (<inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\alpha$$\end{document}</tex-math><mml:math id="M2"><mml:mi>α</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq1.gif"/></alternatives></inline-formula>), typically set to <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\alpha =.05$$\end{document}</tex-math><mml:math id="M4"><mml:mrow><mml:mi>α</mml:mi><mml:mo>=</mml:mo><mml:mo>.</mml:mo><mml:mn>05</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq2.gif"/></alternatives></inline-formula> (but see, e.g., [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]), rejection of the null hypothesis is warranted; otherwise the obtained data do not justify rejection of the null hypothesis.</p>
    <p id="Par11">The NHST approach to inference has been criticized due to certain limitations and erroneous interpretations of <italic>p</italic>-values (e.g., [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR21">21</xref>]), which we briefly describe below. As a result, some methodologists have argued that <italic>p</italic>-values should be mostly abandoned from scientific practice (e.g., [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]).</p>
    <p id="Par12">An alternative to NHST is statistical testing within a Bayesian framework. Bayesian statistics is based on the idea that the credibilities of well-defined parameter values (e.g., effect size) or models (e.g., null and alternative hypotheses) are updated based on new observations [<xref ref-type="bibr" rid="CR24">24</xref>]. With exploding computational power and the rise of Markov chain Monte Carlo methods (e.g., [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]) that are used to estimate probability distributions that cannot be determined analytically, applications of Bayesian inference have recently become tractable. Indeed, Bayesian methods are seeing more and more use in the biomedical field [<xref ref-type="bibr" rid="CR27">27</xref>] and other disciplines [<xref ref-type="bibr" rid="CR28">28</xref>].</p>
    <p id="Par13">Lee and Chu [<xref ref-type="bibr" rid="CR29">29</xref>] have conducted a literature search to investigate how Bayesian inference is typically used in biomedicine. They found that the number of studies using Bayesian inference has been steadily increasing over the last decades, with a majority of studies testing treatment efficacy and with most applications in fields such as oncology, cardiovascular system research, and central nervous system research. Further, most of the studies that used Bayesian methods complemented frequentist results with Bayesian results, and a majority of studies had a continuous or binary endpoint. The results indicated that many studies used Bayesian methods for the purpose of estimation or hypothesis testing, both with informative and non-informative priors, and had two conditions.</p>
    <p id="Par14">There are multiple ways that Bayesian hypothesis testing specifically is done in biomedicine. For instance, the posterior probabilities of the null and alternative hypotheses could be consulted, such that the alternative hypothesis is accepted if its posterior probability is close to 1 or if the posterior probability of the null hypothesis is lower than a predefined threshold (e.g., [<xref ref-type="bibr" rid="CR30">30</xref>]). Alternatively, the highest density interval of the posterior distribution could be compared to a predefined region of practical equivalence: If the highest density interval does not overlap with the region of equivalence, the alternative hypothesis can be accepted [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. Another possibility is the use of Bayes factors [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR36">36</xref>], which quantify the evidence for the alternative hypothesis relative to the evidence for the null hypothesis.</p>
    <p id="Par15">It can be argued that the Bayes factor should be preferred among those options. For example, a Bayes factor is an updating factor that enables researchers to update their individual prior beliefs about the two hypotheses. In other words, in contrast to posterior probabilities for the hypotheses, the Bayes factor is independent of any prior beliefs a researcher might have. Furthermore, a Bayes factor provides the relative evidence for the considered hypotheses. Conducting hypothesis testing with posterior probabilities does not necessarily have this property: evidence against one hypothesis need not be in favor of the other (although for complementary hypotheses this would be true). For these reasons, we only consider Bayes factors in the remainder of this manuscript.</p>
    <p id="Par16">Despite the fact that statistical inference is slowly changing from frequentist methods towards Bayesian methods [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR29">29</xref>], a majority of biomedical research still employs frequentist statistical techniques [<xref ref-type="bibr" rid="CR5">5</xref>]. To some extent, this might be due to a biased statistical education in favor of frequentist inference. Moreover, researchers might perceive statistical inference through NHST and reporting of <italic>p</italic>-values as prescriptive and, hence, adhere to this convention [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. We believe that one of the most crucial factors is the unavailability of easy-to-use Bayesian tools and software, leaving Bayesian hypothesis testing largely to statistical experts. Fortunately, important advances have been made towards user-friendly interfaces for Bayesian analyses with the release of the BayesFactor software [<xref ref-type="bibr" rid="CR39">39</xref>], written in R [<xref ref-type="bibr" rid="CR40">40</xref>], and point-and-click software like JASP [<xref ref-type="bibr" rid="CR41">41</xref>] and Jamovi [<xref ref-type="bibr" rid="CR42">42</xref>], the latter two of which are based to some extent on the BayesFactor software. However, these tools are mainly tailored towards research designs in the social sciences. Easy-to-use Bayesian tools and corresponding accessible software for the analysis of biomedical research designs specifically (e.g., superiority, equivalence, and non-inferiority) are still missing and, thus, urgently needed.</p>
    <p id="Par17">In this article, we provide an R package and a web application for conducting Bayesian hypothesis tests for superiority, equivalence, and non-inferiority designs, which is particularly relevant for the biomedical sciences. Although implementations for the superiority and equivalence test exist elsewhere, the implementation of the non-inferiority test is novel. The main objective of this manuscript is twofold: (1) to provide an easy-to-use software for the calculation of Bayes factors for common biomedical designs that can be used both by researchers who are comfortable programming and those who are not; (2) to provide a tutorial on how to use this software, using an applied example related to biomedicine. First, we outline the traditional frequentist approach to statistical testing for each of these designs. Second, we discuss the key disadvantages and potential pitfalls of this approach and motivate why Bayesian inferential techniques are better suited for these research designs. Third, we explain the conceptual background of Bayes factors [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR36">36</xref>]. Fourth, we provide and introduce baymedr [<xref ref-type="bibr" rid="CR43">43</xref>], an open-source software written in R [<xref ref-type="bibr" rid="CR40">40</xref>] that comes together with a web application (available at [<xref ref-type="bibr" rid="CR44">44</xref>]), for the computation of Bayes factors for common biomedical designs. We provide step-by-step instructions on how to use baymedr. Finally, we present a reanalysis of an existing empirical study to illustrate the most important features of the baymedr R package and the accompanying web application.</p>
    <sec id="Sec2">
      <title>Frequentist inference for superiority, equivalence and non-inferiority designs</title>
      <p id="Par18">The superiority, equivalence, and non-inferiority tests are concerned with research settings in which two conditions (e.g., control and experimental) are compared on some outcome measure [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. For instance, researchers might want to investigate whether a new antidepressant medication is superior, equivalent, or non-inferior compared to a well-established antidepressant. For a continuous outcome variable, the between-group comparison is typically made with one or two <italic>t</italic>-tests. The three designs differ, however, in the precise specification of the <italic>t</italic>-tests (see Fig. <xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Schematic depiction of the superiority, equivalence, and non-inferiority designs. The <italic>x</italic>-axis represents the true population effect size (<inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M6"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq3.gif"/></alternatives></inline-formula>), where <italic>c</italic> is the standardized equivalence margin in case of the equivalence test and the standardized non-inferiority margin in case of the non-inferiority test. Gray regions mark the null hypotheses and white regions the alternative hypotheses. The region with the diagonal black lines is not used for the one-sided superiority design. Note that the diagram assumes that high values on the measure of interest represent superior or non-inferior values and that a one-sided test is used for the superiority design</p></caption><graphic xlink:href="12874_2023_2097_Fig1_HTML" id="MO1"/></fig></p>
      <p id="Par19">In the following, we will assume that higher scores on the outcome measure of interest represent a more favorable outcome (i.e., superiority or non-inferiority) than lower scores. For example, high scores are favorable when the measure of interest represents the number of social interactions in patients with social anxiety, whereas low scores are favorable when the outcome variable is the number of depressive symptoms in patients with major depressive disorder. We will also assume that the outcome variable is continuous and that the residuals within both conditions are Normal distributed in the population, sharing a common population variance. Throughout this article, the true population effect size (<inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M8"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq4.gif"/></alternatives></inline-formula>) reflects the true standardized difference in the outcome between the experimental condition (i.e., <inline-formula id="IEq5"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {e}$$\end{document}</tex-math><mml:math id="M10"><mml:mtext>e</mml:mtext></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq5.gif"/></alternatives></inline-formula>) and the control condition (i.e., <inline-formula id="IEq6"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {c}$$\end{document}</tex-math><mml:math id="M12"><mml:mtext>c</mml:mtext></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq6.gif"/></alternatives></inline-formula>):<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \delta = \frac{\mu _{\text {e}}- \mu _{\text {c}}}{\sigma } \text {.} \end{aligned}$$\end{document}</tex-math><mml:math id="M14" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>μ</mml:mi><mml:mtext>e</mml:mtext></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mtext>c</mml:mtext></mml:msub></mml:mrow><mml:mi>σ</mml:mi></mml:mfrac><mml:mtext>.</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula></p>
      <sec id="Sec3">
        <title>The superiority design</title>
        <p id="Par20">The superiority design tests whether the experimental condition is superior to the control condition (see the first row of Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Conceptually, the superiority design consists of a one-sided test due to its inherent directionality. The null hypothesis <inline-formula id="IEq7"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M16"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq7.gif"/></alternatives></inline-formula> states that the true population effect size is zero, whereas the alternative hypotheses <inline-formula id="IEq8"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M18"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq8.gif"/></alternatives></inline-formula> states that the true population effect size is larger than zero:<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \mathcal {H} _0 {:}\ \, \delta =0\qquad \qquad \mathcal {H} _1 {:}\ \, \delta &gt;0 \text {.} \end{aligned}$$\end{document}</tex-math><mml:math id="M20" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mspace width="0.166667em"/><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mspace width="2em"/><mml:mspace width="2em"/><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mspace width="0.166667em"/><mml:mi>δ</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn><mml:mtext>.</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par21">To test these hypotheses, a one-sided <italic>t</italic>-test is conducted.<xref ref-type="fn" rid="Fn1">1</xref></p>
      </sec>
      <sec id="Sec4">
        <title>The equivalence design</title>
        <p id="Par22">The equivalence design tests whether the experimental and control conditions are practically equivalent (see the second row of Fig. <xref rid="Fig1" ref-type="fig">1</xref>). There are multiple approaches to equivalence testing (see, e.g., [<xref ref-type="bibr" rid="CR45">45</xref>]). A comprehensive treatment of all approaches is beyond the scope of this article. Here, we focus on one popular alternative: the two one-sided tests procedure (TOST; [<xref ref-type="bibr" rid="CR45">45</xref>–<xref ref-type="bibr" rid="CR49">49</xref>]). An equivalence interval must be defined, which can be based, for example, on the smallest effect size of interest [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]. The specification of the equivalence interval is not a statistical question; thus, it should be set by experts in the respective fields [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR48">48</xref>] or comply with regulatory guidelines [<xref ref-type="bibr" rid="CR52">52</xref>]. Importantly, however, the equivalence interval should be determined independent of the obtained data.</p>
        <p id="Par23">TOST involves conducting two one-sided <italic>t</italic>-tests, each one with its own null and alternative hypotheses. For the first test, the null hypothesis states that the true population effect size is smaller than the lower boundary of the equivalence interval, whereas the alternative hypothesis states that the true population effect size is larger than the lower boundary of the equivalence interval. For the second test, the null hypothesis states that the true population effect size is larger than the upper boundary of the equivalence interval, whereas the alternative hypothesis states that the true population effect size is smaller than the upper boundary of the equivalence interval. Assuming that the equivalence interval is symmetric around the null value, these hypotheses can be summarized as follows:<disp-formula id="Equ3"><label>3</label><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \mathcal {H} _0 {:}\ \delta \le -c ~ \text {OR} ~ \delta \ge c \qquad \qquad \mathcal {H} _1 {:}\ \delta &gt; -c\ \text {AND}\ \delta &lt; c \text {,} \end{aligned}$$\end{document}</tex-math><mml:math id="M22" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>≤</mml:mo><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mspace width="3.33333pt"/><mml:mtext>OR</mml:mtext><mml:mspace width="3.33333pt"/><mml:mi>δ</mml:mi><mml:mo>≥</mml:mo><mml:mi>c</mml:mi><mml:mspace width="2em"/><mml:mspace width="2em"/><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&gt;</mml:mo><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mspace width="4pt"/><mml:mtext>AND</mml:mtext><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>c</mml:mi><mml:mtext>,</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula>where <italic>c</italic> represents the margin of the standardized equivalence interval. Two <italic>p</italic>-values (<inline-formula id="IEq9"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p_{-c}$$\end{document}</tex-math><mml:math id="M24"><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq9.gif"/></alternatives></inline-formula> and <inline-formula id="IEq10"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p_{c}$$\end{document}</tex-math><mml:math id="M26"><mml:msub><mml:mi>p</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq10.gif"/></alternatives></inline-formula>) result from the application of the TOST procedure. We reject the null hypothesis of non-equivalence and, thus, establish equivalence if <inline-formula id="IEq11"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\max \left( p_{-c}, ~ p_{c} \right) &lt; \alpha$$\end{document}</tex-math><mml:math id="M28"><mml:mrow><mml:mo movablelimits="true">max</mml:mo><mml:mfenced close=")" open="("><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mspace width="3.33333pt"/><mml:msub><mml:mi>p</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mfenced><mml:mo>&lt;</mml:mo><mml:mi>α</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq11.gif"/></alternatives></inline-formula> (cf. [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]). In other words, both tests need to reach statistical significance.</p>
      </sec>
      <sec id="Sec5">
        <title>The non-inferiority design</title>
        <p id="Par24">In some situations, researchers are interested in testing whether the experimental condition is non-inferior or not worse than the control condition by a certain amount. This is the goal of the non-inferiority design, which consists of a one-tailed test (see the third row of Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Realistic applications might include testing the effectiveness of a new medication that has fewer undesirable adverse effects [<xref ref-type="bibr" rid="CR54">54</xref>], is cheaper [<xref ref-type="bibr" rid="CR55">55</xref>], or is easier to administer than the current medication [<xref ref-type="bibr" rid="CR56">56</xref>]. In these cases, we need to ponder the cost of a somewhat lower or equal effectiveness of the new treatment with the value of the just mentioned benefits [<xref ref-type="bibr" rid="CR57">57</xref>]. The null hypothesis states that the true population effect size is equal to a predetermined threshold, whereas the alternative hypothesis states that the true population effect size is higher than this threshold:<disp-formula id="Equ4"><label>4</label><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \mathcal {H} _0 {:}\ \delta =-c \qquad \qquad \mathcal {H} _1 {:}\ \delta &gt;-c \text {,} \end{aligned}$$\end{document}</tex-math><mml:math id="M30" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mspace width="2em"/><mml:mspace width="2em"/><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&gt;</mml:mo><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mtext>,</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ4.gif" position="anchor"/></alternatives></disp-formula>where <italic>c</italic> represents the standardized non-inferiority margin. As with the equivalence interval, the non-inferiority margin should be defined independent of the obtained data.</p>
      </sec>
      <sec id="Sec6">
        <title>Limitations of frequentist inference</title>
        <p id="Par25">Tests of superiority, equivalence, and non-inferiority have great value in biomedical research. It is the way researchers conduct their statistical analyses that, we argue, should be critically reconsidered. There are several disadvantages associated with the application of NHST to superiority, equivalence, and non-inferiority designs. Here, we limit our discussion to two disadvantages; for a more comprehensive exposition we refer the reader to other sources (e.g., [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>]).</p>
        <p id="Par26">First, researchers need to stick to a predetermined sampling plan [<xref ref-type="bibr" rid="CR60">60</xref>–<xref ref-type="bibr" rid="CR62">62</xref>]. That is, it is not legitimate to decide based on interim results to stop data collection (e.g., because the <italic>p</italic>-value is already smaller than <inline-formula id="IEq12"><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\alpha$$\end{document}</tex-math><mml:math id="M32"><mml:mi>α</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq12.gif"/></alternatives></inline-formula>) or to continue data collection beyond the predetermined sample size (e.g., because the <italic>p</italic>-value almost reaches statistical significance). In principle, researchers can correct for the fact that they inspected the data by reducing the required significance threshold through one of several techniques [<xref ref-type="bibr" rid="CR63">63</xref>]. However, such correction methods are rarely applied. Especially in biomedical research, the possibility of optional stopping could reduce the waste of resources for expensive and time-consuming trials [<xref ref-type="bibr" rid="CR64">64</xref>].</p>
        <p id="Par27">Second, with the traditional frequentist framework it is impossible to quantify evidence in favor of the null hypothesis [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR65">65</xref>–<xref ref-type="bibr" rid="CR67">67</xref>]. Oftentimes, the <italic>p</italic>-value is erroneously interpreted as a posterior probability, in the sense that it represents the probability of the null hypothesis [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. However, a non-significant <italic>p</italic>-value does not only occur when the null hypothesis is in fact true but also when the alternative hypothesis is true, yet there was not enough power to detect an effect [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]. As ([<xref ref-type="bibr" rid="CR71">71</xref>], p.485) put it: “Absence of evidence is not evidence of absence”. Still, a large proportion of biomedical studies falsely claim equivalence based on statistically non-significant <italic>t</italic>-tests [<xref ref-type="bibr" rid="CR72">72</xref>]. Yet, estimating evidence in favor of the null hypothesis is essential for certain designs like the equivalence test [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>].</p>
        <p id="Par28">The TOST procedure for equivalence testing provides a workaround for the problem that evidence for the null hypothesis cannot be quantified with traditional frequentist techniques by defining an equivalence interval around <inline-formula id="IEq13"><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta =0$$\end{document}</tex-math><mml:math id="M34"><mml:mrow><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq13.gif"/></alternatives></inline-formula> and conducting two tests. Without this interval the TOST procedure would inevitably fail (see [<xref ref-type="bibr" rid="CR45">45</xref>] for an explanation of why this is the case). As we will see, the Bayesian equivalence test does not have this restriction; it allows for the specification of interval as well as point null hypotheses.</p>
      </sec>
    </sec>
    <sec id="Sec7">
      <title>Bayesian tests for superiority, equivalence and non-inferiority designs</title>
      <p id="Par29">The Bayesian statistical framework provides a logically sound method to update beliefs about parameters based on new data [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. Bayesian inference can be divided into parameter estimation (e.g., estimating a population correlation) and model comparison (e.g., comparing the relative probabilities of the data under the null and alternative hypotheses) procedures (see, e.g., [<xref ref-type="bibr" rid="CR75">75</xref>], for an overview). Here, we will focus on the latter approach, which is usually accomplished with Bayes factors [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR36">36</xref>]. In our exposition of Bayes factors in general and specifically for superiority, equivalence, and non-inferiority designs, we mostly refrain from complex equations and derivations. Formulas are only provided when we think that they help to communicate the ideas and concepts. We refer readers interested in the mathematics of Bayes factors to other sources (e.g., [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR76">76</xref>–<xref ref-type="bibr" rid="CR78">78</xref>]). The precise derivation of Bayes factors for superiority, equivalence, and non-inferiority designs in particular is treated elsewhere [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR79">79</xref>].</p>
      <sec id="Sec8">
        <title>The Bayes factor</title>
        <p id="Par30">Let us suppose that we have two hypotheses, <inline-formula id="IEq14"><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M36"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq14.gif"/></alternatives></inline-formula> and <inline-formula id="IEq15"><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M38"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq15.gif"/></alternatives></inline-formula>, that we want to contrast. Without considering any data, we have initial beliefs about the probabilities of <inline-formula id="IEq16"><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M40"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq16.gif"/></alternatives></inline-formula> and <inline-formula id="IEq17"><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M42"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq17.gif"/></alternatives></inline-formula>, which are given by the prior probabilities <inline-formula id="IEq18"><alternatives><tex-math id="M43">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _0 \right)$$\end{document}</tex-math><mml:math id="M44"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq18.gif"/></alternatives></inline-formula> and <inline-formula id="IEq19"><alternatives><tex-math id="M45">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _1 \right) =1-p \left( \mathcal {H} _0 \right)$$\end{document}</tex-math><mml:math id="M46"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq19.gif"/></alternatives></inline-formula>. Now, we collect some data <italic>D</italic>. After having seen the data, we have new and refined beliefs about the probabilities that <inline-formula id="IEq20"><alternatives><tex-math id="M47">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M48"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq20.gif"/></alternatives></inline-formula> and <inline-formula id="IEq21"><alternatives><tex-math id="M49">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M50"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq21.gif"/></alternatives></inline-formula> are true, which are given by the posterior probabilities <inline-formula id="IEq22"><alternatives><tex-math id="M51">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _0 \mid D \right)$$\end{document}</tex-math><mml:math id="M52"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq22.gif"/></alternatives></inline-formula> and <inline-formula id="IEq23"><alternatives><tex-math id="M53">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _1 \mid D \right) =1-p \left( \mathcal {H} _0 \mid D \right)$$\end{document}</tex-math><mml:math id="M54"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq23.gif"/></alternatives></inline-formula>. In other words, we update our prior beliefs about the probabilities of <inline-formula id="IEq24"><alternatives><tex-math id="M55">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M56"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq24.gif"/></alternatives></inline-formula> and <inline-formula id="IEq25"><alternatives><tex-math id="M57">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M58"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq25.gif"/></alternatives></inline-formula> by incorporating what the data dictates we should believe and arrive at our posterior beliefs. This relation is expressed in Bayes’ rule:<disp-formula id="Equ5"><label>5</label><alternatives><tex-math id="M59">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \underbrace{p \left( \mathcal {H} _i \mid D \right) }_{\text {Posterior}} = \frac{\overbrace{p \left( D \mid \mathcal {H} _i \right) }^{\text {Likelihood}} \overbrace{p \left( \mathcal {H} _i \right) }^{\text {Prior}}}{\underbrace{p \left( D \mid \mathcal {H} _0 \right) p \left( \mathcal {H} _0 \right) +p \left( D \mid \mathcal {H} _1 \right) p \left( \mathcal {H} _1 \right) }_{\text {Marginal Likelihood}}} \text {,} \end{aligned}$$\end{document}</tex-math><mml:math id="M60" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:munder><mml:munder accentunder="true"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mo>⏟</mml:mo></mml:munder><mml:mtext>Posterior</mml:mtext></mml:munder><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mover><mml:mover accent="true"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow><mml:mo>⏞</mml:mo></mml:mover><mml:mtext>Likelihood</mml:mtext></mml:mover><mml:mover><mml:mover accent="true"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow><mml:mo>⏞</mml:mo></mml:mover><mml:mtext>Prior</mml:mtext></mml:mover></mml:mrow><mml:munder><mml:munder accentunder="true"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mo>+</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mo>⏟</mml:mo></mml:munder><mml:mrow><mml:mtext>Marginal Likelihood</mml:mtext></mml:mrow></mml:munder></mml:mfrac><mml:mtext>,</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ5.gif" position="anchor"/></alternatives></disp-formula>with <inline-formula id="IEq26"><alternatives><tex-math id="M61">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$i= \{0, ~ 1 \}$$\end{document}</tex-math><mml:math id="M62"><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mo stretchy="false">{</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mspace width="3.33333pt"/><mml:mn>1</mml:mn><mml:mo stretchy="false">}</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq26.gif"/></alternatives></inline-formula>, and where <inline-formula id="IEq27"><alternatives><tex-math id="M63">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _i \right)$$\end{document}</tex-math><mml:math id="M64"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq27.gif"/></alternatives></inline-formula> represents the prior probability of <inline-formula id="IEq28"><alternatives><tex-math id="M65">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _i$$\end{document}</tex-math><mml:math id="M66"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq28.gif"/></alternatives></inline-formula>, <inline-formula id="IEq29"><alternatives><tex-math id="M67">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( D \mid \mathcal {H} _i \right)$$\end{document}</tex-math><mml:math id="M68"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq29.gif"/></alternatives></inline-formula> denotes the likelihood of the data under <inline-formula id="IEq30"><alternatives><tex-math id="M69">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _i$$\end{document}</tex-math><mml:math id="M70"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq30.gif"/></alternatives></inline-formula>, <inline-formula id="IEq31"><alternatives><tex-math id="M71">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( D \mid \mathcal {H} _0 \right) p \left( \mathcal {H} _0 \right) +p \left( D \mid \mathcal {H} _1 \right) p \left( \mathcal {H} _1 \right)$$\end{document}</tex-math><mml:math id="M72"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mo>+</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq31.gif"/></alternatives></inline-formula> is the marginal likelihood (also called evidence; [<xref ref-type="bibr" rid="CR24">24</xref>]), and <inline-formula id="IEq32"><alternatives><tex-math id="M73">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _i \mid D \right)$$\end{document}</tex-math><mml:math id="M74"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq32.gif"/></alternatives></inline-formula> is the posterior probability of <inline-formula id="IEq33"><alternatives><tex-math id="M75">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _i$$\end{document}</tex-math><mml:math id="M76"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq33.gif"/></alternatives></inline-formula>.</p>
        <p id="Par31">As we will see, the likelihood in Eq. <xref rid="Equ5" ref-type="disp-formula">5</xref> is actually a marginal likelihood because each model (i.e., <inline-formula id="IEq34"><alternatives><tex-math id="M77">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M78"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq34.gif"/></alternatives></inline-formula> and <inline-formula id="IEq35"><alternatives><tex-math id="M79">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M80"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq35.gif"/></alternatives></inline-formula>) contains certain parameters that are integrated out. The denominator in Eq. <xref rid="Equ5" ref-type="disp-formula">5</xref> (labeled marginal likelihood) serves as a normalization constant, ensuring that the sum of the posterior probabilities is 1. Without this normalization constant, the posterior is still proportional to the product of the likelihood and the prior. Therefore, for <inline-formula id="IEq36"><alternatives><tex-math id="M81">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M82"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq36.gif"/></alternatives></inline-formula> and <inline-formula id="IEq37"><alternatives><tex-math id="M83">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M84"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq37.gif"/></alternatives></inline-formula> we can also write:<disp-formula id="Equ6"><label>6</label><alternatives><tex-math id="M85">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} p \left( \mathcal {H} _i \mid D \right) \propto p \left( D \mid \mathcal {H} _i \right) p \left( \mathcal {H} _i \right) \text {,} \end{aligned}$$\end{document}</tex-math><mml:math id="M86" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced><mml:mo>∝</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mtext>,</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ6.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq38"><alternatives><tex-math id="M87">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\propto$$\end{document}</tex-math><mml:math id="M88"><mml:mo>∝</mml:mo></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq38.gif"/></alternatives></inline-formula> means “is proportional to”.</p>
        <p id="Par32">Rather than using posterior probabilities for each hypothesis, let the ratio of the posterior probabilities for <inline-formula id="IEq39"><alternatives><tex-math id="M89">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M90"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq39.gif"/></alternatives></inline-formula> and <inline-formula id="IEq40"><alternatives><tex-math id="M91">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M92"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq40.gif"/></alternatives></inline-formula> be:<disp-formula id="Equ7"><label>7</label><alternatives><tex-math id="M93">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \underbrace{\frac{p \left( \mathcal {H} _0 \mid D \right) }{p \left( \mathcal {H} _1 \mid D \right) }}_{\text {Posterior odds}} = \underbrace{\frac{p \left( D \mid \mathcal {H} _0 \right) }{p \left( D \mid \mathcal {H} _1 \right) }}_{\text {Bayes factor,} ~ \text {BF}_{01}} \underbrace{\frac{p \left( \mathcal {H} _0 \right) }{p \left( \mathcal {H} _1 \right) }}_{\text {Prior odds}} \text {.} \end{aligned}$$\end{document}</tex-math><mml:math id="M94" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:munder><mml:munder accentunder="true"><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>⏟</mml:mo></mml:munder><mml:mrow><mml:mtext>Posterior odds</mml:mtext></mml:mrow></mml:munder><mml:mo>=</mml:mo><mml:munder><mml:munder accentunder="true"><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>⏟</mml:mo></mml:munder><mml:mrow><mml:mtext>Bayes factor,</mml:mtext><mml:mspace width="3.33333pt"/><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub></mml:mrow></mml:munder><mml:munder><mml:munder accentunder="true"><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>⏟</mml:mo></mml:munder><mml:mrow><mml:mtext>Prior odds</mml:mtext></mml:mrow></mml:munder><mml:mtext>.</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ7.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par33">The quantity <inline-formula id="IEq41"><alternatives><tex-math id="M95">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _0 \mid D \right) /p \left( \mathcal {H} _1 \mid D \right)$$\end{document}</tex-math><mml:math id="M96"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced><mml:mo stretchy="false">/</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq41.gif"/></alternatives></inline-formula> represents the posterior odds and the quantity <inline-formula id="IEq42"><alternatives><tex-math id="M97">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _0 \right) /p \left( \mathcal {H} _1 \right)$$\end{document}</tex-math><mml:math id="M98"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mo stretchy="false">/</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq42.gif"/></alternatives></inline-formula> is called the prior odds. To get the posterior odds, we have to multiply the prior odds with <inline-formula id="IEq43"><alternatives><tex-math id="M99">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( D \mid \mathcal {H} _0 \right) /p \left( D \mid \mathcal {H} _1 \right)$$\end{document}</tex-math><mml:math id="M100"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mo stretchy="false">/</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq43.gif"/></alternatives></inline-formula>, a quantity known as the Bayes factor [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR36">36</xref>], which is a ratio of marginal likelihoods:<disp-formula id="Equ8"><label>8</label><alternatives><tex-math id="M101">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \text {BF}_{01}= \frac{\int _{\varvec{\theta } _0} p \left( D \mid \varvec{\theta } _0, \mathcal {H} _0 \right) p \left( \varvec{\theta } _0 \mid \mathcal {H} _0 \right) d \varvec{\theta } _0}{\int _{\varvec{\theta } _1} p \left( D \mid \varvec{\theta } _1, \mathcal {H} _1 \right) p \left( \varvec{\theta } _1 \mid \mathcal {H} _1 \right) d \varvec{\theta } _1} \text {,} \end{aligned}$$\end{document}</tex-math><mml:math id="M102" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mo>∫</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>0</mml:mn></mml:msub></mml:msub><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>0</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mo>∫</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub></mml:msub><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mtext>,</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ8.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq44"><alternatives><tex-math id="M103">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\varvec{\theta } _0$$\end{document}</tex-math><mml:math id="M104"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq44.gif"/></alternatives></inline-formula> and <inline-formula id="IEq45"><alternatives><tex-math id="M105">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\varvec{\theta } _1$$\end{document}</tex-math><mml:math id="M106"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq45.gif"/></alternatives></inline-formula> are vectors of parameters under <inline-formula id="IEq46"><alternatives><tex-math id="M107">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M108"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq46.gif"/></alternatives></inline-formula> and <inline-formula id="IEq47"><alternatives><tex-math id="M109">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M110"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq47.gif"/></alternatives></inline-formula>, respectively. In other words, the marginal likelihoods in the numerator and denominator of Eq. <xref rid="Equ8" ref-type="disp-formula">8</xref> are weighted averages of the likelihoods, for which the weights are determined by the corresponding prior. In the case where one hypothesis has fixed values for the parameter vector <inline-formula id="IEq48"><alternatives><tex-math id="M111">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\varvec{\theta } _i$$\end{document}</tex-math><mml:math id="M112"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq48.gif"/></alternatives></inline-formula> (e.g., a point null hypothesis), integration over the parameter space and the specification of a prior is not required. In that case, the marginal likelihood becomes a likelihood.</p>
        <p id="Par34">The Bayes factor is the amount by which we would update our prior odds to obtain the posterior odds, after taking into consideration the data. For example, if we had prior odds of 2 and the Bayes factor is 24, then the posterior odds would be 48. In the special case where the prior odds is 1, the Bayes factor is equal to the posterior odds. A major advantage of the Bayes factor is its ease of interpretation. For example, if the Bayes factor (<inline-formula id="IEq49"><alternatives><tex-math id="M113">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{01}$$\end{document}</tex-math><mml:math id="M114"><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq49.gif"/></alternatives></inline-formula>, denoting the fact that <inline-formula id="IEq50"><alternatives><tex-math id="M115">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M116"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq50.gif"/></alternatives></inline-formula> is in the numerator and <inline-formula id="IEq51"><alternatives><tex-math id="M117">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M118"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq51.gif"/></alternatives></inline-formula> in the denominator) equals 10, the data are ten times more likely to have occurred under <inline-formula id="IEq52"><alternatives><tex-math id="M119">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M120"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq52.gif"/></alternatives></inline-formula> compared to <inline-formula id="IEq53"><alternatives><tex-math id="M121">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M122"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq53.gif"/></alternatives></inline-formula>. With <inline-formula id="IEq54"><alternatives><tex-math id="M123">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{01}=0.2$$\end{document}</tex-math><mml:math id="M124"><mml:mrow><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.2</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq54.gif"/></alternatives></inline-formula>, we can say that the data are five times more likely under <inline-formula id="IEq55"><alternatives><tex-math id="M125">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M126"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq55.gif"/></alternatives></inline-formula> compared to <inline-formula id="IEq56"><alternatives><tex-math id="M127">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M128"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq56.gif"/></alternatives></inline-formula> because we can simply take the reciprocal of <inline-formula id="IEq57"><alternatives><tex-math id="M129">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{01}$$\end{document}</tex-math><mml:math id="M130"><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq57.gif"/></alternatives></inline-formula> (i.e., <inline-formula id="IEq58"><alternatives><tex-math id="M131">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{10}=1/\text {BF}_{01}$$\end{document}</tex-math><mml:math id="M132"><mml:mrow><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>10</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq58.gif"/></alternatives></inline-formula>). What constitutes enough evidence is subjective and certainly depends on the context. Nevertheless, rules of thumb for evidence thresholds have been proposed. For instance, [<xref ref-type="bibr" rid="CR36">36</xref>] labeled Bayes factors between 1 and 3 as “not worth more than a bare mention”, Bayes factors between 3 and 20 as “positive”, those between 20 and 150 as “strong”, and anything above 150 as “very strong”, with corresponding thresholds for the reciprocals of the Bayes factors. An alternative classification scheme was already proposed before, with thresholds at 3, 10, 30, and 100 and similar labels [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR80">80</xref>].</p>
        <p id="Par35">Of course, we need to define <inline-formula id="IEq59"><alternatives><tex-math id="M133">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M134"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq59.gif"/></alternatives></inline-formula> and <inline-formula id="IEq60"><alternatives><tex-math id="M135">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M136"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq60.gif"/></alternatives></inline-formula>. In other words, both models contain certain parameters for which we need to determine a prior distribution. Here, we will assume that the residuals of the two groups are Normal distributed in the population with a common population variance. The shape of a Normal distribution is fully determined with the location (mean; <inline-formula id="IEq61"><alternatives><tex-math id="M137">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mu$$\end{document}</tex-math><mml:math id="M138"><mml:mi>μ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq61.gif"/></alternatives></inline-formula>) and the scale (variance; <inline-formula id="IEq62"><alternatives><tex-math id="M139">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma ^2$$\end{document}</tex-math><mml:math id="M140"><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq62.gif"/></alternatives></inline-formula>) parameters. Thus, in principle, both models contain two parameters. Now, we make two important changes.</p>
        <p id="Par36">First, in the case where we have a point null hypothesis, <inline-formula id="IEq63"><alternatives><tex-math id="M141">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mu$$\end{document}</tex-math><mml:math id="M142"><mml:mi>μ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq63.gif"/></alternatives></inline-formula> under <inline-formula id="IEq64"><alternatives><tex-math id="M143">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M144"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq64.gif"/></alternatives></inline-formula> is fixed at <inline-formula id="IEq65"><alternatives><tex-math id="M145">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta = 0$$\end{document}</tex-math><mml:math id="M146"><mml:mrow><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq65.gif"/></alternatives></inline-formula>, leaving <inline-formula id="IEq66"><alternatives><tex-math id="M147">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma ^2$$\end{document}</tex-math><mml:math id="M148"><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq66.gif"/></alternatives></inline-formula> for <inline-formula id="IEq67"><alternatives><tex-math id="M149">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M150"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq67.gif"/></alternatives></inline-formula> and <inline-formula id="IEq68"><alternatives><tex-math id="M151">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mu$$\end{document}</tex-math><mml:math id="M152"><mml:mi>μ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq68.gif"/></alternatives></inline-formula> and <inline-formula id="IEq69"><alternatives><tex-math id="M153">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma ^2$$\end{document}</tex-math><mml:math id="M154"><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq69.gif"/></alternatives></inline-formula> for <inline-formula id="IEq70"><alternatives><tex-math id="M155">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M156"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq70.gif"/></alternatives></inline-formula>. Parameter <inline-formula id="IEq71"><alternatives><tex-math id="M157">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma ^2$$\end{document}</tex-math><mml:math id="M158"><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq71.gif"/></alternatives></inline-formula> is a nuisance parameter because it is common to both models. Placing a Jeffreys prior (also called right Haar prior), <inline-formula id="IEq72"><alternatives><tex-math id="M159">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \sigma ^2 \right) \propto 1/ \sigma ^2$$\end{document}</tex-math><mml:math id="M160"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mfenced><mml:mo>∝</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq72.gif"/></alternatives></inline-formula>, on this nuisance parameter [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR81">81</xref>] has several desirable properties that are explained elsewhere (e.g., [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>]).</p>
        <p id="Par37">Second, <inline-formula id="IEq73"><alternatives><tex-math id="M161">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mu$$\end{document}</tex-math><mml:math id="M162"><mml:mi>μ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq73.gif"/></alternatives></inline-formula> under <inline-formula id="IEq74"><alternatives><tex-math id="M163">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M164"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq74.gif"/></alternatives></inline-formula> can be expressed in terms of a population effect size <inline-formula id="IEq75"><alternatives><tex-math id="M165">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M166"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq75.gif"/></alternatives></inline-formula> [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR81">81</xref>]. This establishes a common and comparable scale across experiments and populations [<xref ref-type="bibr" rid="CR67">67</xref>]. The prior on <inline-formula id="IEq76"><alternatives><tex-math id="M167">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M168"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq76.gif"/></alternatives></inline-formula> could reflect certain hypotheses that we want to test. For instance, we could compare the null hypothesis (<inline-formula id="IEq77"><alternatives><tex-math id="M169">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0 {:}\ \delta = 0$$\end{document}</tex-math><mml:math id="M170"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq77.gif"/></alternatives></inline-formula>) to a two-sided alternative hypotheses (<inline-formula id="IEq78"><alternatives><tex-math id="M171">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1 {:}\ \delta \ne 0$$\end{document}</tex-math><mml:math id="M172"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>≠</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq78.gif"/></alternatives></inline-formula>) or to one of two one-sided alternative hypotheses (<inline-formula id="IEq79"><alternatives><tex-math id="M173">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1 {:}\ \delta &lt; 0$$\end{document}</tex-math><mml:math id="M174"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq79.gif"/></alternatives></inline-formula> or <inline-formula id="IEq80"><alternatives><tex-math id="M175">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1 {:}\ \delta &gt; 0$$\end{document}</tex-math><mml:math id="M176"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq80.gif"/></alternatives></inline-formula>). Alternatively, we could compare an interval hypothesis for the null hypothesis (<inline-formula id="IEq81"><alternatives><tex-math id="M177">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0 {:}\ -c&lt; \delta &lt; c$$\end{document}</tex-math><mml:math id="M178"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>δ</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq81.gif"/></alternatives></inline-formula>) with a corresponding alternative hypothesis (<inline-formula id="IEq82"><alternatives><tex-math id="M179">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1 {:}\ \delta &lt; -c ~ \text {OR} ~ \delta &gt; c$$\end{document}</tex-math><mml:math id="M180"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&lt;</mml:mo><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mspace width="3.33333pt"/><mml:mtext>OR</mml:mtext><mml:mspace width="3.33333pt"/><mml:mi>δ</mml:mi><mml:mo>&gt;</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq82.gif"/></alternatives></inline-formula>).<xref ref-type="fn" rid="Fn2">2</xref> The choice of the specific prior for <inline-formula id="IEq88"><alternatives><tex-math id="M181">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M182"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq88.gif"/></alternatives></inline-formula> is a delicate matter, which is discussed in the next section.</p>
        <p id="Par38">In the most general case, the Bayes factor (i.e., <inline-formula id="IEq89"><alternatives><tex-math id="M183">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{01}$$\end{document}</tex-math><mml:math id="M184"><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq89.gif"/></alternatives></inline-formula>) can be calculated through division of the posterior odds by the prior odds (i.e., rearranging Eq. <xref rid="Equ7" ref-type="disp-formula">7</xref>):<disp-formula id="Equ9"><label>9</label><alternatives><tex-math id="M185">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \text {BF}_{01}= \frac{\left( \frac{p \left( \mathcal {H} _0 \mid D \right) }{p \left( \mathcal {H} _1 \mid D \right) } \right) }{\left( \frac{p \left( \mathcal {H} _0 \right) }{p \left( \mathcal {H} _1 \right) } \right) } = \frac{\left( \frac{p \left( \mathcal {H} _0 \mid D \right) }{p \left( \mathcal {H} _0 \right) } \right) }{\left( \frac{p \left( \mathcal {H} _1 \mid D \right) }{p \left( \mathcal {H} _1 \right) } \right) } \text {;} \end{aligned}$$\end{document}</tex-math><mml:math id="M186" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced></mml:mfrac><mml:mtext>;</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ9.gif" position="anchor"/></alternatives></disp-formula>accordingly, we can also calculate <inline-formula id="IEq90"><alternatives><tex-math id="M187">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{10}$$\end{document}</tex-math><mml:math id="M188"><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>10</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq90.gif"/></alternatives></inline-formula>:<disp-formula id="Equ10"><label>10</label><alternatives><tex-math id="M189">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \text {BF}_{10}= \frac{\left( \frac{p \left( \mathcal {H} _1 \mid D \right) }{p \left( \mathcal {H} _0 \mid D \right) } \right) }{\left( \frac{p \left( \mathcal {H} _1 \right) }{p \left( \mathcal {H} _0 \right) } \right) } = \frac{\left( \frac{p \left( \mathcal {H} _1 \mid D \right) }{p \left( \mathcal {H} _1 \right) } \right) }{\left( \frac{p \left( \mathcal {H} _0 \mid D \right) }{p \left( \mathcal {H} _0 \right) } \right) } \text {.} \end{aligned}$$\end{document}</tex-math><mml:math id="M190" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>10</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced></mml:mfrac><mml:mtext>.</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ10.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par39">Calculating Bayes factors this way often involves solving complex integrals (see, e.g., Eq. <xref rid="Equ8" ref-type="disp-formula">8</xref>; also cf. [<xref ref-type="bibr" rid="CR76">76</xref>]). Fortunately, there is a computational shortcut for the specific but very common scenario where we have a point null hypothesis and a complementary interval alternative hypothesis. This shortcut, which is called the Savage-Dickey density ratio, takes the ratio of the density of the prior and posterior at the null value under the alternative hypothesis to calculate the Bayes factor; this is explained in more detail elsewhere [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR85">85</xref>].</p>
      </sec>
      <sec id="Sec9">
        <title>Default priors</title>
        <p id="Par40">Until this point in our exposition, we were quite vague about the form of the prior for <inline-formula id="IEq91"><alternatives><tex-math id="M191">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M192"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq91.gif"/></alternatives></inline-formula> under <inline-formula id="IEq92"><alternatives><tex-math id="M193">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M194"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq92.gif"/></alternatives></inline-formula>. In principle, the prior for <inline-formula id="IEq93"><alternatives><tex-math id="M195">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M196"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq93.gif"/></alternatives></inline-formula> within <inline-formula id="IEq94"><alternatives><tex-math id="M197">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M198"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq94.gif"/></alternatives></inline-formula> can be defined as desired, conforming to the beliefs of the researcher. In fact, this is a fundamental part of Bayesian inference because various priors allow for the expression of a theory or prior beliefs [<xref ref-type="bibr" rid="CR86">86</xref>, <xref ref-type="bibr" rid="CR87">87</xref>]. Most commonly, however, default or objective priors are employed that aim to increase the objectivity in specifying the prior or serve as a default when no specific prior information is available [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR88">88</xref>]. We employ objective priors in baymedr.</p>
        <p id="Par41">In the situation where we have a point null hypothesis and an alternative hypothesis that involves a range of values, [<xref ref-type="bibr" rid="CR35">35</xref>] proposed to use a Cauchy prior with a scale parameter of <inline-formula id="IEq95"><alternatives><tex-math id="M199">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$r=1$$\end{document}</tex-math><mml:math id="M200"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq95.gif"/></alternatives></inline-formula> for <inline-formula id="IEq96"><alternatives><tex-math id="M201">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M202"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq96.gif"/></alternatives></inline-formula> under <inline-formula id="IEq97"><alternatives><tex-math id="M203">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M204"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq97.gif"/></alternatives></inline-formula>. This Cauchy distribution is equivalent to a Student’s <italic>t</italic> distribution with 1 degree of freedom and resembles a standard Normal distribution, except that the Cauchy distribution has less mass at the center but instead heavier tails (see Fig. <xref rid="Fig2" ref-type="fig">2</xref>; [<xref ref-type="bibr" rid="CR67">67</xref>]). Mathematically, the Cauchy distribution corresponds to the combined specification of (1) a Normal prior with mean <inline-formula id="IEq98"><alternatives><tex-math id="M205">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mu _ \delta$$\end{document}</tex-math><mml:math id="M206"><mml:msub><mml:mi>μ</mml:mi><mml:mi>δ</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq98.gif"/></alternatives></inline-formula> and variance <inline-formula id="IEq99"><alternatives><tex-math id="M207">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma ^2_ \delta$$\end{document}</tex-math><mml:math id="M208"><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>δ</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq99.gif"/></alternatives></inline-formula> on <inline-formula id="IEq100"><alternatives><tex-math id="M209">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M210"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq100.gif"/></alternatives></inline-formula>; and (2) an inverse Chi-square distribution with 1 degree of freedom on <inline-formula id="IEq101"><alternatives><tex-math id="M211">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma ^2_ \delta$$\end{document}</tex-math><mml:math id="M212"><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>δ</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq101.gif"/></alternatives></inline-formula>. Integrating out <inline-formula id="IEq102"><alternatives><tex-math id="M213">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma ^2_ \delta$$\end{document}</tex-math><mml:math id="M214"><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>δ</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq102.gif"/></alternatives></inline-formula> yields the Cauchy distribution [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR89">89</xref>]. The scale parameter <italic>r</italic> defines the width of the Cauchy distribution; that is, half of the mass lies between –<italic>r</italic> and <italic>r</italic>.<fig id="Fig2"><label>Fig. 2</label><caption><p>Comparison of the standard Normal probability density function (solid line) and the standard Cauchy probability density function (dashed line)</p></caption><graphic xlink:href="12874_2023_2097_Fig2_HTML" id="MO2"/></fig></p>
        <p id="Par42">Choosing a Cauchy prior with a location parameter of 0 and a scale parameter of <inline-formula id="IEq103"><alternatives><tex-math id="M215">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$r=1$$\end{document}</tex-math><mml:math id="M216"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq103.gif"/></alternatives></inline-formula> has the advantage that the resulting Bayes factor is 1 in case of completely uninformative data. In turn, the Bayes factor approaches infinity (or 0) for decisive data [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR82">82</xref>]. Still, by varying the Cauchy scale parameter, we can set a different emphasis on the prior credibility of a range of effect sizes. More recently, a Cauchy prior scale of <inline-formula id="IEq104"><alternatives><tex-math id="M217">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$r=1/ \sqrt{2}$$\end{document}</tex-math><mml:math id="M218"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:msqrt><mml:mn>2</mml:mn></mml:msqrt></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq104.gif"/></alternatives></inline-formula> is used as a default setting in the BayesFactor software [<xref ref-type="bibr" rid="CR39">39</xref>], the point-and-click software JASP [<xref ref-type="bibr" rid="CR41">41</xref>], and Jamovi [<xref ref-type="bibr" rid="CR42">42</xref>]. We have adopted this value in baymedr as a default setting. Nevertheless, objective priors are often criticized (see, e.g., [<xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR91">91</xref>]); researchers are encouraged to use more informed priors if relevant knowledge is available [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR79">79</xref>].</p>
      </sec>
    </sec>
  </sec>
  <sec id="Sec10">
    <title>Implementation</title>
    <p id="Par43">With the baymedr software (BAYesian inference for MEDical designs in R; [<xref ref-type="bibr" rid="CR43">43</xref>]), written in R [<xref ref-type="bibr" rid="CR40">40</xref>], and the corresponding web application (accessible at [<xref ref-type="bibr" rid="CR44">44</xref>]) one can easily calculate Bayes factors for superiority, equivalence, and non-inferiority designs. The R package can be used by researchers who have only rudimentary knowledge of R; if that is not the case, researchers can use the web application, which does not require any knowledge of programming. In the following, we will demonstrate how Bayes factors for superiority, equivalence, and non-inferiority designs can be calculated with the baymedr R package; a thorough explanation of the web application is not necessary as it strongly overlaps with the R package. Subsequently, we will showcase (1) the baymedr R package and (2) the corresponding web application by reanalyzing data of an empirical study by [<xref ref-type="bibr" rid="CR92">92</xref>].</p>
    <sec id="Sec11">
      <title>The R package</title>
      <sec id="Sec12">
        <title>Install and load baymedr</title>
        <p id="Par44">To install the latest release of the baymedr R package from The Comprehensive R Archive Network (CRAN), use the following command: <graphic position="anchor" xlink:href="12874_2023_2097_Figa_HTML" id="MO3"/></p>
        <p id="Par45">The most recent version of the R package can be obtained from GitHub with the help of the devtools package [<xref ref-type="bibr" rid="CR93">93</xref>]: <graphic position="anchor" xlink:href="12874_2023_2097_Figb_HTML" id="MO4"/></p>
        <p id="Par46">Once baymedr is installed, it needs to be loaded into memory, after which it is ready for usage: <graphic position="anchor" xlink:href="12874_2023_2097_Figc_HTML" id="MO5"/></p>
      </sec>
      <sec id="Sec13">
        <title>Commonalities across designs</title>
        <p id="Par47">For all three research designs, the user has three options for data input (function arguments that have “x” as a name or suffix refer to the control condition and those with “y” as a name or suffix to the experimental condition): (1) provide the raw data; the relevant arguments are x and y; (2) provide the sample sizes, sample means, and sample standard deviations; the relevant arguments are n_x and n_y for sample sizes, mean_x and mean_y for sample means, and sd_x and sd_y for sample standard deviations; (3) provide the sample sizes, sample means, and the confidence interval for the difference in group means; the relevant arguments are n_x and n_y for sample sizes, mean_x and mean_y for sample means, and ci_margin for the confidence interval margin and ci_level for the confidence level.</p>
        <p id="Par48">The Cauchy distribution is used as the prior for <inline-formula id="IEq105"><alternatives><tex-math id="M219">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M220"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq105.gif"/></alternatives></inline-formula> under the alternative hypothesis for all three tests. The user can set the width of the Cauchy prior with the prior_scale argument, thus, allowing the specification of different ranges of plausible effect sizes. In all three cases, the Cauchy prior is centered on <inline-formula id="IEq106"><alternatives><tex-math id="M221">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta =0$$\end{document}</tex-math><mml:math id="M222"><mml:mrow><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq106.gif"/></alternatives></inline-formula>. Further, baymedr uses a default Cauchy prior scale of <inline-formula id="IEq107"><alternatives><tex-math id="M223">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$r=1/ \sqrt{2}$$\end{document}</tex-math><mml:math id="M224"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:msqrt><mml:mn>2</mml:mn></mml:msqrt></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq107.gif"/></alternatives></inline-formula>, complying with the standard settings of the BayesFactor software [<xref ref-type="bibr" rid="CR39">39</xref>], JASP [<xref ref-type="bibr" rid="CR41">41</xref>], and Jamovi [<xref ref-type="bibr" rid="CR42">42</xref>].</p>
        <p id="Par49">Once a superiority, equivalence, or non-inferiority test is conducted, an informative and accessible output message is printed in the console. For all three designs, this output states the type of test that was conducted and whether raw or summary data were used. Moreover, the corresponding null and alternative hypotheses are restated and the specified Cauchy prior scale is shown. In addition, the lower and upper bounds of the equivalence interval are presented in case an equivalence test was employed; similarly, the non-inferiority margin is printed when the non-inferiority design was chosen. Lastly, the resulting Bayes factor is shown. To avoid any confusion, it is declared in brackets whether the Bayes factor quantifies evidence towards the null (e.g., equivalence) or alternative (e.g., non-inferiority or superiority) hypothesis.</p>
      </sec>
      <sec id="Sec14">
        <title>Conducting superiority, equivalence and non-inferiority tests</title>
        <p id="Par50">The Bayesian superiority test is performed with the super_bf() function. Depending on the research setting, low or high scores on the measure of interest represent “superiority”, which is specified by the argument direction. Since we seek to find evidence for the alternative hypothesis (superiority), the Bayes factor quantifies evidence for <inline-formula id="IEq108"><alternatives><tex-math id="M225">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M226"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq108.gif"/></alternatives></inline-formula> relative to <inline-formula id="IEq109"><alternatives><tex-math id="M227">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M228"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq109.gif"/></alternatives></inline-formula> (i.e., <inline-formula id="IEq110"><alternatives><tex-math id="M229">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{10}$$\end{document}</tex-math><mml:math id="M230"><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>10</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq110.gif"/></alternatives></inline-formula>).</p>
        <p id="Par51">The Bayesian equivalence test is done with the equiv_bf() function. The desired equivalence interval is specified with the interval argument. Several options are possible: A symmetric equivalence interval around <inline-formula id="IEq111"><alternatives><tex-math id="M231">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta =0$$\end{document}</tex-math><mml:math id="M232"><mml:mrow><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq111.gif"/></alternatives></inline-formula> can be indicated by providing one value (e.g., interval = 0.2) or by providing a vector with the negative and the positive values (e.g., interval = c(-0.2, 0.2)). An asymmetric equivalence interval can be specified by providing a vector with the negative and the positive values (e.g., interval = c(-0.3, 0.2)). The implementation of a point null hypothesis is achieved by using either interval = 0 or interval = c(0, 0), which also serves as the default specification. The argument interval_std can be used to declare whether the equivalence interval was specified in standardized or unstandardized units. Since we seek to quantify evidence towards equivalence, we contrast the evidence for <inline-formula id="IEq112"><alternatives><tex-math id="M233">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M234"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq112.gif"/></alternatives></inline-formula> relative to <inline-formula id="IEq113"><alternatives><tex-math id="M235">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M236"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq113.gif"/></alternatives></inline-formula> (i.e., <inline-formula id="IEq114"><alternatives><tex-math id="M237">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{01}$$\end{document}</tex-math><mml:math id="M238"><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq114.gif"/></alternatives></inline-formula>).</p>
        <p id="Par52">The Bayes factor for the non-inferiority design is calculated with the infer_bf() function. The value for the non-inferiority margin can be specified with the ni_margin argument. The argument ni_margin_std can be used to declare whether the non-inferiority margin was given in standardized or unstandardized units. Lastly, depending on whether high or low values on the measure of interest represent “non-inferiority”, one of the options “high” or “low” should be set for the argument direction. We wish to determine the evidence in favor of <inline-formula id="IEq115"><alternatives><tex-math id="M239">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M240"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq115.gif"/></alternatives></inline-formula>; therefore, the evidence is expressed for <inline-formula id="IEq116"><alternatives><tex-math id="M241">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M242"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq116.gif"/></alternatives></inline-formula> relative to <inline-formula id="IEq117"><alternatives><tex-math id="M243">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M244"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq117.gif"/></alternatives></inline-formula> (i.e., <inline-formula id="IEq118"><alternatives><tex-math id="M245">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{10}$$\end{document}</tex-math><mml:math id="M246"><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>10</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq118.gif"/></alternatives></inline-formula>).</p>
      </sec>
    </sec>
  </sec>
  <sec id="Sec15">
    <title>Results</title>
    <p id="Par53">To illustrate how the R package and the web application can be used, we provide one example of an empirical study that employed non-inferiority tests to investigate differences in the amount of sleep, sleepiness, and alertness among medical trainees following either standard or flexible duty-hour programs [<xref ref-type="bibr" rid="CR92">92</xref>]. The authors list several disadvantages of restricted duty-hour programs, such as: (1) “[t]ransitions [as a result of restricted duty hours] into and out of night shifts can result in fatigue from shift-work-related sleep loss and circadian misalignment”; (2) “[p]reventing interns from participating in extended shifts may reduce educational opportunities”; (3) “increase[d] handoffs”; (4) “reduce[d] continuity of care”; and (5) “[r]estricting duty hours may increase the necessity of cross-coverage, contributing to work compression for both interns and more senior residents” ([<xref ref-type="bibr" rid="CR92">92</xref>], p.916). As outlined above, the calculation of Bayes factors for equivalence and superiority tests is done quite similarly to the non-inferiority test, so we do not provide specific examples for those tests. For the purpose of this demonstration, we will only consider the outcome variable sleepiness. Participants were monitored over a period of 14 days and were asked to indicate each morning how sleepy they were by completing the Karolinska sleepiness scale [<xref ref-type="bibr" rid="CR94">94</xref>], a 9-point Likert scale ranging from 1 (extremely alert) to 9 (extremely sleepy, fighting sleep). The dependent variable consisted of the average sleepiness score over the whole observation period of 14 days. The research question was whether the flexible duty-hour program was non-inferior to the standard program in terms of sleepiness.</p>
    <p id="Par54">The null hypothesis was that medical trainees in the flexible program are sleepier by more than a non-inferiority margin than trainees in the standard program. Conversely, the alternative hypothesis was that trainees in the flexible program are not sleepier by more than a non-inferiority margin than trainees in the standard program. The non-inferiority margin was defined as 1 point on the 9-point Likert scale. All relevant summary statistics can be obtained or calculated from Table 1 of [<xref ref-type="bibr" rid="CR92">92</xref>] and the Results section of [<xref ref-type="bibr" rid="CR92">92</xref>]. Table 1 of [<xref ref-type="bibr" rid="CR92">92</xref>] indicates that the flexible program had a mean of <inline-formula id="IEq119"><alternatives><tex-math id="M247">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$M_e=4.8$$\end{document}</tex-math><mml:math id="M248"><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>4.8</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq119.gif"/></alternatives></inline-formula> and the standard program had a mean of <inline-formula id="IEq120"><alternatives><tex-math id="M249">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$M_c=4.7$$\end{document}</tex-math><mml:math id="M250"><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>4.7</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq120.gif"/></alternatives></inline-formula>. From the Results section of [<xref ref-type="bibr" rid="CR92">92</xref>], we can extract that sample sizes were <inline-formula id="IEq121"><alternatives><tex-math id="M251">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n_e=205$$\end{document}</tex-math><mml:math id="M252"><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>205</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq121.gif"/></alternatives></inline-formula> and <inline-formula id="IEq122"><alternatives><tex-math id="M253">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n_c=193$$\end{document}</tex-math><mml:math id="M254"><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>193</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq122.gif"/></alternatives></inline-formula> in the flexible and standard programs, respectively. Further, the margin of the <inline-formula id="IEq123"><alternatives><tex-math id="M255">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$95 \%$$\end{document}</tex-math><mml:math id="M256"><mml:mrow><mml:mn>95</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq123.gif"/></alternatives></inline-formula> CI of the difference between the two conditions was <inline-formula id="IEq124"><alternatives><tex-math id="M257">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$0.31-0.12=0.19$$\end{document}</tex-math><mml:math id="M258"><mml:mrow><mml:mn>0.31</mml:mn><mml:mo>-</mml:mo><mml:mn>0.12</mml:mn><mml:mo>=</mml:mo><mml:mn>0.19</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq124.gif"/></alternatives></inline-formula>. Finally, lower scores on the sleepiness scale constitute favorable (non-inferior) outcomes.</p>
    <sec id="Sec16">
      <title>The R package</title>
      <p id="Par55">Using this information, we can use the baymedr R package to calculate the Bayes factor as follows: <graphic position="anchor" xlink:href="12874_2023_2097_Figd_HTML" id="MO6"/></p>
      <p id="Par56">Note that we decided to use a Cauchy prior scale of <inline-formula id="IEq125"><alternatives><tex-math id="M259">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$r=1/ \sqrt{2}$$\end{document}</tex-math><mml:math id="M260"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:msqrt><mml:mn>2</mml:mn></mml:msqrt></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq125.gif"/></alternatives></inline-formula> for this reanalysis. Since our Cauchy prior scale of choice represents the default value in baymedr, it would not have been necessary to provide this argument; however, for purposes of illustration, we mentioned it explicitly in the function call.</p>
      <p id="Par57">The output provides a user-friendly summary of the analysis: <graphic position="anchor" xlink:href="12874_2023_2097_Fige_HTML" id="MO7"/></p>
      <p id="Par58">This large Bayes factor supports the conclusion from [<xref ref-type="bibr" rid="CR92">92</xref>] that medical trainees in the flexible duty-hour program are non-inferior in terms of sleepiness compared to medical trainees in the standard program (<inline-formula id="IEq126"><alternatives><tex-math id="M261">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p&lt;.001$$\end{document}</tex-math><mml:math id="M262"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mo>.</mml:mo><mml:mn>001</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq126.gif"/></alternatives></inline-formula>). In other words, the data are <inline-formula id="IEq127"><alternatives><tex-math id="M263">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$8.56 \times {10}^{10}$$\end{document}</tex-math><mml:math id="M264"><mml:mrow><mml:mn>8.56</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>10</mml:mn></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq127.gif"/></alternatives></inline-formula> more likely to have occurred under <inline-formula id="IEq128"><alternatives><tex-math id="M265">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M266"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq128.gif"/></alternatives></inline-formula> than <inline-formula id="IEq129"><alternatives><tex-math id="M267">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M268"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq129.gif"/></alternatives></inline-formula>.</p>
    </sec>
    <sec id="Sec17">
      <title>The web application</title>
      <p id="Par59">Similarly, we can use the web application to calculate the Bayes factor. For this, the web application should first be opened in a web browser (available at [<xref ref-type="bibr" rid="CR44">44</xref>]). The just-opened welcome page offers a brief description of the three research designs and Bayes factors and lists several further useful resources for the interested user. Since we want to conduct a non-inferiority test with summary data, we click on “Non-inferiority” and then “Summary data” on the navigation bar at the top (see Fig. <xref rid="Fig3" ref-type="fig">3</xref>). The summary statistics for the example reanalysis of [<xref ref-type="bibr" rid="CR92">92</xref>] can be inserted in the corresponding fields, as shown in Fig. <xref rid="Fig3" ref-type="fig">3</xref>. For some fields a small green question mark is shown, which provides more details and help when the user clicks on them. Furthermore, the scale of the prior distribution can be specified, which by default is set to 1 / sqrt(2). A small dynamic plot accompanies the field for the Cauchy prior scale. That is, once the prior scale is changed, the plot updates automatically, so that users obtain an impression of what the distribution looks like and what effect sizes are included. Once the “Calculate Bayes factor” button is clicked, the output is displayed.<fig id="Fig3"><label>Fig. 3</label><caption><p>Shown is part of the baymedr web application demonstrating how summary statistics can be inserted and further parameters specified for a Bayesian non-inferiority test. In this specific case, the summary statistics correspond to the ones obtained from [<xref ref-type="bibr" rid="CR92">92</xref>]. See text for details</p></caption><graphic xlink:href="12874_2023_2097_Fig3_HTML" id="MO8"/></fig></p>
      <p id="Par60">Figure <xref rid="Fig4" ref-type="fig">4</xref> shows the output of the calculations. The top of the left column displays the same output that is given with the R package. Further, upon clicking on “Show frequentist results”, the results of the frequentist non-inferiority test are shown and clicking on “Hide frequentist results” in turn hides those results. Below that output is the formula for the Bayes factor, with different elements printed in colors that correspond to dots in matching colors in the plots on the right column of the results output. The upper plot shows the prior and posterior for contrasting <inline-formula id="IEq130"><alternatives><tex-math id="M269">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0{:}\ \delta = c$$\end{document}</tex-math><mml:math id="M270"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq130.gif"/></alternatives></inline-formula> with <inline-formula id="IEq131"><alternatives><tex-math id="M271">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1{:}\ \delta &lt; c$$\end{document}</tex-math><mml:math id="M272"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq131.gif"/></alternatives></inline-formula>. The two distributions are truncated, meaning that they are cut off at <inline-formula id="IEq132"><alternatives><tex-math id="M273">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta = c$$\end{document}</tex-math><mml:math id="M274"><mml:mrow><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq132.gif"/></alternatives></inline-formula>. Similarly, the lower plot shows the truncated prior and posterior for contrasting <inline-formula id="IEq133"><alternatives><tex-math id="M275">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0{:}\ \delta = c$$\end{document}</tex-math><mml:math id="M276"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq133.gif"/></alternatives></inline-formula> with <inline-formula id="IEq134"><alternatives><tex-math id="M277">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1{:}\ \delta &gt; c$$\end{document}</tex-math><mml:math id="M278"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&gt;</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq134.gif"/></alternatives></inline-formula>. Through a heuristic called the Savage-Dickey density ratio [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR85">85</xref>], the ratio of the heights of the colored dots gives us the Bayes factor (see the colored expressions in the formula on the right side of the results output). The text above the two plots explains the plots as well.<fig id="Fig4"><label>Fig. 4</label><caption><p>Shown is part of the baymedr web application showing the results of a Bayesian non-inferiority test. In this specific case, the results correspond to a reanalysis using summary statistics obtained from [<xref ref-type="bibr" rid="CR92">92</xref>]. See text for details</p></caption><graphic xlink:href="12874_2023_2097_Fig4_HTML" id="MO9"/></fig></p>
    </sec>
  </sec>
  <sec id="Sec18">
    <title>Conclusions</title>
    <p id="Par61">Tests of superiority, equivalence, and non-inferiority are important means to compare the effectiveness of medications and treatments in biomedical research. Despite several limitations, researchers overwhelmingly rely on traditional frequentist inference to analyze the corresponding data for these research designs [<xref ref-type="bibr" rid="CR5">5</xref>]. Bayes factors [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR36">36</xref>] are an attractive alternative to NHST and <italic>p</italic>-values because they allow researchers to quantify evidence in favor of the null hypothesis [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>] and permit sequential testing and optional stopping [<xref ref-type="bibr" rid="CR60">60</xref>–<xref ref-type="bibr" rid="CR62">62</xref>]. In fact, the possibility for optional stopping and sequential testing has the potential to largely reduce the waste of scarce resources. This is especially important in the field of biomedicine, where clinical trials might be expensive or even harmful for participants.</p>
    <p id="Par62">Although Bayes factors have many advantages over NHST, they bring along their own challenges (for a discussion, see [<xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR96">96</xref>]). For instance, the choice of the prior distribution can have a large impact on the resulting Bayes factor [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR86">86</xref>, <xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR91">91</xref>, <xref ref-type="bibr" rid="CR97">97</xref>, <xref ref-type="bibr" rid="CR98">98</xref>]. In the extreme case, the Bayes factor and results from frequentist analyses can lead to diverging conclusions, something known as Lindley’s paradox [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR99">99</xref>]. Thus, the choice of prior distribution is important but subjective and often difficult to make. Most of the time, however, Bayes factors and results from NHST are in agreement [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. Related to that, misspecification of the model might lead to erroneous and misleading conclusions. That is, a Bayes factor only makes a comparison of the models under investigation (i.e., <inline-formula id="IEq135"><alternatives><tex-math id="M279">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M280"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq135.gif"/></alternatives></inline-formula> and <inline-formula id="IEq136"><alternatives><tex-math id="M281">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M282"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq136.gif"/></alternatives></inline-formula>). If these models are inadequate or do not fulfill certain assumptions (e.g., Normality of residuals), the Bayes factor might not be trustworthy. Moreover, the Bayes factor is not immune to misinterpretations: [<xref ref-type="bibr" rid="CR100">100</xref>] have shown that among the most common false interpretations of Bayes factors are the interpretation of a Bayes factor as posterior odds (i.e., a ratio of probabilities in favor of or against <inline-formula id="IEq137"><alternatives><tex-math id="M283">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M284"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq137.gif"/></alternatives></inline-formula> and <inline-formula id="IEq138"><alternatives><tex-math id="M285">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M286"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq138.gif"/></alternatives></inline-formula>) and ignoring that Bayes factors only provide relative instead of absolute evidence (see also [<xref ref-type="bibr" rid="CR90">90</xref>]). Lastly, the computation of Bayes factors is complex and involves solving integrals [<xref ref-type="bibr" rid="CR90">90</xref>]. For this reason, easy-to-use software is needed.</p>
    <p id="Par63">Our baymedr R package and web application [<xref ref-type="bibr" rid="CR43">43</xref>] enable researchers to conduct Bayesian superiority, equivalence, and non-inferiority tests. baymedr is characterized by a user-friendly implementation, making it convenient for researchers who are not statistical experts. Furthermore, using baymedr, it is possible to calculate Bayes factors based on raw data and summary statistics, allowing for the reanalysis of published studies, for which the full data set is not available. To further promote the use of Bayesian statistics in biomedical research, more easy-to-use software and tutorial papers are urgently needed.</p>
  </sec>
  <sec id="Sec19">
    <title>Availability and requirements</title>
    <p id="Par64">Project name: baymedr</p>
    <p id="Par65">Project home page: <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/baymedr/index.html">https://cran.r-project.org/web/packages/baymedr/index.html</ext-link></p>
    <p id="Par66">Operating system(s): Platform independent</p>
    <p id="Par67">Programming language: R</p>
    <p id="Par68">Other requirements: Not applicable.</p>
    <p id="Par69">License: GPL-3</p>
    <p id="Par70">Any restrictions to use by non-academics: Not applicable.</p>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>NHST</term>
        <def>
          <p id="Par4">Null hypothesis significance testing</p>
        </def>
      </def-item>
      <def-item>
        <term>TOST</term>
        <def>
          <p id="Par5">Two one-sided tests</p>
        </def>
      </def-item>
      <def-item>
        <term>CRAN</term>
        <def>
          <p id="Par6">Comprehensive R Archive Network</p>
        </def>
      </def-item>
      <def-item>
        <term>CI</term>
        <def>
          <p id="Par7">Confidence interval</p>
        </def>
      </def-item>
      <def-item>
        <term>Fig</term>
        <def>
          <p id="Par8">Figure</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn id="Fn1">
      <label>1</label>
      <p id="Par74">Researchers often conduct a two-sided <italic>t</italic>-test and then confirm that the observed effect goes in the expected direction. We do not describe this approach because we have the opinion that a one-sided <italic>t</italic>-test should be conducted for the superiority test, whose name already implies a uni-directional alternative hypothesis.</p>
    </fn>
    <fn id="Fn2">
      <label>2</label>
      <p id="Par75">Note that the hypotheses represent exactly the opposite of the hypotheses in TOST (i.e., <inline-formula id="IEq83"><alternatives><tex-math id="M287">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M288"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq83.gif"/></alternatives></inline-formula> of equivalence corresponds to <inline-formula id="IEq84"><alternatives><tex-math id="M289">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M290"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq84.gif"/></alternatives></inline-formula> of equivalence in TOST, and vice versa). Evidence in favor of equivalence in TOST can only be obtained by rejecting two null hypotheses: <inline-formula id="IEq85"><alternatives><tex-math id="M291">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0 {:}\ \delta &lt; -c$$\end{document}</tex-math><mml:math id="M292"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&lt;</mml:mo><mml:mo>-</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq85.gif"/></alternatives></inline-formula> and <inline-formula id="IEq86"><alternatives><tex-math id="M293">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0 {:}\ \delta &gt; c$$\end{document}</tex-math><mml:math id="M294"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&gt;</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq86.gif"/></alternatives></inline-formula>. For the Bayesian equivalence test we use the more intuitive null hypothesis of equivalence (i.e., <inline-formula id="IEq87"><alternatives><tex-math id="M295">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0 {:}\ -c&lt; \delta &lt; c$$\end{document}</tex-math><mml:math id="M296"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>δ</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq87.gif"/></alternatives></inline-formula>).</p>
    </fn>
    <fn>
      <p>
        <bold>Publisher’s Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>Not applicable.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>ML and DvR jointly conceptualized the project. ML wrote the first draft of the manuscript, implemented the software, and conducted the analyses. DvR edited the manuscript and tested the software. All authors have read and approved the manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>Open Access funding enabled and organized by Projekt DEAL. This research was supported by a Dutch scientific organization VIDI fellowship grant awarded to Don van Ravenzwaaij (016.Vidi.188.001). The funder was not involved in the design of the study, collection, analysis, and interpretation of data, or writing.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>Not applicable.</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar1">
      <title>Ethics approval and consent to participate</title>
      <p id="Par71">Not applicable.</p>
    </notes>
    <notes id="FPar2">
      <title>Consent for publication</title>
      <p id="Par72">Not applicable.</p>
    </notes>
    <notes id="FPar3" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par73">The authors declare that they have no competing interests.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Christensen</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Methodology of Superiority vs. Equivalence Trials and Non-Inferiority Trials</article-title>
        <source>J Hepatol.</source>
        <year>2007</year>
        <volume>46</volume>
        <issue>5</issue>
        <fpage>947</fpage>
        <lpage>954</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jhep.2007.02.015</pub-id>
        <?supplied-pmid 17412447?>
        <pub-id pub-id-type="pmid">17412447</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Friedman</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Furberg</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>DeMets</surname>
            <given-names>DL</given-names>
          </name>
          <name>
            <surname>Reboussin</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Granger</surname>
            <given-names>CB</given-names>
          </name>
        </person-group>
        <source>Fundamentals of Clinical Trials</source>
        <year>2010</year>
        <edition>4</edition>
        <publisher-loc>New York</publisher-loc>
        <publisher-name>Springer</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lesaffre</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Superiority, Equivalence, and Non-inferiority Trials</article-title>
        <source>Bull NYU Hosp Joint Dis.</source>
        <year>2008</year>
        <volume>66</volume>
        <issue>2</issue>
        <fpage>150</fpage>
        <lpage>154</lpage>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Piaggio</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Elbourne</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Pocock</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Evans</surname>
            <given-names>SJW</given-names>
          </name>
          <name>
            <surname>Altman</surname>
            <given-names>DG</given-names>
          </name>
        </person-group>
        <article-title>Reporting of Noninferiority and Equivalence Randomized Trials</article-title>
        <source>J Am Med Assoc.</source>
        <year>2012</year>
        <volume>308</volume>
        <issue>24</issue>
        <fpage>2594</fpage>
        <lpage>2604</lpage>
        <pub-id pub-id-type="doi">10.1001/jama.2012.87802</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chavalarias</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Wallach</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>AHT</given-names>
          </name>
          <name>
            <surname>Ioannidis</surname>
            <given-names>JPA</given-names>
          </name>
        </person-group>
        <article-title>Evolution of Reporting p Values in the Biomedical Literature, 1990–2015</article-title>
        <source>J Am Med Assoc.</source>
        <year>2016</year>
        <volume>315</volume>
        <issue>11</issue>
        <fpage>1141</fpage>
        <lpage>1148</lpage>
        <pub-id pub-id-type="doi">10.1001/jama.2016.1952</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Christensen</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Testing Fisher, Neyman, Pearson, and Bayes</article-title>
        <source>Am Stat.</source>
        <year>2005</year>
        <volume>59</volume>
        <issue>2</issue>
        <fpage>121</fpage>
        <lpage>126</lpage>
        <pub-id pub-id-type="doi">10.1198/000313005X20871</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Benjamin</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Berger</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Johannesson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nosek</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Berk</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Redefine Statistical Significance</article-title>
        <source>Nat Hum Behav.</source>
        <year>2018</year>
        <volume>2</volume>
        <issue>1</issue>
        <fpage>6</fpage>
        <lpage>10</lpage>
        <pub-id pub-id-type="doi">10.1038/s41562-017-0189-z</pub-id>
        <?supplied-pmid 30980045?>
        <pub-id pub-id-type="pmid">30980045</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lakens</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Adolfi</surname>
            <given-names>FG</given-names>
          </name>
          <name>
            <surname>Albers</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Anvari</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Apps</surname>
            <given-names>MAJ</given-names>
          </name>
          <name>
            <surname>Argamon</surname>
            <given-names>SE</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Justify Your Alpha</article-title>
        <source>Nat Hum Behav.</source>
        <year>2018</year>
        <volume>2</volume>
        <issue>3</issue>
        <fpage>168</fpage>
        <lpage>171</lpage>
        <pub-id pub-id-type="doi">10.1038/s41562-018-0311-x</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berger</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Sellke</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Testing a Point Null Hypothesis: The Irreconcilability of p Values and Evidence</article-title>
        <source>J Am Stat Assoc.</source>
        <year>1987</year>
        <volume>82</volume>
        <issue>397</issue>
        <fpage>112</fpage>
        <lpage>122</lpage>
        <pub-id pub-id-type="doi">10.2307/2289131</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <mixed-citation publication-type="other">Cohen J. The Earth Is Round (p <inline-formula id="IEq141"><alternatives><tex-math id="M297">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$&lt;$$\end{document}</tex-math><mml:math id="M298"><mml:mo>&lt;</mml:mo></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq141.gif"/></alternatives></inline-formula> .05). Am Psychol. 1994;49(12):997–1003. 10.1037/0003-066X.49.12.997.</mixed-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dienes</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Versus Orthodox Statistics: Which Side Are You on?</article-title>
        <source>Perspect Psychol Sci.</source>
        <year>2011</year>
        <volume>6</volume>
        <issue>3</issue>
        <fpage>274</fpage>
        <lpage>290</lpage>
        <pub-id pub-id-type="doi">10.1177/1745691611406920</pub-id>
        <?supplied-pmid 26168518?>
        <pub-id pub-id-type="pmid">26168518</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Gigerenzer</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Krauss</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Vitouch</surname>
            <given-names>O</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Kaplan</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>The Null Ritual: What You Always Wanted to Know about Significance Testing but Were Afraid to Ask</article-title>
        <source>The Sage Handbook of Quantitative Methodology for the Social Sciences</source>
        <year>2004</year>
        <publisher-loc>Thousand Oaks</publisher-loc>
        <publisher-name>Sage</publisher-name>
        <fpage>391</fpage>
        <lpage>408</lpage>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <mixed-citation publication-type="other">Goodman SN. Toward Evidence-based Medical Statistics. 1: The p Value Fallacy. Ann Intern Med. 1999;130(12):995–1004. 10.7326/0003-4819-130-12-199906150-00008.</mixed-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Goodman</surname>
            <given-names>SN</given-names>
          </name>
        </person-group>
        <article-title>A Dirty Dozen: Twelve <italic>p</italic>-value Misconceptions</article-title>
        <source>Semin Hematol.</source>
        <year>2008</year>
        <volume>45</volume>
        <issue>3</issue>
        <fpage>135</fpage>
        <lpage>140</lpage>
        <pub-id pub-id-type="doi">10.1053/j.seminhematol.2008.04.003</pub-id>
        <?supplied-pmid 18582619?>
        <pub-id pub-id-type="pmid">18582619</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Loftus</surname>
            <given-names>GR</given-names>
          </name>
        </person-group>
        <article-title>Psychology Will Be a Much Better Science When We Change the Way We Analyze Data</article-title>
        <source>Curr Dir Psychol Sci.</source>
        <year>1996</year>
        <volume>5</volume>
        <issue>6</issue>
        <fpage>161</fpage>
        <lpage>171</lpage>
        <pub-id pub-id-type="doi">10.1111/1467-8721.ep11512376</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <article-title>A Practical Solution to the Pervasive Problems of <italic>p</italic> values</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2007</year>
        <volume>14</volume>
        <issue>5</issue>
        <fpage>779</fpage>
        <lpage>804</lpage>
        <pub-id pub-id-type="doi">10.3758/BF03194105</pub-id>
        <?supplied-pmid 18087943?>
        <pub-id pub-id-type="pmid">18087943</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <mixed-citation publication-type="other">Wagenmakers EJ, Marsman M, Jamil T, Ly A, Verhagen J, Love J, et al. Bayesian Inference for Psychology. Part I: Theoretical Advantages and Practical Ramifications. Psychon Bull Rev. 2018;25(1):35–57. 10.3758/s13423-017-1343-3.</mixed-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wetzels</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Matzke</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Rouder</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Iverson</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <article-title>Statistical Evidence in Experimental Psychology: An Empirical Comparison Using 855 t Tests</article-title>
        <source>Perspect Psychol Sci.</source>
        <year>2011</year>
        <volume>6</volume>
        <issue>3</issue>
        <fpage>291</fpage>
        <lpage>298</lpage>
        <pub-id pub-id-type="doi">10.1177/1745691611406923</pub-id>
        <?supplied-pmid 26168519?>
        <pub-id pub-id-type="pmid">26168519</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <mixed-citation publication-type="other">Goodman SN. Toward Evidence-based Medical Statistics. 2: The Bayes Factor. Ann Intern Med. 1999;130(12):1005–1013. 10.7326/0003-4819-130-12-199906150-00019.</mixed-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van Ravenzwaaij</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ioannidis</surname>
            <given-names>JPA</given-names>
          </name>
        </person-group>
        <article-title>A Simulation Study of the Strength of Evidence in the Recommendation of Medications Based on Two Trials with Statistically Significant Results</article-title>
        <source>PLoS ONE.</source>
        <year>2017</year>
        <volume>12</volume>
        <issue>3</issue>
        <fpage>e0173184</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0173184</pub-id>
        <?supplied-pmid 28273140?>
        <pub-id pub-id-type="pmid">28273140</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wasserstein</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Lazar</surname>
            <given-names>NA</given-names>
          </name>
        </person-group>
        <article-title>The ASA’s Statement on p-values: Context, Process, and Purpose</article-title>
        <source>Am Stat.</source>
        <year>2016</year>
        <volume>70</volume>
        <issue>2</issue>
        <fpage>129</fpage>
        <lpage>133</lpage>
        <pub-id pub-id-type="doi">10.1080/00031305.2016.1154108</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berger</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Delampady</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Testing Precise Hypotheses</article-title>
        <source>Stat Sci.</source>
        <year>1987</year>
        <volume>2</volume>
        <issue>3</issue>
        <fpage>317</fpage>
        <lpage>335</lpage>
        <pub-id pub-id-type="doi">10.1214/ss/1177013238</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McShane</surname>
            <given-names>BB</given-names>
          </name>
          <name>
            <surname>Gal</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Gelman</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Robert</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Tackett</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>Abandon Statistical Significance</article-title>
        <source>Am Stat.</source>
        <year>2019</year>
        <volume>73</volume>
        <issue>sup1</issue>
        <fpage>235</fpage>
        <lpage>245</lpage>
        <pub-id pub-id-type="doi">10.1080/00031305.2018.1527253</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Kruschke</surname>
            <given-names>JK</given-names>
          </name>
        </person-group>
        <source>Doing Bayesian Data Analysis: A Tutorial with R, JAGS, and Stan</source>
        <year>2015</year>
        <edition>2</edition>
        <publisher-loc>Boston</publisher-loc>
        <publisher-name>Academic Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Gilks</surname>
            <given-names>WR</given-names>
          </name>
          <name>
            <surname>Richardson</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Spiegelhalter</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <source>Markov Chain Monte Carlo in Practice</source>
        <year>1995</year>
        <publisher-loc>Boca Raton</publisher-loc>
        <publisher-name>Chapman &amp; Hall/CRC</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van Ravenzwaaij</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Cassey</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>SD</given-names>
          </name>
        </person-group>
        <article-title>A Simple Introduction to Markov Chain Monte-Carlo Sampling</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2018</year>
        <volume>25</volume>
        <issue>1</issue>
        <fpage>143</fpage>
        <lpage>154</lpage>
        <pub-id pub-id-type="doi">10.3758/s13423-016-1015-8</pub-id>
        <?supplied-pmid 26968853?>
        <pub-id pub-id-type="pmid">26968853</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berry</surname>
            <given-names>DA</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Clinical Trials</article-title>
        <source>Nat Rev Drug Discov.</source>
        <year>2006</year>
        <volume>5</volume>
        <issue>1</issue>
        <fpage>27</fpage>
        <lpage>36</lpage>
        <pub-id pub-id-type="doi">10.1038/nrd1927</pub-id>
        <?supplied-pmid 16485344?>
        <pub-id pub-id-type="pmid">16485344</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van de Schoot</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Winter</surname>
            <given-names>SD</given-names>
          </name>
          <name>
            <surname>Ryan</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Zondervan-Zwijnenburg</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Depaoli</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>A Systematic Review of Bayesian Articles in Psychology: The Last 25 Years</article-title>
        <source>Psychol Methods.</source>
        <year>2017</year>
        <volume>22</volume>
        <issue>2</issue>
        <fpage>217</fpage>
        <lpage>239</lpage>
        <pub-id pub-id-type="doi">10.1037/met0000100.supp</pub-id>
        <?supplied-pmid 28594224?>
        <pub-id pub-id-type="pmid">28594224</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Chu</surname>
            <given-names>CT</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Clinical Trials in Action</article-title>
        <source>Stat Med.</source>
        <year>2012</year>
        <volume>31</volume>
        <issue>25</issue>
        <fpage>2937</fpage>
        <lpage>3072</lpage>
        <pub-id pub-id-type="doi">10.1002/sim.5404</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zaslavsky</surname>
            <given-names>BG</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Hypothesis Testing in Two-arm Trials with Dichotomous Outcomes</article-title>
        <source>Biometrics.</source>
        <year>2013</year>
        <volume>69</volume>
        <issue>1</issue>
        <fpage>157</fpage>
        <lpage>163</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1541-0420.2012.01806.x</pub-id>
        <?supplied-pmid 23002906?>
        <pub-id pub-id-type="pmid">23002906</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kruschke</surname>
            <given-names>JK</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Assessment of Null Values via Parameter Estimation and Model Comparison</article-title>
        <source>Perspect Psychol Sci.</source>
        <year>2011</year>
        <volume>6</volume>
        <issue>3</issue>
        <fpage>299</fpage>
        <lpage>312</lpage>
        <pub-id pub-id-type="doi">10.1177/1745691611406925</pub-id>
        <?supplied-pmid 26168520?>
        <pub-id pub-id-type="pmid">26168520</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kruschke</surname>
            <given-names>JK</given-names>
          </name>
        </person-group>
        <article-title>Rejecting or Accepting Parameter Values in Bayesian Estimation</article-title>
        <source>Adv Methods Pract Psychol Sci.</source>
        <year>2018</year>
        <volume>1</volume>
        <issue>2</issue>
        <fpage>270</fpage>
        <lpage>280</lpage>
        <pub-id pub-id-type="doi">10.1177/2515245918771304</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Jeffreys</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <source>Theory of Probability</source>
        <year>1939</year>
        <publisher-loc>Oxford</publisher-loc>
        <publisher-name>The Clarendon Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Jeffreys</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <source>Theory of Probability</source>
        <year>1948</year>
        <edition>2</edition>
        <publisher-loc>Oxford</publisher-loc>
        <publisher-name>The Clarendon Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Jeffreys</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <source>Theory of Probability</source>
        <year>1961</year>
        <edition>3</edition>
        <publisher-loc>Oxford</publisher-loc>
        <publisher-name>Oxford University Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kass</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Raftery</surname>
            <given-names>AE</given-names>
          </name>
        </person-group>
        <article-title>Bayes Factors</article-title>
        <source>J Am Stat Assoc.</source>
        <year>1995</year>
        <volume>90</volume>
        <issue>430</issue>
        <fpage>773</fpage>
        <lpage>795</lpage>
        <pub-id pub-id-type="doi">10.2307/2291091</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Winkler</surname>
            <given-names>RL</given-names>
          </name>
        </person-group>
        <article-title>Why Bayesian Analysis Hasn’t Caught on in Healthcare Decision Making</article-title>
        <source>Int J Technol Assess Health Care.</source>
        <year>2001</year>
        <volume>17</volume>
        <issue>1</issue>
        <fpage>56</fpage>
        <lpage>66</lpage>
        <pub-id pub-id-type="doi">10.1017/S026646230110406X</pub-id>
        <?supplied-pmid 11329845?>
        <pub-id pub-id-type="pmid">11329845</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gigerenzer</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Mindless Statistics</article-title>
        <source>J Socio-Econ.</source>
        <year>2004</year>
        <volume>33</volume>
        <issue>5</issue>
        <fpage>587</fpage>
        <lpage>606</lpage>
        <pub-id pub-id-type="doi">10.1016/j.socec.2004.09.033</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <mixed-citation publication-type="other">Morey RD, Rouder JN. BayesFactor: Computation of Bayes Factors for Common Designs. 2018. R package version 0.9.12-4.2. <ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=BayesFactor">https://CRAN.R-project.org/package=BayesFactor</ext-link>. Accessed 14 Sept 2022.</mixed-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <mixed-citation publication-type="other">R Core Team. R: A Language and Environment for Statistical Computing. Vienna. 2021. <ext-link ext-link-type="uri" xlink:href="https://www.R-project.org/">https://www.R-project.org/</ext-link>. Accessed 14 Sept 2022.</mixed-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <mixed-citation publication-type="other">JASP Team. JASP (Version 0.15)[Computer software]. 2021. <ext-link ext-link-type="uri" xlink:href="https://jasp-stats.org/">https://jasp-stats.org/</ext-link>. Accessed 14 Sept 2022.</mixed-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <mixed-citation publication-type="other">The jamovi project. jamovi (Version 1.6) [Computer Software]. 2021. <ext-link ext-link-type="uri" xlink:href="https://www.jamovi.org">https://www.jamovi.org</ext-link>. Accessed 14 Sept 2022.</mixed-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <mixed-citation publication-type="other">Linde M, van Ravenzwaaij D. baymedr: Computation of Bayes Factors for Common Biomedical Designs. 2021. R package version 0.1.1. <ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=baymedr">https://CRAN.R-project.org/package=baymedr</ext-link>. Accessed 14 Sept 2022.</mixed-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <mixed-citation publication-type="other">Linde M. baymedr. 2022. <ext-link ext-link-type="uri" xlink:href="https://maxlinde.shinyapps.io/baymedr/">https://maxlinde.shinyapps.io/baymedr/</ext-link>. Accessed 14 Sept 2022.</mixed-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Meyners</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Equivalence Tests - A Review</article-title>
        <source>Food Qual Prefer.</source>
        <year>2012</year>
        <volume>26</volume>
        <issue>2</issue>
        <fpage>231</fpage>
        <lpage>245</lpage>
        <pub-id pub-id-type="doi">10.1016/j.foodqual.2012.05.003</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hodges</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Lehmann</surname>
            <given-names>EL</given-names>
          </name>
        </person-group>
        <article-title>Testing the Approximate Validity of Statistical Hypotheses</article-title>
        <source>J R Stat Soc Ser B (Methodol).</source>
        <year>1954</year>
        <volume>16</volume>
        <issue>2</issue>
        <fpage>261</fpage>
        <lpage>268</lpage>
        <pub-id pub-id-type="doi">10.1007/978-1-4614-1412-4_15</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Westlake</surname>
            <given-names>WJ</given-names>
          </name>
        </person-group>
        <article-title>Symmetrical Confidence Intervals for Bioequivalence Trials</article-title>
        <source>Biometrics.</source>
        <year>1976</year>
        <volume>32</volume>
        <issue>4</issue>
        <fpage>741</fpage>
        <lpage>744</lpage>
        <pub-id pub-id-type="doi">10.2307/2529259</pub-id>
        <?supplied-pmid 1009222?>
        <pub-id pub-id-type="pmid">1009222</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schuirmann</surname>
            <given-names>DJ</given-names>
          </name>
        </person-group>
        <article-title>A Comparison of the Two One-sided Tests Procedure and the Power Approach for Assessing the Equivalence of Average Bioavailability</article-title>
        <source>J Pharmacokinet Biopharm.</source>
        <year>1987</year>
        <volume>15</volume>
        <issue>6</issue>
        <fpage>657</fpage>
        <lpage>680</lpage>
        <pub-id pub-id-type="doi">10.1007/BF01068419</pub-id>
        <?supplied-pmid 3450848?>
        <pub-id pub-id-type="pmid">3450848</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Senn</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <source>Statistical Issues in Drug Development</source>
        <year>2008</year>
        <edition>2</edition>
        <publisher-loc>Chichester</publisher-loc>
        <publisher-name>Wiley</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lakens</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Equivalence Tests: A Practical Primer for t Tests, Correlations, and Meta-analyses</article-title>
        <source>Soc Psychol Personal Sci.</source>
        <year>2017</year>
        <volume>8</volume>
        <issue>4</issue>
        <fpage>355</fpage>
        <lpage>362</lpage>
        <pub-id pub-id-type="doi">10.1177/1948550617697177</pub-id>
        <?supplied-pmid 28736600?>
        <pub-id pub-id-type="pmid">28736600</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lakens</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Scheel</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Isager</surname>
            <given-names>PM</given-names>
          </name>
        </person-group>
        <article-title>Equivalence Testing for Psychological Research: A Tutorial</article-title>
        <source>Adv Methods Pract Psychol Sci.</source>
        <year>2018</year>
        <volume>1</volume>
        <issue>2</issue>
        <fpage>259</fpage>
        <lpage>269</lpage>
        <pub-id pub-id-type="doi">10.1177/2515245918770963</pub-id>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Garrett</surname>
            <given-names>AD</given-names>
          </name>
        </person-group>
        <article-title>Therapeutic Equivalence: Fallacies and Falsification</article-title>
        <source>Stat Med.</source>
        <year>2003</year>
        <volume>22</volume>
        <issue>5</issue>
        <fpage>741</fpage>
        <lpage>762</lpage>
        <pub-id pub-id-type="doi">10.1002/sim.1360</pub-id>
        <?supplied-pmid 12587103?>
        <pub-id pub-id-type="pmid">12587103</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Walker</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Nowacki</surname>
            <given-names>AS</given-names>
          </name>
        </person-group>
        <article-title>Understanding Equivalence and Noninferiority Testing</article-title>
        <source>J Gen Intern Med.</source>
        <year>2011</year>
        <volume>26</volume>
        <issue>2</issue>
        <fpage>192</fpage>
        <lpage>196</lpage>
        <pub-id pub-id-type="doi">10.1007/s11606-010-1513-8</pub-id>
        <?supplied-pmid 20857339?>
        <pub-id pub-id-type="pmid">20857339</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <mixed-citation publication-type="other">Chadwick D, Vigabatrin European Monotherapy Study Group. Safety and Efficacy of Vigabatrin and Carbamazepine in Newly Diagnosed Epilepsy: A Multicentre Randomised Double-blind Study. Lancet. 1999;354(9172):13–19. 10.1016/S0140-6736(98)10531-7.</mixed-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kaul</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Diamond</surname>
            <given-names>GA</given-names>
          </name>
        </person-group>
        <article-title>Good Enough: A Primer on the Analysis and Interpretation of Noninferiority Trials</article-title>
        <source>Ann Intern Med.</source>
        <year>2006</year>
        <volume>145</volume>
        <issue>1</issue>
        <fpage>62</fpage>
        <lpage>69</lpage>
        <pub-id pub-id-type="doi">10.7326/0003-4819-145-1-200607040-00011</pub-id>
        <?supplied-pmid 16818930?>
        <pub-id pub-id-type="pmid">16818930</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Van de Werf</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Adgey</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ardissino</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Armstrong</surname>
            <given-names>PW</given-names>
          </name>
          <name>
            <surname>Aylward</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Barbash</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Single-bolus Tenecteplase Compared with Front-loaded Alteplase in Acute Myocardial Infarction: The ASSENT-2 Double-blind Randomised Trial</article-title>
        <source>Lancet.</source>
        <year>1999</year>
        <volume>354</volume>
        <issue>9180</issue>
        <fpage>716</fpage>
        <lpage>722</lpage>
        <pub-id pub-id-type="doi">10.1016/S0140-6736(99)07403-6</pub-id>
        <?supplied-pmid 10475182?>
        <pub-id pub-id-type="pmid">10475182</pub-id>
      </element-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hills</surname>
            <given-names>RK</given-names>
          </name>
        </person-group>
        <article-title>Non-inferiority Trials: No Better? No Worse? No Change? No Pain?</article-title>
        <source>Br J Haematol.</source>
        <year>2017</year>
        <volume>176</volume>
        <issue>6</issue>
        <fpage>883</fpage>
        <lpage>887</lpage>
        <pub-id pub-id-type="doi">10.1111/bjh.14504</pub-id>
        <?supplied-pmid 28106905?>
        <pub-id pub-id-type="pmid">28106905</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <mixed-citation publication-type="other">Rennie D. Vive La Différence (p<inline-formula id="IEq142"><alternatives><tex-math id="M299">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$&lt;$$\end{document}</tex-math><mml:math id="M300"><mml:mo>&lt;</mml:mo></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq142.gif"/></alternatives></inline-formula>0.05). N Engl J Med. 1978;299:828–829. 10.1056/NEJM197810122991509.</mixed-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <mixed-citation publication-type="other">International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Pathology. 1997;29:441–447. 10.1080/00313029700169515.</mixed-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rouder</surname>
            <given-names>JN</given-names>
          </name>
        </person-group>
        <article-title>Optional Stopping: No Problem for Bayesians</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2014</year>
        <volume>21</volume>
        <issue>2</issue>
        <fpage>301</fpage>
        <lpage>308</lpage>
        <pub-id pub-id-type="doi">10.3758/s13423-014-0595-4</pub-id>
        <?supplied-pmid 24659049?>
        <pub-id pub-id-type="pmid">24659049</pub-id>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schönbrodt</surname>
            <given-names>FD</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Zehetleitner</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Perugini</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Sequential Hypothesis Testing with Bayes Factors: Efficiently Testing Mean Differences</article-title>
        <source>Psychol Methods.</source>
        <year>2017</year>
        <volume>22</volume>
        <issue>2</issue>
        <fpage>322</fpage>
        <lpage>339</lpage>
        <pub-id pub-id-type="doi">10.1037/met0000061</pub-id>
        <?supplied-pmid 26651986?>
        <pub-id pub-id-type="pmid">26651986</pub-id>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schönbrodt</surname>
            <given-names>FD</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <article-title>Bayes Factor Design Analysis: Planning for Compelling Evidence</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2018</year>
        <volume>25</volume>
        <issue>1</issue>
        <fpage>128</fpage>
        <lpage>142</lpage>
        <pub-id pub-id-type="doi">10.3758/s13423-017-1230-y</pub-id>
        <?supplied-pmid 28251595?>
        <pub-id pub-id-type="pmid">28251595</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ranganathan</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Pramesh</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Buyse</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Common Pitfalls in Statistical Analysis: The Perils of Multiple Testing</article-title>
        <source>Perspect Clin Res.</source>
        <year>2016</year>
        <volume>7</volume>
        <issue>2</issue>
        <fpage>106</fpage>
        <lpage>107</lpage>
        <pub-id pub-id-type="doi">10.4103/2229-3485.179436</pub-id>
        <?supplied-pmid 27141478?>
        <pub-id pub-id-type="pmid">27141478</pub-id>
      </element-citation>
    </ref>
    <ref id="CR64">
      <label>64.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chalmers</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Glasziou</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Avoidable Waste in the Production and Reporting of Research Evidence</article-title>
        <source>Lancet.</source>
        <year>2009</year>
        <volume>374</volume>
        <issue>9683</issue>
        <fpage>86</fpage>
        <lpage>89</lpage>
        <pub-id pub-id-type="doi">10.1016/S0140-6736(09)60329-9</pub-id>
        <?supplied-pmid 19525005?>
        <pub-id pub-id-type="pmid">19525005</pub-id>
      </element-citation>
    </ref>
    <ref id="CR65">
      <label>65.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van Ravenzwaaij</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Monden</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Tendeiro</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Ioannidis</surname>
            <given-names>JPA</given-names>
          </name>
        </person-group>
        <article-title>Bayes Factors for Superiority, Non-inferiority, and Equivalence Designs</article-title>
        <source>BMC Med Res Methodol.</source>
        <year>2019</year>
        <volume>19</volume>
        <issue>1</issue>
        <fpage>71</fpage>
        <pub-id pub-id-type="doi">10.1186/s12874-019-0699-7</pub-id>
        <?supplied-pmid 30925900?>
        <pub-id pub-id-type="pmid">30925900</pub-id>
      </element-citation>
    </ref>
    <ref id="CR66">
      <label>66.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gallistel</surname>
            <given-names>CR</given-names>
          </name>
        </person-group>
        <article-title>The Importance of Proving the Null</article-title>
        <source>Psychol Rev.</source>
        <year>2009</year>
        <volume>116</volume>
        <issue>2</issue>
        <fpage>439</fpage>
        <lpage>453</lpage>
        <pub-id pub-id-type="doi">10.1037/a0015251</pub-id>
        <?supplied-pmid 19348549?>
        <pub-id pub-id-type="pmid">19348549</pub-id>
      </element-citation>
    </ref>
    <ref id="CR67">
      <label>67.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rouder</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Speckman</surname>
            <given-names>PL</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Morey</surname>
            <given-names>RD</given-names>
          </name>
          <name>
            <surname>Iverson</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Bayesian t Tests for Accepting and Rejecting the Null Hypothesis</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2009</year>
        <volume>16</volume>
        <issue>2</issue>
        <fpage>225</fpage>
        <lpage>237</lpage>
        <pub-id pub-id-type="doi">10.3758/PBR.16.2.225</pub-id>
        <?supplied-pmid 19293088?>
        <pub-id pub-id-type="pmid">19293088</pub-id>
      </element-citation>
    </ref>
    <ref id="CR68">
      <label>68.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gelman</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>p Values and Statistical Practice</article-title>
        <source>Epidemiology.</source>
        <year>2013</year>
        <volume>24</volume>
        <issue>1</issue>
        <fpage>69</fpage>
        <lpage>72</lpage>
        <pub-id pub-id-type="doi">10.1097/EDE.0b013e31827886f7</pub-id>
        <?supplied-pmid 23232612?>
        <pub-id pub-id-type="pmid">23232612</pub-id>
      </element-citation>
    </ref>
    <ref id="CR69">
      <label>69.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Haller</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Krauss</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Misinterpretation of Significance: A Problem Students Share with Their Teachers?</article-title>
        <source>Methods Psychol Res.</source>
        <year>2002</year>
        <volume>7</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>20</lpage>
      </element-citation>
    </ref>
    <ref id="CR70">
      <label>70.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bakan</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>The Test of Significance in Psychological Research</article-title>
        <source>Psychol Bull.</source>
        <year>1966</year>
        <volume>66</volume>
        <issue>6</issue>
        <fpage>423</fpage>
        <lpage>437</lpage>
        <pub-id pub-id-type="doi">10.1037/h0020412</pub-id>
        <?supplied-pmid 5974619?>
        <pub-id pub-id-type="pmid">5974619</pub-id>
      </element-citation>
    </ref>
    <ref id="CR71">
      <label>71.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Altman</surname>
            <given-names>DG</given-names>
          </name>
          <name>
            <surname>Bland</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>Absence of Evidence Is Not Evidence of Absence</article-title>
        <source>BMJ.</source>
        <year>1995</year>
        <volume>311</volume>
        <issue>7003</issue>
        <fpage>485</fpage>
        <pub-id pub-id-type="doi">10.1136/bmj.311.7003.485</pub-id>
        <?supplied-pmid 7647644?>
        <pub-id pub-id-type="pmid">7647644</pub-id>
      </element-citation>
    </ref>
    <ref id="CR72">
      <label>72.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Greene</surname>
            <given-names>WL</given-names>
          </name>
          <name>
            <surname>Concato</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Feinstein</surname>
            <given-names>AR</given-names>
          </name>
        </person-group>
        <article-title>Claims of Equivalence in Medical Research: Are They Supported by the Evidence?</article-title>
        <source>Ann Intern Med.</source>
        <year>2000</year>
        <volume>132</volume>
        <issue>9</issue>
        <fpage>715</fpage>
        <lpage>722</lpage>
        <pub-id pub-id-type="doi">10.7326/0003-4819-132-9-200005020-00006</pub-id>
        <?supplied-pmid 10787365?>
        <pub-id pub-id-type="pmid">10787365</pub-id>
      </element-citation>
    </ref>
    <ref id="CR73">
      <label>73.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Blackwelder</surname>
            <given-names>WC</given-names>
          </name>
        </person-group>
        <article-title>Proving the Null Hypothesis</article-title>
        <source>Clinical Trials. Controlled Clinical Trials.</source>
        <year>1982</year>
        <volume>3</volume>
        <issue>4</issue>
        <fpage>345</fpage>
        <lpage>353</lpage>
        <pub-id pub-id-type="doi">10.1016/0197-2456(82)90024-1</pub-id>
        <?supplied-pmid 7160191?>
        <pub-id pub-id-type="pmid">7160191</pub-id>
      </element-citation>
    </ref>
    <ref id="CR74">
      <label>74.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hoekstra</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Monden</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>van Ravenzwaaij</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Reanalysis of Null Results Reported in Medicine: Strong yet Variable Evidence for the Absence of Treatment Effects</article-title>
        <source>PLoS ONE.</source>
        <year>2018</year>
        <volume>13</volume>
        <issue>4</issue>
        <fpage>e0195474</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0195474</pub-id>
        <?supplied-pmid 29694370?>
        <pub-id pub-id-type="pmid">29694370</pub-id>
      </element-citation>
    </ref>
    <ref id="CR75">
      <label>75.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kruschke</surname>
            <given-names>JK</given-names>
          </name>
          <name>
            <surname>Liddell</surname>
            <given-names>TM</given-names>
          </name>
        </person-group>
        <article-title>The Bayesian New Statistics: Hypothesis Testing, Estimation, Meta-analysis, and Power Analysis from a Bayesian Perspective</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2018</year>
        <volume>25</volume>
        <issue>1</issue>
        <fpage>178</fpage>
        <lpage>206</lpage>
        <pub-id pub-id-type="doi">10.3758/s13423-016-1221-4</pub-id>
        <?supplied-pmid 28176294?>
        <pub-id pub-id-type="pmid">28176294</pub-id>
      </element-citation>
    </ref>
    <ref id="CR76">
      <label>76.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Lodewyckx</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kuriyal</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Grasman</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Hypothesis Testing for Psychologists: A Tutorial on the Savage-Dickey Method</article-title>
        <source>Cogn Psychol.</source>
        <year>2010</year>
        <volume>60</volume>
        <issue>3</issue>
        <fpage>158</fpage>
        <lpage>189</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cogpsych.2009.12.001</pub-id>
        <?supplied-pmid 20064637?>
        <pub-id pub-id-type="pmid">20064637</pub-id>
      </element-citation>
    </ref>
    <ref id="CR77">
      <label>77.</label>
      <mixed-citation publication-type="other">O’Hagan A, Forster J. Kendall’s Advanced Theory of Statistics: Vol. 2B. Bayesian Inference. 2nd ed. London: Arnold; 2004.</mixed-citation>
    </ref>
    <ref id="CR78">
      <label>78.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Etz</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Vandekerckhove</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Introduction to Bayesian Inference for Psychology</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2018</year>
        <volume>25</volume>
        <issue>1</issue>
        <fpage>5</fpage>
        <lpage>34</lpage>
        <pub-id pub-id-type="doi">10.3758/s13423-017-1262-3</pub-id>
        <?supplied-pmid 28378250?>
        <pub-id pub-id-type="pmid">28378250</pub-id>
      </element-citation>
    </ref>
    <ref id="CR79">
      <label>79.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gronau</surname>
            <given-names>QF</given-names>
          </name>
          <name>
            <surname>Ly</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <article-title>Informed Bayesian t-tests</article-title>
        <source>Am Stat.</source>
        <year>2020</year>
        <volume>74</volume>
        <issue>2</issue>
        <fpage>137</fpage>
        <lpage>143</lpage>
        <pub-id pub-id-type="doi">10.1080/00031305.2018.1562983</pub-id>
      </element-citation>
    </ref>
    <ref id="CR80">
      <label>80.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <source>Bayesian Cognitive Modeling: A Practical Course</source>
        <year>2013</year>
        <publisher-loc>Cambridge</publisher-loc>
        <publisher-name>Cambridge University Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR81">
      <label>81.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gönen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>WO</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Westfall</surname>
            <given-names>PH</given-names>
          </name>
        </person-group>
        <article-title>The Bayesian Two-sample t Test</article-title>
        <source>Am Stat.</source>
        <year>2005</year>
        <volume>59</volume>
        <issue>3</issue>
        <fpage>252</fpage>
        <lpage>257</lpage>
        <pub-id pub-id-type="doi">10.1198/000313005X55233</pub-id>
      </element-citation>
    </ref>
    <ref id="CR82">
      <label>82.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bayarri</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Berger</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Forte</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>García-Donato</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Criteria for Bayesian Model Choice with Application to Variable Selection</article-title>
        <source>Ann Stat.</source>
        <year>2012</year>
        <volume>40</volume>
        <issue>3</issue>
        <fpage>1550</fpage>
        <lpage>1577</lpage>
        <pub-id pub-id-type="doi">10.1214/12-AOS1013</pub-id>
      </element-citation>
    </ref>
    <ref id="CR83">
      <label>83.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berger</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Pericchi</surname>
            <given-names>LR</given-names>
          </name>
          <name>
            <surname>Varshavsky</surname>
            <given-names>JA</given-names>
          </name>
        </person-group>
        <article-title>Bayes Factors and Marginal Distributions in Invariant Situations</article-title>
        <source>Sankhyā Indian J Stat.</source>
        <year>1998</year>
        <volume>60</volume>
        <fpage>307</fpage>
        <lpage>321</lpage>
      </element-citation>
    </ref>
    <ref id="CR84">
      <label>84.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dickey</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Lientz</surname>
            <given-names>BP</given-names>
          </name>
        </person-group>
        <article-title>The Weighted Likelihood Ratio, Sharp Hypotheses about Chances, the Order of a Markov Chain</article-title>
        <source>Ann Math Stat.</source>
        <year>1970</year>
        <volume>41</volume>
        <issue>1</issue>
        <fpage>214</fpage>
        <lpage>226</lpage>
        <pub-id pub-id-type="doi">10.1214/aoms/1177697203</pub-id>
      </element-citation>
    </ref>
    <ref id="CR85">
      <label>85.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van Ravenzwaaij</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Etz</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Simulation Studies as a Tool to Understand Bayes Factors</article-title>
        <source>Adv Methods Pract Psychol Sci.</source>
        <year>2021</year>
        <volume>4</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>20</lpage>
        <pub-id pub-id-type="doi">10.1177/2515245920972624</pub-id>
      </element-citation>
    </ref>
    <ref id="CR86">
      <label>86.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vanpaemel</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Prior Sensitivity in Theory Testing: An Apologia for the Bayes Factor</article-title>
        <source>J Math Psychol.</source>
        <year>2010</year>
        <volume>54</volume>
        <issue>6</issue>
        <fpage>491</fpage>
        <lpage>498</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jmp.2010.07.003</pub-id>
      </element-citation>
    </ref>
    <ref id="CR87">
      <label>87.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Morey</surname>
            <given-names>RD</given-names>
          </name>
          <name>
            <surname>Romeijn</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>Rouder</surname>
            <given-names>JN</given-names>
          </name>
        </person-group>
        <article-title>The Philosophy of Bayes Factors and the Quantification of Statistical Evidence</article-title>
        <source>J Math Psychol.</source>
        <year>2016</year>
        <volume>72</volume>
        <fpage>6</fpage>
        <lpage>18</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jmp.2015.11.001</pub-id>
      </element-citation>
    </ref>
    <ref id="CR88">
      <label>88.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Consonni</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Fouskakis</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Liseo</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ntzoufras</surname>
            <given-names>I</given-names>
          </name>
        </person-group>
        <article-title>Prior Distributions for Objective Bayesian Analysis</article-title>
        <source>Bayesian Anal.</source>
        <year>2018</year>
        <volume>13</volume>
        <issue>2</issue>
        <fpage>627</fpage>
        <lpage>679</lpage>
        <pub-id pub-id-type="doi">10.1214/18-BA1103</pub-id>
      </element-citation>
    </ref>
    <ref id="CR89">
      <label>89.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Paulo</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Molina</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Clyde</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Berger</surname>
            <given-names>JO</given-names>
          </name>
        </person-group>
        <article-title>Mixtures of g Priors for Bayesian Variable Selection</article-title>
        <source>J Am Stat Assoc.</source>
        <year>2008</year>
        <volume>103</volume>
        <issue>481</issue>
        <fpage>410</fpage>
        <lpage>423</lpage>
        <pub-id pub-id-type="doi">10.1198/016214507000001337</pub-id>
      </element-citation>
    </ref>
    <ref id="CR90">
      <label>90.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tendeiro</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Kiers</surname>
            <given-names>HAL</given-names>
          </name>
        </person-group>
        <article-title>A Review of Issues about Null Hypothesis Bayesian Testing</article-title>
        <source>Psychol Methods.</source>
        <year>2019</year>
        <volume>24</volume>
        <issue>6</issue>
        <fpage>774</fpage>
        <lpage>795</lpage>
        <pub-id pub-id-type="doi">10.1037/met0000221</pub-id>
        <?supplied-pmid 31094544?>
        <pub-id pub-id-type="pmid">31094544</pub-id>
      </element-citation>
    </ref>
    <ref id="CR91">
      <label>91.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kruschke</surname>
            <given-names>JK</given-names>
          </name>
          <name>
            <surname>Liddell</surname>
            <given-names>TM</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Data Analysis for Newcomers</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2018</year>
        <volume>25</volume>
        <issue>1</issue>
        <fpage>155</fpage>
        <lpage>177</lpage>
        <pub-id pub-id-type="doi">10.3758/s13423-017-1272-1</pub-id>
        <?supplied-pmid 28405907?>
        <pub-id pub-id-type="pmid">28405907</pub-id>
      </element-citation>
    </ref>
    <ref id="CR92">
      <label>92.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Basner</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Asch</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Shea</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Bellini</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Carlin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ecker</surname>
            <given-names>AJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Sleep and Alertness in a Duty-hour Flexibility Trial in Internal Medicine</article-title>
        <source>N Engl J Med.</source>
        <year>2019</year>
        <volume>380</volume>
        <issue>10</issue>
        <fpage>915</fpage>
        <lpage>923</lpage>
        <pub-id pub-id-type="doi">10.1056/NEJMoa1810641</pub-id>
        <?supplied-pmid 30855741?>
        <pub-id pub-id-type="pmid">30855741</pub-id>
      </element-citation>
    </ref>
    <ref id="CR93">
      <label>93.</label>
      <mixed-citation publication-type="other">Wickham H, Hester J, Chang W. devtools: Tools to Make Developing R Packages Easier. 2019. R package version 2.2.0. <ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=devtools">https://CRAN.R-project.org/package=devtools</ext-link>. Accessed 14 Sept 2022.</mixed-citation>
    </ref>
    <ref id="CR94">
      <label>94.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Åkerstedt</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Gillberg</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Subjective and Objective Sleepiness in the Active Individual</article-title>
        <source>International Journal of Neuroscience.</source>
        <year>1990</year>
        <volume>52</volume>
        <issue>1–2</issue>
        <fpage>29</fpage>
        <lpage>37</lpage>
        <pub-id pub-id-type="doi">10.3109/00207459008994241</pub-id>
        <?supplied-pmid 2265922?>
        <pub-id pub-id-type="pmid">2265922</pub-id>
      </element-citation>
    </ref>
    <ref id="CR95">
      <label>95.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van Ravenzwaaij</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <article-title>Advantages Masquerading as “Issues” in Bayesian Hypothesis Testing: A Commentary on Tendeiro and Kiers (2019)</article-title>
        <source>Psychol Methods.</source>
        <year>2022</year>
        <volume>27</volume>
        <issue>3</issue>
        <fpage>451</fpage>
        <lpage>465</lpage>
        <pub-id pub-id-type="doi">10.1037/met0000415</pub-id>
        <?supplied-pmid 34881956?>
        <pub-id pub-id-type="pmid">34881956</pub-id>
      </element-citation>
    </ref>
    <ref id="CR96">
      <label>96.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tendeiro</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Kiers</surname>
            <given-names>HAL</given-names>
          </name>
        </person-group>
        <article-title>On the White, the Black, and the Many Shades of Gray in Between: Our Reply to van Ravenzwaaij and Wagenmakers (2021)</article-title>
        <source>Psychol Methods.</source>
        <year>2022</year>
        <volume>27</volume>
        <issue>3</issue>
        <fpage>466</fpage>
        <lpage>475</lpage>
        <pub-id pub-id-type="doi">10.1037/met0000505</pub-id>
        <?supplied-pmid 35901398?>
        <pub-id pub-id-type="pmid">35901398</pub-id>
      </element-citation>
    </ref>
    <ref id="CR97">
      <label>97.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sinharay</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Stern</surname>
            <given-names>HS</given-names>
          </name>
        </person-group>
        <article-title>On the Sensitivity of Bayes Factors to the Prior Distributions</article-title>
        <source>Am Stat.</source>
        <year>2002</year>
        <volume>56</volume>
        <issue>3</issue>
        <fpage>196</fpage>
        <lpage>201</lpage>
        <pub-id pub-id-type="doi">10.1198/000313002137</pub-id>
      </element-citation>
    </ref>
    <ref id="CR98">
      <label>98.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Aitkin</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Bayes Factors: Prior Sensitivity and Model Generalizability</article-title>
        <source>J Math Psychol.</source>
        <year>2008</year>
        <volume>52</volume>
        <issue>6</issue>
        <fpage>362</fpage>
        <lpage>375</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jmp.2008.03.002</pub-id>
      </element-citation>
    </ref>
    <ref id="CR99">
      <label>99.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lindley</surname>
            <given-names>DV</given-names>
          </name>
        </person-group>
        <article-title>A Statistical Paradox</article-title>
        <source>Biometrika.</source>
        <year>1957</year>
        <volume>44</volume>
        <issue>1/2</issue>
        <fpage>187</fpage>
        <lpage>192</lpage>
        <pub-id pub-id-type="doi">10.2307/2333251</pub-id>
      </element-citation>
    </ref>
    <ref id="CR100">
      <label>100.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wong</surname>
            <given-names>TK</given-names>
          </name>
          <name>
            <surname>Kiers</surname>
            <given-names>HAL</given-names>
          </name>
          <name>
            <surname>Tendeiro</surname>
            <given-names>JN</given-names>
          </name>
        </person-group>
        <article-title>On the Potential Mismatch Between the Function of the Bayes Factor and Researchers’ Expectations</article-title>
        <source>Collabra Psychol.</source>
        <year>2022</year>
        <volume>8</volume>
        <issue>1</issue>
        <fpage>36357</fpage>
        <pub-id pub-id-type="doi">10.1525/collabra.36357</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Med Res Methodol</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Med Res Methodol</journal-id>
    <journal-title-group>
      <journal-title>BMC Medical Research Methodology</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2288</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10668366</article-id>
    <article-id pub-id-type="publisher-id">2097</article-id>
    <article-id pub-id-type="doi">10.1186/s12874-023-02097-y</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Software</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>baymedr: an R package and web application for the calculation of Bayes factors for superiority, equivalence, and non-inferiority designs</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8421-090X</contrib-id>
        <name>
          <surname>Linde</surname>
          <given-names>Maximilian</given-names>
        </name>
        <address>
          <email>maximilian.linde@gesis.org</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5030-4091</contrib-id>
        <name>
          <surname>van Ravenzwaaij</surname>
          <given-names>Don</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/018afyw53</institution-id><institution-id institution-id-type="GRID">grid.425053.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 1013 1176</institution-id><institution>GESIS - Leibniz Institute for the Social Sciences, </institution></institution-wrap>Cologne, Germany </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/012p63287</institution-id><institution-id institution-id-type="GRID">grid.4830.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0407 1981</institution-id><institution>University of Groningen, </institution></institution-wrap>Groningen, The Netherlands </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>24</day>
      <month>11</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>24</day>
      <month>11</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <volume>23</volume>
    <elocation-id>279</elocation-id>
    <history>
      <date date-type="received">
        <day>14</day>
        <month>9</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>3</day>
        <month>11</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">Clinical trials often seek to determine the superiority, equivalence, or non-inferiority of an experimental condition (e.g., a new drug) compared to a control condition (e.g., a placebo or an already existing drug). The use of frequentist statistical methods to analyze data for these types of designs is ubiquitous even though they have several limitations. Bayesian inference remedies many of these shortcomings and allows for intuitive interpretations, but are currently difficult to implement for the applied researcher.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">We outline the frequentist conceptualization of superiority, equivalence, and non-inferiority designs and discuss its disadvantages. Subsequently, we explain how Bayes factors can be used to compare the relative plausibility of competing hypotheses. We present baymedr, an R package and web application, that provides user-friendly tools for the computation of Bayes factors for superiority, equivalence, and non-inferiority designs. Instructions on how to use baymedr are provided and an example illustrates how existing results can be reanalyzed with baymedr.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">Our baymedr R package and web application enable researchers to conduct Bayesian superiority, equivalence, and non-inferiority tests. baymedr is characterized by a user-friendly implementation, making it convenient for researchers who are not statistical experts. Using baymedr, it is possible to calculate Bayes factors based on raw data and summary statistics.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Bayes factor</kwd>
      <kwd>baymedr</kwd>
      <kwd>Equivalence</kwd>
      <kwd>Non-inferiority</kwd>
      <kwd>Superiority</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003246</institution-id>
            <institution>Nederlandse Organisatie voor Wetenschappelijk Onderzoek</institution>
          </institution-wrap>
        </funding-source>
        <award-id>016.Vidi.188.001</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>GESIS – Leibniz-Institut für Sozialwissenschaften e.V. (3447)</institution>
        </funding-source>
      </award-group>
      <open-access>
        <p>Open Access funding enabled and organized by Projekt DEAL.</p>
      </open-access>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© BioMed Central Ltd., part of Springer Nature 2023</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par9">Researchers generally agree that the clinical trial is the best method to determine and compare the effects of medications and treatments [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Although clinical trials are often similar in design, different statistical procedures need to be employed depending on the nature of the research question. Commonly, clinical trials seek to determine the superiority, equivalence, or non-inferiority of an experimental condition (e.g., subjects receiving a new medication) compared to a control condition (e.g., subjects receiving a placebo or an already existing medication; [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]). For these goals, statistical inference is often conducted in the form of testing.</p>
    <p id="Par10">Usually, the frequentist approach to statistical testing forms the framework in which data for these research designs are analyzed [<xref ref-type="bibr" rid="CR5">5</xref>]. In particular, researchers often rely on null hypothesis significance testing (NHST), which quantifies evidence through a <italic>p</italic>-value. This <italic>p</italic>-value represents the probability of obtaining a test statistic (e.g., a <italic>t</italic>-value) at least as extreme as the one observed, assuming that the null hypothesis is true. In other words, the <italic>p</italic>-value is an indicator of the unusualness of the obtained test statistic under the null hypothesis, forming a “proof by contradiction” ([<xref ref-type="bibr" rid="CR6">6</xref>], p. 123). If the <italic>p</italic>-value is smaller than a predefined Type I error rate (<inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\alpha$$\end{document}</tex-math><mml:math id="M2"><mml:mi>α</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq1.gif"/></alternatives></inline-formula>), typically set to <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\alpha =.05$$\end{document}</tex-math><mml:math id="M4"><mml:mrow><mml:mi>α</mml:mi><mml:mo>=</mml:mo><mml:mo>.</mml:mo><mml:mn>05</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq2.gif"/></alternatives></inline-formula> (but see, e.g., [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]), rejection of the null hypothesis is warranted; otherwise the obtained data do not justify rejection of the null hypothesis.</p>
    <p id="Par11">The NHST approach to inference has been criticized due to certain limitations and erroneous interpretations of <italic>p</italic>-values (e.g., [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR21">21</xref>]), which we briefly describe below. As a result, some methodologists have argued that <italic>p</italic>-values should be mostly abandoned from scientific practice (e.g., [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]).</p>
    <p id="Par12">An alternative to NHST is statistical testing within a Bayesian framework. Bayesian statistics is based on the idea that the credibilities of well-defined parameter values (e.g., effect size) or models (e.g., null and alternative hypotheses) are updated based on new observations [<xref ref-type="bibr" rid="CR24">24</xref>]. With exploding computational power and the rise of Markov chain Monte Carlo methods (e.g., [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]) that are used to estimate probability distributions that cannot be determined analytically, applications of Bayesian inference have recently become tractable. Indeed, Bayesian methods are seeing more and more use in the biomedical field [<xref ref-type="bibr" rid="CR27">27</xref>] and other disciplines [<xref ref-type="bibr" rid="CR28">28</xref>].</p>
    <p id="Par13">Lee and Chu [<xref ref-type="bibr" rid="CR29">29</xref>] have conducted a literature search to investigate how Bayesian inference is typically used in biomedicine. They found that the number of studies using Bayesian inference has been steadily increasing over the last decades, with a majority of studies testing treatment efficacy and with most applications in fields such as oncology, cardiovascular system research, and central nervous system research. Further, most of the studies that used Bayesian methods complemented frequentist results with Bayesian results, and a majority of studies had a continuous or binary endpoint. The results indicated that many studies used Bayesian methods for the purpose of estimation or hypothesis testing, both with informative and non-informative priors, and had two conditions.</p>
    <p id="Par14">There are multiple ways that Bayesian hypothesis testing specifically is done in biomedicine. For instance, the posterior probabilities of the null and alternative hypotheses could be consulted, such that the alternative hypothesis is accepted if its posterior probability is close to 1 or if the posterior probability of the null hypothesis is lower than a predefined threshold (e.g., [<xref ref-type="bibr" rid="CR30">30</xref>]). Alternatively, the highest density interval of the posterior distribution could be compared to a predefined region of practical equivalence: If the highest density interval does not overlap with the region of equivalence, the alternative hypothesis can be accepted [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. Another possibility is the use of Bayes factors [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR36">36</xref>], which quantify the evidence for the alternative hypothesis relative to the evidence for the null hypothesis.</p>
    <p id="Par15">It can be argued that the Bayes factor should be preferred among those options. For example, a Bayes factor is an updating factor that enables researchers to update their individual prior beliefs about the two hypotheses. In other words, in contrast to posterior probabilities for the hypotheses, the Bayes factor is independent of any prior beliefs a researcher might have. Furthermore, a Bayes factor provides the relative evidence for the considered hypotheses. Conducting hypothesis testing with posterior probabilities does not necessarily have this property: evidence against one hypothesis need not be in favor of the other (although for complementary hypotheses this would be true). For these reasons, we only consider Bayes factors in the remainder of this manuscript.</p>
    <p id="Par16">Despite the fact that statistical inference is slowly changing from frequentist methods towards Bayesian methods [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR29">29</xref>], a majority of biomedical research still employs frequentist statistical techniques [<xref ref-type="bibr" rid="CR5">5</xref>]. To some extent, this might be due to a biased statistical education in favor of frequentist inference. Moreover, researchers might perceive statistical inference through NHST and reporting of <italic>p</italic>-values as prescriptive and, hence, adhere to this convention [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. We believe that one of the most crucial factors is the unavailability of easy-to-use Bayesian tools and software, leaving Bayesian hypothesis testing largely to statistical experts. Fortunately, important advances have been made towards user-friendly interfaces for Bayesian analyses with the release of the BayesFactor software [<xref ref-type="bibr" rid="CR39">39</xref>], written in R [<xref ref-type="bibr" rid="CR40">40</xref>], and point-and-click software like JASP [<xref ref-type="bibr" rid="CR41">41</xref>] and Jamovi [<xref ref-type="bibr" rid="CR42">42</xref>], the latter two of which are based to some extent on the BayesFactor software. However, these tools are mainly tailored towards research designs in the social sciences. Easy-to-use Bayesian tools and corresponding accessible software for the analysis of biomedical research designs specifically (e.g., superiority, equivalence, and non-inferiority) are still missing and, thus, urgently needed.</p>
    <p id="Par17">In this article, we provide an R package and a web application for conducting Bayesian hypothesis tests for superiority, equivalence, and non-inferiority designs, which is particularly relevant for the biomedical sciences. Although implementations for the superiority and equivalence test exist elsewhere, the implementation of the non-inferiority test is novel. The main objective of this manuscript is twofold: (1) to provide an easy-to-use software for the calculation of Bayes factors for common biomedical designs that can be used both by researchers who are comfortable programming and those who are not; (2) to provide a tutorial on how to use this software, using an applied example related to biomedicine. First, we outline the traditional frequentist approach to statistical testing for each of these designs. Second, we discuss the key disadvantages and potential pitfalls of this approach and motivate why Bayesian inferential techniques are better suited for these research designs. Third, we explain the conceptual background of Bayes factors [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR36">36</xref>]. Fourth, we provide and introduce baymedr [<xref ref-type="bibr" rid="CR43">43</xref>], an open-source software written in R [<xref ref-type="bibr" rid="CR40">40</xref>] that comes together with a web application (available at [<xref ref-type="bibr" rid="CR44">44</xref>]), for the computation of Bayes factors for common biomedical designs. We provide step-by-step instructions on how to use baymedr. Finally, we present a reanalysis of an existing empirical study to illustrate the most important features of the baymedr R package and the accompanying web application.</p>
    <sec id="Sec2">
      <title>Frequentist inference for superiority, equivalence and non-inferiority designs</title>
      <p id="Par18">The superiority, equivalence, and non-inferiority tests are concerned with research settings in which two conditions (e.g., control and experimental) are compared on some outcome measure [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. For instance, researchers might want to investigate whether a new antidepressant medication is superior, equivalent, or non-inferior compared to a well-established antidepressant. For a continuous outcome variable, the between-group comparison is typically made with one or two <italic>t</italic>-tests. The three designs differ, however, in the precise specification of the <italic>t</italic>-tests (see Fig. <xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Schematic depiction of the superiority, equivalence, and non-inferiority designs. The <italic>x</italic>-axis represents the true population effect size (<inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M6"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq3.gif"/></alternatives></inline-formula>), where <italic>c</italic> is the standardized equivalence margin in case of the equivalence test and the standardized non-inferiority margin in case of the non-inferiority test. Gray regions mark the null hypotheses and white regions the alternative hypotheses. The region with the diagonal black lines is not used for the one-sided superiority design. Note that the diagram assumes that high values on the measure of interest represent superior or non-inferior values and that a one-sided test is used for the superiority design</p></caption><graphic xlink:href="12874_2023_2097_Fig1_HTML" id="MO1"/></fig></p>
      <p id="Par19">In the following, we will assume that higher scores on the outcome measure of interest represent a more favorable outcome (i.e., superiority or non-inferiority) than lower scores. For example, high scores are favorable when the measure of interest represents the number of social interactions in patients with social anxiety, whereas low scores are favorable when the outcome variable is the number of depressive symptoms in patients with major depressive disorder. We will also assume that the outcome variable is continuous and that the residuals within both conditions are Normal distributed in the population, sharing a common population variance. Throughout this article, the true population effect size (<inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M8"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq4.gif"/></alternatives></inline-formula>) reflects the true standardized difference in the outcome between the experimental condition (i.e., <inline-formula id="IEq5"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {e}$$\end{document}</tex-math><mml:math id="M10"><mml:mtext>e</mml:mtext></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq5.gif"/></alternatives></inline-formula>) and the control condition (i.e., <inline-formula id="IEq6"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {c}$$\end{document}</tex-math><mml:math id="M12"><mml:mtext>c</mml:mtext></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq6.gif"/></alternatives></inline-formula>):<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \delta = \frac{\mu _{\text {e}}- \mu _{\text {c}}}{\sigma } \text {.} \end{aligned}$$\end{document}</tex-math><mml:math id="M14" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>μ</mml:mi><mml:mtext>e</mml:mtext></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mtext>c</mml:mtext></mml:msub></mml:mrow><mml:mi>σ</mml:mi></mml:mfrac><mml:mtext>.</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula></p>
      <sec id="Sec3">
        <title>The superiority design</title>
        <p id="Par20">The superiority design tests whether the experimental condition is superior to the control condition (see the first row of Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Conceptually, the superiority design consists of a one-sided test due to its inherent directionality. The null hypothesis <inline-formula id="IEq7"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M16"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq7.gif"/></alternatives></inline-formula> states that the true population effect size is zero, whereas the alternative hypotheses <inline-formula id="IEq8"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M18"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq8.gif"/></alternatives></inline-formula> states that the true population effect size is larger than zero:<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \mathcal {H} _0 {:}\ \, \delta =0\qquad \qquad \mathcal {H} _1 {:}\ \, \delta &gt;0 \text {.} \end{aligned}$$\end{document}</tex-math><mml:math id="M20" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mspace width="0.166667em"/><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mspace width="2em"/><mml:mspace width="2em"/><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mspace width="0.166667em"/><mml:mi>δ</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn><mml:mtext>.</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par21">To test these hypotheses, a one-sided <italic>t</italic>-test is conducted.<xref ref-type="fn" rid="Fn1">1</xref></p>
      </sec>
      <sec id="Sec4">
        <title>The equivalence design</title>
        <p id="Par22">The equivalence design tests whether the experimental and control conditions are practically equivalent (see the second row of Fig. <xref rid="Fig1" ref-type="fig">1</xref>). There are multiple approaches to equivalence testing (see, e.g., [<xref ref-type="bibr" rid="CR45">45</xref>]). A comprehensive treatment of all approaches is beyond the scope of this article. Here, we focus on one popular alternative: the two one-sided tests procedure (TOST; [<xref ref-type="bibr" rid="CR45">45</xref>–<xref ref-type="bibr" rid="CR49">49</xref>]). An equivalence interval must be defined, which can be based, for example, on the smallest effect size of interest [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]. The specification of the equivalence interval is not a statistical question; thus, it should be set by experts in the respective fields [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR48">48</xref>] or comply with regulatory guidelines [<xref ref-type="bibr" rid="CR52">52</xref>]. Importantly, however, the equivalence interval should be determined independent of the obtained data.</p>
        <p id="Par23">TOST involves conducting two one-sided <italic>t</italic>-tests, each one with its own null and alternative hypotheses. For the first test, the null hypothesis states that the true population effect size is smaller than the lower boundary of the equivalence interval, whereas the alternative hypothesis states that the true population effect size is larger than the lower boundary of the equivalence interval. For the second test, the null hypothesis states that the true population effect size is larger than the upper boundary of the equivalence interval, whereas the alternative hypothesis states that the true population effect size is smaller than the upper boundary of the equivalence interval. Assuming that the equivalence interval is symmetric around the null value, these hypotheses can be summarized as follows:<disp-formula id="Equ3"><label>3</label><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \mathcal {H} _0 {:}\ \delta \le -c ~ \text {OR} ~ \delta \ge c \qquad \qquad \mathcal {H} _1 {:}\ \delta &gt; -c\ \text {AND}\ \delta &lt; c \text {,} \end{aligned}$$\end{document}</tex-math><mml:math id="M22" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>≤</mml:mo><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mspace width="3.33333pt"/><mml:mtext>OR</mml:mtext><mml:mspace width="3.33333pt"/><mml:mi>δ</mml:mi><mml:mo>≥</mml:mo><mml:mi>c</mml:mi><mml:mspace width="2em"/><mml:mspace width="2em"/><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&gt;</mml:mo><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mspace width="4pt"/><mml:mtext>AND</mml:mtext><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>c</mml:mi><mml:mtext>,</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula>where <italic>c</italic> represents the margin of the standardized equivalence interval. Two <italic>p</italic>-values (<inline-formula id="IEq9"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p_{-c}$$\end{document}</tex-math><mml:math id="M24"><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq9.gif"/></alternatives></inline-formula> and <inline-formula id="IEq10"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p_{c}$$\end{document}</tex-math><mml:math id="M26"><mml:msub><mml:mi>p</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq10.gif"/></alternatives></inline-formula>) result from the application of the TOST procedure. We reject the null hypothesis of non-equivalence and, thus, establish equivalence if <inline-formula id="IEq11"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\max \left( p_{-c}, ~ p_{c} \right) &lt; \alpha$$\end{document}</tex-math><mml:math id="M28"><mml:mrow><mml:mo movablelimits="true">max</mml:mo><mml:mfenced close=")" open="("><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mspace width="3.33333pt"/><mml:msub><mml:mi>p</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mfenced><mml:mo>&lt;</mml:mo><mml:mi>α</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq11.gif"/></alternatives></inline-formula> (cf. [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]). In other words, both tests need to reach statistical significance.</p>
      </sec>
      <sec id="Sec5">
        <title>The non-inferiority design</title>
        <p id="Par24">In some situations, researchers are interested in testing whether the experimental condition is non-inferior or not worse than the control condition by a certain amount. This is the goal of the non-inferiority design, which consists of a one-tailed test (see the third row of Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Realistic applications might include testing the effectiveness of a new medication that has fewer undesirable adverse effects [<xref ref-type="bibr" rid="CR54">54</xref>], is cheaper [<xref ref-type="bibr" rid="CR55">55</xref>], or is easier to administer than the current medication [<xref ref-type="bibr" rid="CR56">56</xref>]. In these cases, we need to ponder the cost of a somewhat lower or equal effectiveness of the new treatment with the value of the just mentioned benefits [<xref ref-type="bibr" rid="CR57">57</xref>]. The null hypothesis states that the true population effect size is equal to a predetermined threshold, whereas the alternative hypothesis states that the true population effect size is higher than this threshold:<disp-formula id="Equ4"><label>4</label><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \mathcal {H} _0 {:}\ \delta =-c \qquad \qquad \mathcal {H} _1 {:}\ \delta &gt;-c \text {,} \end{aligned}$$\end{document}</tex-math><mml:math id="M30" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mspace width="2em"/><mml:mspace width="2em"/><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&gt;</mml:mo><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mtext>,</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ4.gif" position="anchor"/></alternatives></disp-formula>where <italic>c</italic> represents the standardized non-inferiority margin. As with the equivalence interval, the non-inferiority margin should be defined independent of the obtained data.</p>
      </sec>
      <sec id="Sec6">
        <title>Limitations of frequentist inference</title>
        <p id="Par25">Tests of superiority, equivalence, and non-inferiority have great value in biomedical research. It is the way researchers conduct their statistical analyses that, we argue, should be critically reconsidered. There are several disadvantages associated with the application of NHST to superiority, equivalence, and non-inferiority designs. Here, we limit our discussion to two disadvantages; for a more comprehensive exposition we refer the reader to other sources (e.g., [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>]).</p>
        <p id="Par26">First, researchers need to stick to a predetermined sampling plan [<xref ref-type="bibr" rid="CR60">60</xref>–<xref ref-type="bibr" rid="CR62">62</xref>]. That is, it is not legitimate to decide based on interim results to stop data collection (e.g., because the <italic>p</italic>-value is already smaller than <inline-formula id="IEq12"><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\alpha$$\end{document}</tex-math><mml:math id="M32"><mml:mi>α</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq12.gif"/></alternatives></inline-formula>) or to continue data collection beyond the predetermined sample size (e.g., because the <italic>p</italic>-value almost reaches statistical significance). In principle, researchers can correct for the fact that they inspected the data by reducing the required significance threshold through one of several techniques [<xref ref-type="bibr" rid="CR63">63</xref>]. However, such correction methods are rarely applied. Especially in biomedical research, the possibility of optional stopping could reduce the waste of resources for expensive and time-consuming trials [<xref ref-type="bibr" rid="CR64">64</xref>].</p>
        <p id="Par27">Second, with the traditional frequentist framework it is impossible to quantify evidence in favor of the null hypothesis [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR65">65</xref>–<xref ref-type="bibr" rid="CR67">67</xref>]. Oftentimes, the <italic>p</italic>-value is erroneously interpreted as a posterior probability, in the sense that it represents the probability of the null hypothesis [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. However, a non-significant <italic>p</italic>-value does not only occur when the null hypothesis is in fact true but also when the alternative hypothesis is true, yet there was not enough power to detect an effect [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]. As ([<xref ref-type="bibr" rid="CR71">71</xref>], p.485) put it: “Absence of evidence is not evidence of absence”. Still, a large proportion of biomedical studies falsely claim equivalence based on statistically non-significant <italic>t</italic>-tests [<xref ref-type="bibr" rid="CR72">72</xref>]. Yet, estimating evidence in favor of the null hypothesis is essential for certain designs like the equivalence test [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>].</p>
        <p id="Par28">The TOST procedure for equivalence testing provides a workaround for the problem that evidence for the null hypothesis cannot be quantified with traditional frequentist techniques by defining an equivalence interval around <inline-formula id="IEq13"><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta =0$$\end{document}</tex-math><mml:math id="M34"><mml:mrow><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq13.gif"/></alternatives></inline-formula> and conducting two tests. Without this interval the TOST procedure would inevitably fail (see [<xref ref-type="bibr" rid="CR45">45</xref>] for an explanation of why this is the case). As we will see, the Bayesian equivalence test does not have this restriction; it allows for the specification of interval as well as point null hypotheses.</p>
      </sec>
    </sec>
    <sec id="Sec7">
      <title>Bayesian tests for superiority, equivalence and non-inferiority designs</title>
      <p id="Par29">The Bayesian statistical framework provides a logically sound method to update beliefs about parameters based on new data [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. Bayesian inference can be divided into parameter estimation (e.g., estimating a population correlation) and model comparison (e.g., comparing the relative probabilities of the data under the null and alternative hypotheses) procedures (see, e.g., [<xref ref-type="bibr" rid="CR75">75</xref>], for an overview). Here, we will focus on the latter approach, which is usually accomplished with Bayes factors [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR36">36</xref>]. In our exposition of Bayes factors in general and specifically for superiority, equivalence, and non-inferiority designs, we mostly refrain from complex equations and derivations. Formulas are only provided when we think that they help to communicate the ideas and concepts. We refer readers interested in the mathematics of Bayes factors to other sources (e.g., [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR76">76</xref>–<xref ref-type="bibr" rid="CR78">78</xref>]). The precise derivation of Bayes factors for superiority, equivalence, and non-inferiority designs in particular is treated elsewhere [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR79">79</xref>].</p>
      <sec id="Sec8">
        <title>The Bayes factor</title>
        <p id="Par30">Let us suppose that we have two hypotheses, <inline-formula id="IEq14"><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M36"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq14.gif"/></alternatives></inline-formula> and <inline-formula id="IEq15"><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M38"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq15.gif"/></alternatives></inline-formula>, that we want to contrast. Without considering any data, we have initial beliefs about the probabilities of <inline-formula id="IEq16"><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M40"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq16.gif"/></alternatives></inline-formula> and <inline-formula id="IEq17"><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M42"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq17.gif"/></alternatives></inline-formula>, which are given by the prior probabilities <inline-formula id="IEq18"><alternatives><tex-math id="M43">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _0 \right)$$\end{document}</tex-math><mml:math id="M44"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq18.gif"/></alternatives></inline-formula> and <inline-formula id="IEq19"><alternatives><tex-math id="M45">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _1 \right) =1-p \left( \mathcal {H} _0 \right)$$\end{document}</tex-math><mml:math id="M46"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq19.gif"/></alternatives></inline-formula>. Now, we collect some data <italic>D</italic>. After having seen the data, we have new and refined beliefs about the probabilities that <inline-formula id="IEq20"><alternatives><tex-math id="M47">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M48"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq20.gif"/></alternatives></inline-formula> and <inline-formula id="IEq21"><alternatives><tex-math id="M49">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M50"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq21.gif"/></alternatives></inline-formula> are true, which are given by the posterior probabilities <inline-formula id="IEq22"><alternatives><tex-math id="M51">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _0 \mid D \right)$$\end{document}</tex-math><mml:math id="M52"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq22.gif"/></alternatives></inline-formula> and <inline-formula id="IEq23"><alternatives><tex-math id="M53">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _1 \mid D \right) =1-p \left( \mathcal {H} _0 \mid D \right)$$\end{document}</tex-math><mml:math id="M54"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq23.gif"/></alternatives></inline-formula>. In other words, we update our prior beliefs about the probabilities of <inline-formula id="IEq24"><alternatives><tex-math id="M55">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M56"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq24.gif"/></alternatives></inline-formula> and <inline-formula id="IEq25"><alternatives><tex-math id="M57">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M58"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq25.gif"/></alternatives></inline-formula> by incorporating what the data dictates we should believe and arrive at our posterior beliefs. This relation is expressed in Bayes’ rule:<disp-formula id="Equ5"><label>5</label><alternatives><tex-math id="M59">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \underbrace{p \left( \mathcal {H} _i \mid D \right) }_{\text {Posterior}} = \frac{\overbrace{p \left( D \mid \mathcal {H} _i \right) }^{\text {Likelihood}} \overbrace{p \left( \mathcal {H} _i \right) }^{\text {Prior}}}{\underbrace{p \left( D \mid \mathcal {H} _0 \right) p \left( \mathcal {H} _0 \right) +p \left( D \mid \mathcal {H} _1 \right) p \left( \mathcal {H} _1 \right) }_{\text {Marginal Likelihood}}} \text {,} \end{aligned}$$\end{document}</tex-math><mml:math id="M60" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:munder><mml:munder accentunder="true"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mo>⏟</mml:mo></mml:munder><mml:mtext>Posterior</mml:mtext></mml:munder><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mover><mml:mover accent="true"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow><mml:mo>⏞</mml:mo></mml:mover><mml:mtext>Likelihood</mml:mtext></mml:mover><mml:mover><mml:mover accent="true"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow><mml:mo>⏞</mml:mo></mml:mover><mml:mtext>Prior</mml:mtext></mml:mover></mml:mrow><mml:munder><mml:munder accentunder="true"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mo>+</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mo>⏟</mml:mo></mml:munder><mml:mrow><mml:mtext>Marginal Likelihood</mml:mtext></mml:mrow></mml:munder></mml:mfrac><mml:mtext>,</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ5.gif" position="anchor"/></alternatives></disp-formula>with <inline-formula id="IEq26"><alternatives><tex-math id="M61">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$i= \{0, ~ 1 \}$$\end{document}</tex-math><mml:math id="M62"><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mo stretchy="false">{</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mspace width="3.33333pt"/><mml:mn>1</mml:mn><mml:mo stretchy="false">}</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq26.gif"/></alternatives></inline-formula>, and where <inline-formula id="IEq27"><alternatives><tex-math id="M63">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _i \right)$$\end{document}</tex-math><mml:math id="M64"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq27.gif"/></alternatives></inline-formula> represents the prior probability of <inline-formula id="IEq28"><alternatives><tex-math id="M65">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _i$$\end{document}</tex-math><mml:math id="M66"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq28.gif"/></alternatives></inline-formula>, <inline-formula id="IEq29"><alternatives><tex-math id="M67">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( D \mid \mathcal {H} _i \right)$$\end{document}</tex-math><mml:math id="M68"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq29.gif"/></alternatives></inline-formula> denotes the likelihood of the data under <inline-formula id="IEq30"><alternatives><tex-math id="M69">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _i$$\end{document}</tex-math><mml:math id="M70"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq30.gif"/></alternatives></inline-formula>, <inline-formula id="IEq31"><alternatives><tex-math id="M71">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( D \mid \mathcal {H} _0 \right) p \left( \mathcal {H} _0 \right) +p \left( D \mid \mathcal {H} _1 \right) p \left( \mathcal {H} _1 \right)$$\end{document}</tex-math><mml:math id="M72"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mo>+</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq31.gif"/></alternatives></inline-formula> is the marginal likelihood (also called evidence; [<xref ref-type="bibr" rid="CR24">24</xref>]), and <inline-formula id="IEq32"><alternatives><tex-math id="M73">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _i \mid D \right)$$\end{document}</tex-math><mml:math id="M74"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq32.gif"/></alternatives></inline-formula> is the posterior probability of <inline-formula id="IEq33"><alternatives><tex-math id="M75">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _i$$\end{document}</tex-math><mml:math id="M76"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq33.gif"/></alternatives></inline-formula>.</p>
        <p id="Par31">As we will see, the likelihood in Eq. <xref rid="Equ5" ref-type="disp-formula">5</xref> is actually a marginal likelihood because each model (i.e., <inline-formula id="IEq34"><alternatives><tex-math id="M77">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M78"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq34.gif"/></alternatives></inline-formula> and <inline-formula id="IEq35"><alternatives><tex-math id="M79">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M80"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq35.gif"/></alternatives></inline-formula>) contains certain parameters that are integrated out. The denominator in Eq. <xref rid="Equ5" ref-type="disp-formula">5</xref> (labeled marginal likelihood) serves as a normalization constant, ensuring that the sum of the posterior probabilities is 1. Without this normalization constant, the posterior is still proportional to the product of the likelihood and the prior. Therefore, for <inline-formula id="IEq36"><alternatives><tex-math id="M81">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M82"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq36.gif"/></alternatives></inline-formula> and <inline-formula id="IEq37"><alternatives><tex-math id="M83">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M84"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq37.gif"/></alternatives></inline-formula> we can also write:<disp-formula id="Equ6"><label>6</label><alternatives><tex-math id="M85">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} p \left( \mathcal {H} _i \mid D \right) \propto p \left( D \mid \mathcal {H} _i \right) p \left( \mathcal {H} _i \right) \text {,} \end{aligned}$$\end{document}</tex-math><mml:math id="M86" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced><mml:mo>∝</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mtext>,</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ6.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq38"><alternatives><tex-math id="M87">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\propto$$\end{document}</tex-math><mml:math id="M88"><mml:mo>∝</mml:mo></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq38.gif"/></alternatives></inline-formula> means “is proportional to”.</p>
        <p id="Par32">Rather than using posterior probabilities for each hypothesis, let the ratio of the posterior probabilities for <inline-formula id="IEq39"><alternatives><tex-math id="M89">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M90"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq39.gif"/></alternatives></inline-formula> and <inline-formula id="IEq40"><alternatives><tex-math id="M91">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M92"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq40.gif"/></alternatives></inline-formula> be:<disp-formula id="Equ7"><label>7</label><alternatives><tex-math id="M93">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \underbrace{\frac{p \left( \mathcal {H} _0 \mid D \right) }{p \left( \mathcal {H} _1 \mid D \right) }}_{\text {Posterior odds}} = \underbrace{\frac{p \left( D \mid \mathcal {H} _0 \right) }{p \left( D \mid \mathcal {H} _1 \right) }}_{\text {Bayes factor,} ~ \text {BF}_{01}} \underbrace{\frac{p \left( \mathcal {H} _0 \right) }{p \left( \mathcal {H} _1 \right) }}_{\text {Prior odds}} \text {.} \end{aligned}$$\end{document}</tex-math><mml:math id="M94" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:munder><mml:munder accentunder="true"><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>⏟</mml:mo></mml:munder><mml:mrow><mml:mtext>Posterior odds</mml:mtext></mml:mrow></mml:munder><mml:mo>=</mml:mo><mml:munder><mml:munder accentunder="true"><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>⏟</mml:mo></mml:munder><mml:mrow><mml:mtext>Bayes factor,</mml:mtext><mml:mspace width="3.33333pt"/><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub></mml:mrow></mml:munder><mml:munder><mml:munder accentunder="true"><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>⏟</mml:mo></mml:munder><mml:mrow><mml:mtext>Prior odds</mml:mtext></mml:mrow></mml:munder><mml:mtext>.</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ7.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par33">The quantity <inline-formula id="IEq41"><alternatives><tex-math id="M95">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _0 \mid D \right) /p \left( \mathcal {H} _1 \mid D \right)$$\end{document}</tex-math><mml:math id="M96"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced><mml:mo stretchy="false">/</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq41.gif"/></alternatives></inline-formula> represents the posterior odds and the quantity <inline-formula id="IEq42"><alternatives><tex-math id="M97">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _0 \right) /p \left( \mathcal {H} _1 \right)$$\end{document}</tex-math><mml:math id="M98"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mo stretchy="false">/</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq42.gif"/></alternatives></inline-formula> is called the prior odds. To get the posterior odds, we have to multiply the prior odds with <inline-formula id="IEq43"><alternatives><tex-math id="M99">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( D \mid \mathcal {H} _0 \right) /p \left( D \mid \mathcal {H} _1 \right)$$\end{document}</tex-math><mml:math id="M100"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mo stretchy="false">/</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq43.gif"/></alternatives></inline-formula>, a quantity known as the Bayes factor [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR36">36</xref>], which is a ratio of marginal likelihoods:<disp-formula id="Equ8"><label>8</label><alternatives><tex-math id="M101">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \text {BF}_{01}= \frac{\int _{\varvec{\theta } _0} p \left( D \mid \varvec{\theta } _0, \mathcal {H} _0 \right) p \left( \varvec{\theta } _0 \mid \mathcal {H} _0 \right) d \varvec{\theta } _0}{\int _{\varvec{\theta } _1} p \left( D \mid \varvec{\theta } _1, \mathcal {H} _1 \right) p \left( \varvec{\theta } _1 \mid \mathcal {H} _1 \right) d \varvec{\theta } _1} \text {,} \end{aligned}$$\end{document}</tex-math><mml:math id="M102" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mo>∫</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>0</mml:mn></mml:msub></mml:msub><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>0</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mo>∫</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub></mml:msub><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mtext>,</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ8.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq44"><alternatives><tex-math id="M103">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\varvec{\theta } _0$$\end{document}</tex-math><mml:math id="M104"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq44.gif"/></alternatives></inline-formula> and <inline-formula id="IEq45"><alternatives><tex-math id="M105">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\varvec{\theta } _1$$\end{document}</tex-math><mml:math id="M106"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq45.gif"/></alternatives></inline-formula> are vectors of parameters under <inline-formula id="IEq46"><alternatives><tex-math id="M107">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M108"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq46.gif"/></alternatives></inline-formula> and <inline-formula id="IEq47"><alternatives><tex-math id="M109">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M110"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq47.gif"/></alternatives></inline-formula>, respectively. In other words, the marginal likelihoods in the numerator and denominator of Eq. <xref rid="Equ8" ref-type="disp-formula">8</xref> are weighted averages of the likelihoods, for which the weights are determined by the corresponding prior. In the case where one hypothesis has fixed values for the parameter vector <inline-formula id="IEq48"><alternatives><tex-math id="M111">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\varvec{\theta } _i$$\end{document}</tex-math><mml:math id="M112"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq48.gif"/></alternatives></inline-formula> (e.g., a point null hypothesis), integration over the parameter space and the specification of a prior is not required. In that case, the marginal likelihood becomes a likelihood.</p>
        <p id="Par34">The Bayes factor is the amount by which we would update our prior odds to obtain the posterior odds, after taking into consideration the data. For example, if we had prior odds of 2 and the Bayes factor is 24, then the posterior odds would be 48. In the special case where the prior odds is 1, the Bayes factor is equal to the posterior odds. A major advantage of the Bayes factor is its ease of interpretation. For example, if the Bayes factor (<inline-formula id="IEq49"><alternatives><tex-math id="M113">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{01}$$\end{document}</tex-math><mml:math id="M114"><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq49.gif"/></alternatives></inline-formula>, denoting the fact that <inline-formula id="IEq50"><alternatives><tex-math id="M115">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M116"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq50.gif"/></alternatives></inline-formula> is in the numerator and <inline-formula id="IEq51"><alternatives><tex-math id="M117">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M118"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq51.gif"/></alternatives></inline-formula> in the denominator) equals 10, the data are ten times more likely to have occurred under <inline-formula id="IEq52"><alternatives><tex-math id="M119">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M120"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq52.gif"/></alternatives></inline-formula> compared to <inline-formula id="IEq53"><alternatives><tex-math id="M121">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M122"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq53.gif"/></alternatives></inline-formula>. With <inline-formula id="IEq54"><alternatives><tex-math id="M123">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{01}=0.2$$\end{document}</tex-math><mml:math id="M124"><mml:mrow><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.2</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq54.gif"/></alternatives></inline-formula>, we can say that the data are five times more likely under <inline-formula id="IEq55"><alternatives><tex-math id="M125">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M126"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq55.gif"/></alternatives></inline-formula> compared to <inline-formula id="IEq56"><alternatives><tex-math id="M127">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M128"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq56.gif"/></alternatives></inline-formula> because we can simply take the reciprocal of <inline-formula id="IEq57"><alternatives><tex-math id="M129">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{01}$$\end{document}</tex-math><mml:math id="M130"><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq57.gif"/></alternatives></inline-formula> (i.e., <inline-formula id="IEq58"><alternatives><tex-math id="M131">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{10}=1/\text {BF}_{01}$$\end{document}</tex-math><mml:math id="M132"><mml:mrow><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>10</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq58.gif"/></alternatives></inline-formula>). What constitutes enough evidence is subjective and certainly depends on the context. Nevertheless, rules of thumb for evidence thresholds have been proposed. For instance, [<xref ref-type="bibr" rid="CR36">36</xref>] labeled Bayes factors between 1 and 3 as “not worth more than a bare mention”, Bayes factors between 3 and 20 as “positive”, those between 20 and 150 as “strong”, and anything above 150 as “very strong”, with corresponding thresholds for the reciprocals of the Bayes factors. An alternative classification scheme was already proposed before, with thresholds at 3, 10, 30, and 100 and similar labels [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR80">80</xref>].</p>
        <p id="Par35">Of course, we need to define <inline-formula id="IEq59"><alternatives><tex-math id="M133">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M134"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq59.gif"/></alternatives></inline-formula> and <inline-formula id="IEq60"><alternatives><tex-math id="M135">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M136"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq60.gif"/></alternatives></inline-formula>. In other words, both models contain certain parameters for which we need to determine a prior distribution. Here, we will assume that the residuals of the two groups are Normal distributed in the population with a common population variance. The shape of a Normal distribution is fully determined with the location (mean; <inline-formula id="IEq61"><alternatives><tex-math id="M137">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mu$$\end{document}</tex-math><mml:math id="M138"><mml:mi>μ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq61.gif"/></alternatives></inline-formula>) and the scale (variance; <inline-formula id="IEq62"><alternatives><tex-math id="M139">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma ^2$$\end{document}</tex-math><mml:math id="M140"><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq62.gif"/></alternatives></inline-formula>) parameters. Thus, in principle, both models contain two parameters. Now, we make two important changes.</p>
        <p id="Par36">First, in the case where we have a point null hypothesis, <inline-formula id="IEq63"><alternatives><tex-math id="M141">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mu$$\end{document}</tex-math><mml:math id="M142"><mml:mi>μ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq63.gif"/></alternatives></inline-formula> under <inline-formula id="IEq64"><alternatives><tex-math id="M143">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M144"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq64.gif"/></alternatives></inline-formula> is fixed at <inline-formula id="IEq65"><alternatives><tex-math id="M145">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta = 0$$\end{document}</tex-math><mml:math id="M146"><mml:mrow><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq65.gif"/></alternatives></inline-formula>, leaving <inline-formula id="IEq66"><alternatives><tex-math id="M147">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma ^2$$\end{document}</tex-math><mml:math id="M148"><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq66.gif"/></alternatives></inline-formula> for <inline-formula id="IEq67"><alternatives><tex-math id="M149">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M150"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq67.gif"/></alternatives></inline-formula> and <inline-formula id="IEq68"><alternatives><tex-math id="M151">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mu$$\end{document}</tex-math><mml:math id="M152"><mml:mi>μ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq68.gif"/></alternatives></inline-formula> and <inline-formula id="IEq69"><alternatives><tex-math id="M153">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma ^2$$\end{document}</tex-math><mml:math id="M154"><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq69.gif"/></alternatives></inline-formula> for <inline-formula id="IEq70"><alternatives><tex-math id="M155">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M156"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq70.gif"/></alternatives></inline-formula>. Parameter <inline-formula id="IEq71"><alternatives><tex-math id="M157">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma ^2$$\end{document}</tex-math><mml:math id="M158"><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq71.gif"/></alternatives></inline-formula> is a nuisance parameter because it is common to both models. Placing a Jeffreys prior (also called right Haar prior), <inline-formula id="IEq72"><alternatives><tex-math id="M159">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \sigma ^2 \right) \propto 1/ \sigma ^2$$\end{document}</tex-math><mml:math id="M160"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mfenced><mml:mo>∝</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq72.gif"/></alternatives></inline-formula>, on this nuisance parameter [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR81">81</xref>] has several desirable properties that are explained elsewhere (e.g., [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>]).</p>
        <p id="Par37">Second, <inline-formula id="IEq73"><alternatives><tex-math id="M161">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mu$$\end{document}</tex-math><mml:math id="M162"><mml:mi>μ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq73.gif"/></alternatives></inline-formula> under <inline-formula id="IEq74"><alternatives><tex-math id="M163">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M164"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq74.gif"/></alternatives></inline-formula> can be expressed in terms of a population effect size <inline-formula id="IEq75"><alternatives><tex-math id="M165">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M166"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq75.gif"/></alternatives></inline-formula> [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR81">81</xref>]. This establishes a common and comparable scale across experiments and populations [<xref ref-type="bibr" rid="CR67">67</xref>]. The prior on <inline-formula id="IEq76"><alternatives><tex-math id="M167">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M168"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq76.gif"/></alternatives></inline-formula> could reflect certain hypotheses that we want to test. For instance, we could compare the null hypothesis (<inline-formula id="IEq77"><alternatives><tex-math id="M169">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0 {:}\ \delta = 0$$\end{document}</tex-math><mml:math id="M170"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq77.gif"/></alternatives></inline-formula>) to a two-sided alternative hypotheses (<inline-formula id="IEq78"><alternatives><tex-math id="M171">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1 {:}\ \delta \ne 0$$\end{document}</tex-math><mml:math id="M172"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>≠</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq78.gif"/></alternatives></inline-formula>) or to one of two one-sided alternative hypotheses (<inline-formula id="IEq79"><alternatives><tex-math id="M173">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1 {:}\ \delta &lt; 0$$\end{document}</tex-math><mml:math id="M174"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq79.gif"/></alternatives></inline-formula> or <inline-formula id="IEq80"><alternatives><tex-math id="M175">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1 {:}\ \delta &gt; 0$$\end{document}</tex-math><mml:math id="M176"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq80.gif"/></alternatives></inline-formula>). Alternatively, we could compare an interval hypothesis for the null hypothesis (<inline-formula id="IEq81"><alternatives><tex-math id="M177">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0 {:}\ -c&lt; \delta &lt; c$$\end{document}</tex-math><mml:math id="M178"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>δ</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq81.gif"/></alternatives></inline-formula>) with a corresponding alternative hypothesis (<inline-formula id="IEq82"><alternatives><tex-math id="M179">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1 {:}\ \delta &lt; -c ~ \text {OR} ~ \delta &gt; c$$\end{document}</tex-math><mml:math id="M180"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&lt;</mml:mo><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mspace width="3.33333pt"/><mml:mtext>OR</mml:mtext><mml:mspace width="3.33333pt"/><mml:mi>δ</mml:mi><mml:mo>&gt;</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq82.gif"/></alternatives></inline-formula>).<xref ref-type="fn" rid="Fn2">2</xref> The choice of the specific prior for <inline-formula id="IEq88"><alternatives><tex-math id="M181">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M182"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq88.gif"/></alternatives></inline-formula> is a delicate matter, which is discussed in the next section.</p>
        <p id="Par38">In the most general case, the Bayes factor (i.e., <inline-formula id="IEq89"><alternatives><tex-math id="M183">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{01}$$\end{document}</tex-math><mml:math id="M184"><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq89.gif"/></alternatives></inline-formula>) can be calculated through division of the posterior odds by the prior odds (i.e., rearranging Eq. <xref rid="Equ7" ref-type="disp-formula">7</xref>):<disp-formula id="Equ9"><label>9</label><alternatives><tex-math id="M185">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \text {BF}_{01}= \frac{\left( \frac{p \left( \mathcal {H} _0 \mid D \right) }{p \left( \mathcal {H} _1 \mid D \right) } \right) }{\left( \frac{p \left( \mathcal {H} _0 \right) }{p \left( \mathcal {H} _1 \right) } \right) } = \frac{\left( \frac{p \left( \mathcal {H} _0 \mid D \right) }{p \left( \mathcal {H} _0 \right) } \right) }{\left( \frac{p \left( \mathcal {H} _1 \mid D \right) }{p \left( \mathcal {H} _1 \right) } \right) } \text {;} \end{aligned}$$\end{document}</tex-math><mml:math id="M186" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced></mml:mfrac><mml:mtext>;</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ9.gif" position="anchor"/></alternatives></disp-formula>accordingly, we can also calculate <inline-formula id="IEq90"><alternatives><tex-math id="M187">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{10}$$\end{document}</tex-math><mml:math id="M188"><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>10</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq90.gif"/></alternatives></inline-formula>:<disp-formula id="Equ10"><label>10</label><alternatives><tex-math id="M189">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \text {BF}_{10}= \frac{\left( \frac{p \left( \mathcal {H} _1 \mid D \right) }{p \left( \mathcal {H} _0 \mid D \right) } \right) }{\left( \frac{p \left( \mathcal {H} _1 \right) }{p \left( \mathcal {H} _0 \right) } \right) } = \frac{\left( \frac{p \left( \mathcal {H} _1 \mid D \right) }{p \left( \mathcal {H} _1 \right) } \right) }{\left( \frac{p \left( \mathcal {H} _0 \mid D \right) }{p \left( \mathcal {H} _0 \right) } \right) } \text {.} \end{aligned}$$\end{document}</tex-math><mml:math id="M190" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>10</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced></mml:mfrac><mml:mtext>.</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ10.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par39">Calculating Bayes factors this way often involves solving complex integrals (see, e.g., Eq. <xref rid="Equ8" ref-type="disp-formula">8</xref>; also cf. [<xref ref-type="bibr" rid="CR76">76</xref>]). Fortunately, there is a computational shortcut for the specific but very common scenario where we have a point null hypothesis and a complementary interval alternative hypothesis. This shortcut, which is called the Savage-Dickey density ratio, takes the ratio of the density of the prior and posterior at the null value under the alternative hypothesis to calculate the Bayes factor; this is explained in more detail elsewhere [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR85">85</xref>].</p>
      </sec>
      <sec id="Sec9">
        <title>Default priors</title>
        <p id="Par40">Until this point in our exposition, we were quite vague about the form of the prior for <inline-formula id="IEq91"><alternatives><tex-math id="M191">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M192"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq91.gif"/></alternatives></inline-formula> under <inline-formula id="IEq92"><alternatives><tex-math id="M193">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M194"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq92.gif"/></alternatives></inline-formula>. In principle, the prior for <inline-formula id="IEq93"><alternatives><tex-math id="M195">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M196"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq93.gif"/></alternatives></inline-formula> within <inline-formula id="IEq94"><alternatives><tex-math id="M197">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M198"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq94.gif"/></alternatives></inline-formula> can be defined as desired, conforming to the beliefs of the researcher. In fact, this is a fundamental part of Bayesian inference because various priors allow for the expression of a theory or prior beliefs [<xref ref-type="bibr" rid="CR86">86</xref>, <xref ref-type="bibr" rid="CR87">87</xref>]. Most commonly, however, default or objective priors are employed that aim to increase the objectivity in specifying the prior or serve as a default when no specific prior information is available [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR88">88</xref>]. We employ objective priors in baymedr.</p>
        <p id="Par41">In the situation where we have a point null hypothesis and an alternative hypothesis that involves a range of values, [<xref ref-type="bibr" rid="CR35">35</xref>] proposed to use a Cauchy prior with a scale parameter of <inline-formula id="IEq95"><alternatives><tex-math id="M199">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$r=1$$\end{document}</tex-math><mml:math id="M200"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq95.gif"/></alternatives></inline-formula> for <inline-formula id="IEq96"><alternatives><tex-math id="M201">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M202"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq96.gif"/></alternatives></inline-formula> under <inline-formula id="IEq97"><alternatives><tex-math id="M203">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M204"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq97.gif"/></alternatives></inline-formula>. This Cauchy distribution is equivalent to a Student’s <italic>t</italic> distribution with 1 degree of freedom and resembles a standard Normal distribution, except that the Cauchy distribution has less mass at the center but instead heavier tails (see Fig. <xref rid="Fig2" ref-type="fig">2</xref>; [<xref ref-type="bibr" rid="CR67">67</xref>]). Mathematically, the Cauchy distribution corresponds to the combined specification of (1) a Normal prior with mean <inline-formula id="IEq98"><alternatives><tex-math id="M205">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mu _ \delta$$\end{document}</tex-math><mml:math id="M206"><mml:msub><mml:mi>μ</mml:mi><mml:mi>δ</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq98.gif"/></alternatives></inline-formula> and variance <inline-formula id="IEq99"><alternatives><tex-math id="M207">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma ^2_ \delta$$\end{document}</tex-math><mml:math id="M208"><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>δ</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq99.gif"/></alternatives></inline-formula> on <inline-formula id="IEq100"><alternatives><tex-math id="M209">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M210"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq100.gif"/></alternatives></inline-formula>; and (2) an inverse Chi-square distribution with 1 degree of freedom on <inline-formula id="IEq101"><alternatives><tex-math id="M211">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma ^2_ \delta$$\end{document}</tex-math><mml:math id="M212"><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>δ</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq101.gif"/></alternatives></inline-formula>. Integrating out <inline-formula id="IEq102"><alternatives><tex-math id="M213">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma ^2_ \delta$$\end{document}</tex-math><mml:math id="M214"><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>δ</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq102.gif"/></alternatives></inline-formula> yields the Cauchy distribution [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR89">89</xref>]. The scale parameter <italic>r</italic> defines the width of the Cauchy distribution; that is, half of the mass lies between –<italic>r</italic> and <italic>r</italic>.<fig id="Fig2"><label>Fig. 2</label><caption><p>Comparison of the standard Normal probability density function (solid line) and the standard Cauchy probability density function (dashed line)</p></caption><graphic xlink:href="12874_2023_2097_Fig2_HTML" id="MO2"/></fig></p>
        <p id="Par42">Choosing a Cauchy prior with a location parameter of 0 and a scale parameter of <inline-formula id="IEq103"><alternatives><tex-math id="M215">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$r=1$$\end{document}</tex-math><mml:math id="M216"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq103.gif"/></alternatives></inline-formula> has the advantage that the resulting Bayes factor is 1 in case of completely uninformative data. In turn, the Bayes factor approaches infinity (or 0) for decisive data [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR82">82</xref>]. Still, by varying the Cauchy scale parameter, we can set a different emphasis on the prior credibility of a range of effect sizes. More recently, a Cauchy prior scale of <inline-formula id="IEq104"><alternatives><tex-math id="M217">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$r=1/ \sqrt{2}$$\end{document}</tex-math><mml:math id="M218"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:msqrt><mml:mn>2</mml:mn></mml:msqrt></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq104.gif"/></alternatives></inline-formula> is used as a default setting in the BayesFactor software [<xref ref-type="bibr" rid="CR39">39</xref>], the point-and-click software JASP [<xref ref-type="bibr" rid="CR41">41</xref>], and Jamovi [<xref ref-type="bibr" rid="CR42">42</xref>]. We have adopted this value in baymedr as a default setting. Nevertheless, objective priors are often criticized (see, e.g., [<xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR91">91</xref>]); researchers are encouraged to use more informed priors if relevant knowledge is available [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR79">79</xref>].</p>
      </sec>
    </sec>
  </sec>
  <sec id="Sec10">
    <title>Implementation</title>
    <p id="Par43">With the baymedr software (BAYesian inference for MEDical designs in R; [<xref ref-type="bibr" rid="CR43">43</xref>]), written in R [<xref ref-type="bibr" rid="CR40">40</xref>], and the corresponding web application (accessible at [<xref ref-type="bibr" rid="CR44">44</xref>]) one can easily calculate Bayes factors for superiority, equivalence, and non-inferiority designs. The R package can be used by researchers who have only rudimentary knowledge of R; if that is not the case, researchers can use the web application, which does not require any knowledge of programming. In the following, we will demonstrate how Bayes factors for superiority, equivalence, and non-inferiority designs can be calculated with the baymedr R package; a thorough explanation of the web application is not necessary as it strongly overlaps with the R package. Subsequently, we will showcase (1) the baymedr R package and (2) the corresponding web application by reanalyzing data of an empirical study by [<xref ref-type="bibr" rid="CR92">92</xref>].</p>
    <sec id="Sec11">
      <title>The R package</title>
      <sec id="Sec12">
        <title>Install and load baymedr</title>
        <p id="Par44">To install the latest release of the baymedr R package from The Comprehensive R Archive Network (CRAN), use the following command: <graphic position="anchor" xlink:href="12874_2023_2097_Figa_HTML" id="MO3"/></p>
        <p id="Par45">The most recent version of the R package can be obtained from GitHub with the help of the devtools package [<xref ref-type="bibr" rid="CR93">93</xref>]: <graphic position="anchor" xlink:href="12874_2023_2097_Figb_HTML" id="MO4"/></p>
        <p id="Par46">Once baymedr is installed, it needs to be loaded into memory, after which it is ready for usage: <graphic position="anchor" xlink:href="12874_2023_2097_Figc_HTML" id="MO5"/></p>
      </sec>
      <sec id="Sec13">
        <title>Commonalities across designs</title>
        <p id="Par47">For all three research designs, the user has three options for data input (function arguments that have “x” as a name or suffix refer to the control condition and those with “y” as a name or suffix to the experimental condition): (1) provide the raw data; the relevant arguments are x and y; (2) provide the sample sizes, sample means, and sample standard deviations; the relevant arguments are n_x and n_y for sample sizes, mean_x and mean_y for sample means, and sd_x and sd_y for sample standard deviations; (3) provide the sample sizes, sample means, and the confidence interval for the difference in group means; the relevant arguments are n_x and n_y for sample sizes, mean_x and mean_y for sample means, and ci_margin for the confidence interval margin and ci_level for the confidence level.</p>
        <p id="Par48">The Cauchy distribution is used as the prior for <inline-formula id="IEq105"><alternatives><tex-math id="M219">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M220"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq105.gif"/></alternatives></inline-formula> under the alternative hypothesis for all three tests. The user can set the width of the Cauchy prior with the prior_scale argument, thus, allowing the specification of different ranges of plausible effect sizes. In all three cases, the Cauchy prior is centered on <inline-formula id="IEq106"><alternatives><tex-math id="M221">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta =0$$\end{document}</tex-math><mml:math id="M222"><mml:mrow><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq106.gif"/></alternatives></inline-formula>. Further, baymedr uses a default Cauchy prior scale of <inline-formula id="IEq107"><alternatives><tex-math id="M223">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$r=1/ \sqrt{2}$$\end{document}</tex-math><mml:math id="M224"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:msqrt><mml:mn>2</mml:mn></mml:msqrt></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq107.gif"/></alternatives></inline-formula>, complying with the standard settings of the BayesFactor software [<xref ref-type="bibr" rid="CR39">39</xref>], JASP [<xref ref-type="bibr" rid="CR41">41</xref>], and Jamovi [<xref ref-type="bibr" rid="CR42">42</xref>].</p>
        <p id="Par49">Once a superiority, equivalence, or non-inferiority test is conducted, an informative and accessible output message is printed in the console. For all three designs, this output states the type of test that was conducted and whether raw or summary data were used. Moreover, the corresponding null and alternative hypotheses are restated and the specified Cauchy prior scale is shown. In addition, the lower and upper bounds of the equivalence interval are presented in case an equivalence test was employed; similarly, the non-inferiority margin is printed when the non-inferiority design was chosen. Lastly, the resulting Bayes factor is shown. To avoid any confusion, it is declared in brackets whether the Bayes factor quantifies evidence towards the null (e.g., equivalence) or alternative (e.g., non-inferiority or superiority) hypothesis.</p>
      </sec>
      <sec id="Sec14">
        <title>Conducting superiority, equivalence and non-inferiority tests</title>
        <p id="Par50">The Bayesian superiority test is performed with the super_bf() function. Depending on the research setting, low or high scores on the measure of interest represent “superiority”, which is specified by the argument direction. Since we seek to find evidence for the alternative hypothesis (superiority), the Bayes factor quantifies evidence for <inline-formula id="IEq108"><alternatives><tex-math id="M225">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M226"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq108.gif"/></alternatives></inline-formula> relative to <inline-formula id="IEq109"><alternatives><tex-math id="M227">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M228"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq109.gif"/></alternatives></inline-formula> (i.e., <inline-formula id="IEq110"><alternatives><tex-math id="M229">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{10}$$\end{document}</tex-math><mml:math id="M230"><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>10</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq110.gif"/></alternatives></inline-formula>).</p>
        <p id="Par51">The Bayesian equivalence test is done with the equiv_bf() function. The desired equivalence interval is specified with the interval argument. Several options are possible: A symmetric equivalence interval around <inline-formula id="IEq111"><alternatives><tex-math id="M231">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta =0$$\end{document}</tex-math><mml:math id="M232"><mml:mrow><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq111.gif"/></alternatives></inline-formula> can be indicated by providing one value (e.g., interval = 0.2) or by providing a vector with the negative and the positive values (e.g., interval = c(-0.2, 0.2)). An asymmetric equivalence interval can be specified by providing a vector with the negative and the positive values (e.g., interval = c(-0.3, 0.2)). The implementation of a point null hypothesis is achieved by using either interval = 0 or interval = c(0, 0), which also serves as the default specification. The argument interval_std can be used to declare whether the equivalence interval was specified in standardized or unstandardized units. Since we seek to quantify evidence towards equivalence, we contrast the evidence for <inline-formula id="IEq112"><alternatives><tex-math id="M233">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M234"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq112.gif"/></alternatives></inline-formula> relative to <inline-formula id="IEq113"><alternatives><tex-math id="M235">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M236"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq113.gif"/></alternatives></inline-formula> (i.e., <inline-formula id="IEq114"><alternatives><tex-math id="M237">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{01}$$\end{document}</tex-math><mml:math id="M238"><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq114.gif"/></alternatives></inline-formula>).</p>
        <p id="Par52">The Bayes factor for the non-inferiority design is calculated with the infer_bf() function. The value for the non-inferiority margin can be specified with the ni_margin argument. The argument ni_margin_std can be used to declare whether the non-inferiority margin was given in standardized or unstandardized units. Lastly, depending on whether high or low values on the measure of interest represent “non-inferiority”, one of the options “high” or “low” should be set for the argument direction. We wish to determine the evidence in favor of <inline-formula id="IEq115"><alternatives><tex-math id="M239">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M240"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq115.gif"/></alternatives></inline-formula>; therefore, the evidence is expressed for <inline-formula id="IEq116"><alternatives><tex-math id="M241">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M242"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq116.gif"/></alternatives></inline-formula> relative to <inline-formula id="IEq117"><alternatives><tex-math id="M243">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M244"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq117.gif"/></alternatives></inline-formula> (i.e., <inline-formula id="IEq118"><alternatives><tex-math id="M245">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{10}$$\end{document}</tex-math><mml:math id="M246"><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>10</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq118.gif"/></alternatives></inline-formula>).</p>
      </sec>
    </sec>
  </sec>
  <sec id="Sec15">
    <title>Results</title>
    <p id="Par53">To illustrate how the R package and the web application can be used, we provide one example of an empirical study that employed non-inferiority tests to investigate differences in the amount of sleep, sleepiness, and alertness among medical trainees following either standard or flexible duty-hour programs [<xref ref-type="bibr" rid="CR92">92</xref>]. The authors list several disadvantages of restricted duty-hour programs, such as: (1) “[t]ransitions [as a result of restricted duty hours] into and out of night shifts can result in fatigue from shift-work-related sleep loss and circadian misalignment”; (2) “[p]reventing interns from participating in extended shifts may reduce educational opportunities”; (3) “increase[d] handoffs”; (4) “reduce[d] continuity of care”; and (5) “[r]estricting duty hours may increase the necessity of cross-coverage, contributing to work compression for both interns and more senior residents” ([<xref ref-type="bibr" rid="CR92">92</xref>], p.916). As outlined above, the calculation of Bayes factors for equivalence and superiority tests is done quite similarly to the non-inferiority test, so we do not provide specific examples for those tests. For the purpose of this demonstration, we will only consider the outcome variable sleepiness. Participants were monitored over a period of 14 days and were asked to indicate each morning how sleepy they were by completing the Karolinska sleepiness scale [<xref ref-type="bibr" rid="CR94">94</xref>], a 9-point Likert scale ranging from 1 (extremely alert) to 9 (extremely sleepy, fighting sleep). The dependent variable consisted of the average sleepiness score over the whole observation period of 14 days. The research question was whether the flexible duty-hour program was non-inferior to the standard program in terms of sleepiness.</p>
    <p id="Par54">The null hypothesis was that medical trainees in the flexible program are sleepier by more than a non-inferiority margin than trainees in the standard program. Conversely, the alternative hypothesis was that trainees in the flexible program are not sleepier by more than a non-inferiority margin than trainees in the standard program. The non-inferiority margin was defined as 1 point on the 9-point Likert scale. All relevant summary statistics can be obtained or calculated from Table 1 of [<xref ref-type="bibr" rid="CR92">92</xref>] and the Results section of [<xref ref-type="bibr" rid="CR92">92</xref>]. Table 1 of [<xref ref-type="bibr" rid="CR92">92</xref>] indicates that the flexible program had a mean of <inline-formula id="IEq119"><alternatives><tex-math id="M247">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$M_e=4.8$$\end{document}</tex-math><mml:math id="M248"><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>4.8</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq119.gif"/></alternatives></inline-formula> and the standard program had a mean of <inline-formula id="IEq120"><alternatives><tex-math id="M249">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$M_c=4.7$$\end{document}</tex-math><mml:math id="M250"><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>4.7</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq120.gif"/></alternatives></inline-formula>. From the Results section of [<xref ref-type="bibr" rid="CR92">92</xref>], we can extract that sample sizes were <inline-formula id="IEq121"><alternatives><tex-math id="M251">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n_e=205$$\end{document}</tex-math><mml:math id="M252"><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>205</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq121.gif"/></alternatives></inline-formula> and <inline-formula id="IEq122"><alternatives><tex-math id="M253">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n_c=193$$\end{document}</tex-math><mml:math id="M254"><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>193</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq122.gif"/></alternatives></inline-formula> in the flexible and standard programs, respectively. Further, the margin of the <inline-formula id="IEq123"><alternatives><tex-math id="M255">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$95 \%$$\end{document}</tex-math><mml:math id="M256"><mml:mrow><mml:mn>95</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq123.gif"/></alternatives></inline-formula> CI of the difference between the two conditions was <inline-formula id="IEq124"><alternatives><tex-math id="M257">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$0.31-0.12=0.19$$\end{document}</tex-math><mml:math id="M258"><mml:mrow><mml:mn>0.31</mml:mn><mml:mo>-</mml:mo><mml:mn>0.12</mml:mn><mml:mo>=</mml:mo><mml:mn>0.19</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq124.gif"/></alternatives></inline-formula>. Finally, lower scores on the sleepiness scale constitute favorable (non-inferior) outcomes.</p>
    <sec id="Sec16">
      <title>The R package</title>
      <p id="Par55">Using this information, we can use the baymedr R package to calculate the Bayes factor as follows: <graphic position="anchor" xlink:href="12874_2023_2097_Figd_HTML" id="MO6"/></p>
      <p id="Par56">Note that we decided to use a Cauchy prior scale of <inline-formula id="IEq125"><alternatives><tex-math id="M259">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$r=1/ \sqrt{2}$$\end{document}</tex-math><mml:math id="M260"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:msqrt><mml:mn>2</mml:mn></mml:msqrt></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq125.gif"/></alternatives></inline-formula> for this reanalysis. Since our Cauchy prior scale of choice represents the default value in baymedr, it would not have been necessary to provide this argument; however, for purposes of illustration, we mentioned it explicitly in the function call.</p>
      <p id="Par57">The output provides a user-friendly summary of the analysis: <graphic position="anchor" xlink:href="12874_2023_2097_Fige_HTML" id="MO7"/></p>
      <p id="Par58">This large Bayes factor supports the conclusion from [<xref ref-type="bibr" rid="CR92">92</xref>] that medical trainees in the flexible duty-hour program are non-inferior in terms of sleepiness compared to medical trainees in the standard program (<inline-formula id="IEq126"><alternatives><tex-math id="M261">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p&lt;.001$$\end{document}</tex-math><mml:math id="M262"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mo>.</mml:mo><mml:mn>001</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq126.gif"/></alternatives></inline-formula>). In other words, the data are <inline-formula id="IEq127"><alternatives><tex-math id="M263">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$8.56 \times {10}^{10}$$\end{document}</tex-math><mml:math id="M264"><mml:mrow><mml:mn>8.56</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>10</mml:mn></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq127.gif"/></alternatives></inline-formula> more likely to have occurred under <inline-formula id="IEq128"><alternatives><tex-math id="M265">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M266"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq128.gif"/></alternatives></inline-formula> than <inline-formula id="IEq129"><alternatives><tex-math id="M267">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M268"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq129.gif"/></alternatives></inline-formula>.</p>
    </sec>
    <sec id="Sec17">
      <title>The web application</title>
      <p id="Par59">Similarly, we can use the web application to calculate the Bayes factor. For this, the web application should first be opened in a web browser (available at [<xref ref-type="bibr" rid="CR44">44</xref>]). The just-opened welcome page offers a brief description of the three research designs and Bayes factors and lists several further useful resources for the interested user. Since we want to conduct a non-inferiority test with summary data, we click on “Non-inferiority” and then “Summary data” on the navigation bar at the top (see Fig. <xref rid="Fig3" ref-type="fig">3</xref>). The summary statistics for the example reanalysis of [<xref ref-type="bibr" rid="CR92">92</xref>] can be inserted in the corresponding fields, as shown in Fig. <xref rid="Fig3" ref-type="fig">3</xref>. For some fields a small green question mark is shown, which provides more details and help when the user clicks on them. Furthermore, the scale of the prior distribution can be specified, which by default is set to 1 / sqrt(2). A small dynamic plot accompanies the field for the Cauchy prior scale. That is, once the prior scale is changed, the plot updates automatically, so that users obtain an impression of what the distribution looks like and what effect sizes are included. Once the “Calculate Bayes factor” button is clicked, the output is displayed.<fig id="Fig3"><label>Fig. 3</label><caption><p>Shown is part of the baymedr web application demonstrating how summary statistics can be inserted and further parameters specified for a Bayesian non-inferiority test. In this specific case, the summary statistics correspond to the ones obtained from [<xref ref-type="bibr" rid="CR92">92</xref>]. See text for details</p></caption><graphic xlink:href="12874_2023_2097_Fig3_HTML" id="MO8"/></fig></p>
      <p id="Par60">Figure <xref rid="Fig4" ref-type="fig">4</xref> shows the output of the calculations. The top of the left column displays the same output that is given with the R package. Further, upon clicking on “Show frequentist results”, the results of the frequentist non-inferiority test are shown and clicking on “Hide frequentist results” in turn hides those results. Below that output is the formula for the Bayes factor, with different elements printed in colors that correspond to dots in matching colors in the plots on the right column of the results output. The upper plot shows the prior and posterior for contrasting <inline-formula id="IEq130"><alternatives><tex-math id="M269">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0{:}\ \delta = c$$\end{document}</tex-math><mml:math id="M270"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq130.gif"/></alternatives></inline-formula> with <inline-formula id="IEq131"><alternatives><tex-math id="M271">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1{:}\ \delta &lt; c$$\end{document}</tex-math><mml:math id="M272"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq131.gif"/></alternatives></inline-formula>. The two distributions are truncated, meaning that they are cut off at <inline-formula id="IEq132"><alternatives><tex-math id="M273">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta = c$$\end{document}</tex-math><mml:math id="M274"><mml:mrow><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq132.gif"/></alternatives></inline-formula>. Similarly, the lower plot shows the truncated prior and posterior for contrasting <inline-formula id="IEq133"><alternatives><tex-math id="M275">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0{:}\ \delta = c$$\end{document}</tex-math><mml:math id="M276"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq133.gif"/></alternatives></inline-formula> with <inline-formula id="IEq134"><alternatives><tex-math id="M277">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1{:}\ \delta &gt; c$$\end{document}</tex-math><mml:math id="M278"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&gt;</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq134.gif"/></alternatives></inline-formula>. Through a heuristic called the Savage-Dickey density ratio [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR85">85</xref>], the ratio of the heights of the colored dots gives us the Bayes factor (see the colored expressions in the formula on the right side of the results output). The text above the two plots explains the plots as well.<fig id="Fig4"><label>Fig. 4</label><caption><p>Shown is part of the baymedr web application showing the results of a Bayesian non-inferiority test. In this specific case, the results correspond to a reanalysis using summary statistics obtained from [<xref ref-type="bibr" rid="CR92">92</xref>]. See text for details</p></caption><graphic xlink:href="12874_2023_2097_Fig4_HTML" id="MO9"/></fig></p>
    </sec>
  </sec>
  <sec id="Sec18">
    <title>Conclusions</title>
    <p id="Par61">Tests of superiority, equivalence, and non-inferiority are important means to compare the effectiveness of medications and treatments in biomedical research. Despite several limitations, researchers overwhelmingly rely on traditional frequentist inference to analyze the corresponding data for these research designs [<xref ref-type="bibr" rid="CR5">5</xref>]. Bayes factors [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR36">36</xref>] are an attractive alternative to NHST and <italic>p</italic>-values because they allow researchers to quantify evidence in favor of the null hypothesis [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>] and permit sequential testing and optional stopping [<xref ref-type="bibr" rid="CR60">60</xref>–<xref ref-type="bibr" rid="CR62">62</xref>]. In fact, the possibility for optional stopping and sequential testing has the potential to largely reduce the waste of scarce resources. This is especially important in the field of biomedicine, where clinical trials might be expensive or even harmful for participants.</p>
    <p id="Par62">Although Bayes factors have many advantages over NHST, they bring along their own challenges (for a discussion, see [<xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR96">96</xref>]). For instance, the choice of the prior distribution can have a large impact on the resulting Bayes factor [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR86">86</xref>, <xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR91">91</xref>, <xref ref-type="bibr" rid="CR97">97</xref>, <xref ref-type="bibr" rid="CR98">98</xref>]. In the extreme case, the Bayes factor and results from frequentist analyses can lead to diverging conclusions, something known as Lindley’s paradox [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR99">99</xref>]. Thus, the choice of prior distribution is important but subjective and often difficult to make. Most of the time, however, Bayes factors and results from NHST are in agreement [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. Related to that, misspecification of the model might lead to erroneous and misleading conclusions. That is, a Bayes factor only makes a comparison of the models under investigation (i.e., <inline-formula id="IEq135"><alternatives><tex-math id="M279">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M280"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq135.gif"/></alternatives></inline-formula> and <inline-formula id="IEq136"><alternatives><tex-math id="M281">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M282"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq136.gif"/></alternatives></inline-formula>). If these models are inadequate or do not fulfill certain assumptions (e.g., Normality of residuals), the Bayes factor might not be trustworthy. Moreover, the Bayes factor is not immune to misinterpretations: [<xref ref-type="bibr" rid="CR100">100</xref>] have shown that among the most common false interpretations of Bayes factors are the interpretation of a Bayes factor as posterior odds (i.e., a ratio of probabilities in favor of or against <inline-formula id="IEq137"><alternatives><tex-math id="M283">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M284"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq137.gif"/></alternatives></inline-formula> and <inline-formula id="IEq138"><alternatives><tex-math id="M285">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M286"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq138.gif"/></alternatives></inline-formula>) and ignoring that Bayes factors only provide relative instead of absolute evidence (see also [<xref ref-type="bibr" rid="CR90">90</xref>]). Lastly, the computation of Bayes factors is complex and involves solving integrals [<xref ref-type="bibr" rid="CR90">90</xref>]. For this reason, easy-to-use software is needed.</p>
    <p id="Par63">Our baymedr R package and web application [<xref ref-type="bibr" rid="CR43">43</xref>] enable researchers to conduct Bayesian superiority, equivalence, and non-inferiority tests. baymedr is characterized by a user-friendly implementation, making it convenient for researchers who are not statistical experts. Furthermore, using baymedr, it is possible to calculate Bayes factors based on raw data and summary statistics, allowing for the reanalysis of published studies, for which the full data set is not available. To further promote the use of Bayesian statistics in biomedical research, more easy-to-use software and tutorial papers are urgently needed.</p>
  </sec>
  <sec id="Sec19">
    <title>Availability and requirements</title>
    <p id="Par64">Project name: baymedr</p>
    <p id="Par65">Project home page: <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/baymedr/index.html">https://cran.r-project.org/web/packages/baymedr/index.html</ext-link></p>
    <p id="Par66">Operating system(s): Platform independent</p>
    <p id="Par67">Programming language: R</p>
    <p id="Par68">Other requirements: Not applicable.</p>
    <p id="Par69">License: GPL-3</p>
    <p id="Par70">Any restrictions to use by non-academics: Not applicable.</p>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>NHST</term>
        <def>
          <p id="Par4">Null hypothesis significance testing</p>
        </def>
      </def-item>
      <def-item>
        <term>TOST</term>
        <def>
          <p id="Par5">Two one-sided tests</p>
        </def>
      </def-item>
      <def-item>
        <term>CRAN</term>
        <def>
          <p id="Par6">Comprehensive R Archive Network</p>
        </def>
      </def-item>
      <def-item>
        <term>CI</term>
        <def>
          <p id="Par7">Confidence interval</p>
        </def>
      </def-item>
      <def-item>
        <term>Fig</term>
        <def>
          <p id="Par8">Figure</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn id="Fn1">
      <label>1</label>
      <p id="Par74">Researchers often conduct a two-sided <italic>t</italic>-test and then confirm that the observed effect goes in the expected direction. We do not describe this approach because we have the opinion that a one-sided <italic>t</italic>-test should be conducted for the superiority test, whose name already implies a uni-directional alternative hypothesis.</p>
    </fn>
    <fn id="Fn2">
      <label>2</label>
      <p id="Par75">Note that the hypotheses represent exactly the opposite of the hypotheses in TOST (i.e., <inline-formula id="IEq83"><alternatives><tex-math id="M287">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M288"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq83.gif"/></alternatives></inline-formula> of equivalence corresponds to <inline-formula id="IEq84"><alternatives><tex-math id="M289">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M290"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq84.gif"/></alternatives></inline-formula> of equivalence in TOST, and vice versa). Evidence in favor of equivalence in TOST can only be obtained by rejecting two null hypotheses: <inline-formula id="IEq85"><alternatives><tex-math id="M291">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0 {:}\ \delta &lt; -c$$\end{document}</tex-math><mml:math id="M292"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&lt;</mml:mo><mml:mo>-</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq85.gif"/></alternatives></inline-formula> and <inline-formula id="IEq86"><alternatives><tex-math id="M293">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0 {:}\ \delta &gt; c$$\end{document}</tex-math><mml:math id="M294"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&gt;</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq86.gif"/></alternatives></inline-formula>. For the Bayesian equivalence test we use the more intuitive null hypothesis of equivalence (i.e., <inline-formula id="IEq87"><alternatives><tex-math id="M295">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0 {:}\ -c&lt; \delta &lt; c$$\end{document}</tex-math><mml:math id="M296"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>δ</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq87.gif"/></alternatives></inline-formula>).</p>
    </fn>
    <fn>
      <p>
        <bold>Publisher’s Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>Not applicable.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>ML and DvR jointly conceptualized the project. ML wrote the first draft of the manuscript, implemented the software, and conducted the analyses. DvR edited the manuscript and tested the software. All authors have read and approved the manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>Open Access funding enabled and organized by Projekt DEAL. This research was supported by a Dutch scientific organization VIDI fellowship grant awarded to Don van Ravenzwaaij (016.Vidi.188.001). The funder was not involved in the design of the study, collection, analysis, and interpretation of data, or writing.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>Not applicable.</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar1">
      <title>Ethics approval and consent to participate</title>
      <p id="Par71">Not applicable.</p>
    </notes>
    <notes id="FPar2">
      <title>Consent for publication</title>
      <p id="Par72">Not applicable.</p>
    </notes>
    <notes id="FPar3" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par73">The authors declare that they have no competing interests.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Christensen</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Methodology of Superiority vs. Equivalence Trials and Non-Inferiority Trials</article-title>
        <source>J Hepatol.</source>
        <year>2007</year>
        <volume>46</volume>
        <issue>5</issue>
        <fpage>947</fpage>
        <lpage>954</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jhep.2007.02.015</pub-id>
        <?supplied-pmid 17412447?>
        <pub-id pub-id-type="pmid">17412447</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Friedman</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Furberg</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>DeMets</surname>
            <given-names>DL</given-names>
          </name>
          <name>
            <surname>Reboussin</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Granger</surname>
            <given-names>CB</given-names>
          </name>
        </person-group>
        <source>Fundamentals of Clinical Trials</source>
        <year>2010</year>
        <edition>4</edition>
        <publisher-loc>New York</publisher-loc>
        <publisher-name>Springer</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lesaffre</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Superiority, Equivalence, and Non-inferiority Trials</article-title>
        <source>Bull NYU Hosp Joint Dis.</source>
        <year>2008</year>
        <volume>66</volume>
        <issue>2</issue>
        <fpage>150</fpage>
        <lpage>154</lpage>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Piaggio</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Elbourne</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Pocock</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Evans</surname>
            <given-names>SJW</given-names>
          </name>
          <name>
            <surname>Altman</surname>
            <given-names>DG</given-names>
          </name>
        </person-group>
        <article-title>Reporting of Noninferiority and Equivalence Randomized Trials</article-title>
        <source>J Am Med Assoc.</source>
        <year>2012</year>
        <volume>308</volume>
        <issue>24</issue>
        <fpage>2594</fpage>
        <lpage>2604</lpage>
        <pub-id pub-id-type="doi">10.1001/jama.2012.87802</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chavalarias</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Wallach</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>AHT</given-names>
          </name>
          <name>
            <surname>Ioannidis</surname>
            <given-names>JPA</given-names>
          </name>
        </person-group>
        <article-title>Evolution of Reporting p Values in the Biomedical Literature, 1990–2015</article-title>
        <source>J Am Med Assoc.</source>
        <year>2016</year>
        <volume>315</volume>
        <issue>11</issue>
        <fpage>1141</fpage>
        <lpage>1148</lpage>
        <pub-id pub-id-type="doi">10.1001/jama.2016.1952</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Christensen</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Testing Fisher, Neyman, Pearson, and Bayes</article-title>
        <source>Am Stat.</source>
        <year>2005</year>
        <volume>59</volume>
        <issue>2</issue>
        <fpage>121</fpage>
        <lpage>126</lpage>
        <pub-id pub-id-type="doi">10.1198/000313005X20871</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Benjamin</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Berger</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Johannesson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nosek</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Berk</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Redefine Statistical Significance</article-title>
        <source>Nat Hum Behav.</source>
        <year>2018</year>
        <volume>2</volume>
        <issue>1</issue>
        <fpage>6</fpage>
        <lpage>10</lpage>
        <pub-id pub-id-type="doi">10.1038/s41562-017-0189-z</pub-id>
        <?supplied-pmid 30980045?>
        <pub-id pub-id-type="pmid">30980045</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lakens</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Adolfi</surname>
            <given-names>FG</given-names>
          </name>
          <name>
            <surname>Albers</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Anvari</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Apps</surname>
            <given-names>MAJ</given-names>
          </name>
          <name>
            <surname>Argamon</surname>
            <given-names>SE</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Justify Your Alpha</article-title>
        <source>Nat Hum Behav.</source>
        <year>2018</year>
        <volume>2</volume>
        <issue>3</issue>
        <fpage>168</fpage>
        <lpage>171</lpage>
        <pub-id pub-id-type="doi">10.1038/s41562-018-0311-x</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berger</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Sellke</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Testing a Point Null Hypothesis: The Irreconcilability of p Values and Evidence</article-title>
        <source>J Am Stat Assoc.</source>
        <year>1987</year>
        <volume>82</volume>
        <issue>397</issue>
        <fpage>112</fpage>
        <lpage>122</lpage>
        <pub-id pub-id-type="doi">10.2307/2289131</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <mixed-citation publication-type="other">Cohen J. The Earth Is Round (p <inline-formula id="IEq141"><alternatives><tex-math id="M297">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$&lt;$$\end{document}</tex-math><mml:math id="M298"><mml:mo>&lt;</mml:mo></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq141.gif"/></alternatives></inline-formula> .05). Am Psychol. 1994;49(12):997–1003. 10.1037/0003-066X.49.12.997.</mixed-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dienes</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Versus Orthodox Statistics: Which Side Are You on?</article-title>
        <source>Perspect Psychol Sci.</source>
        <year>2011</year>
        <volume>6</volume>
        <issue>3</issue>
        <fpage>274</fpage>
        <lpage>290</lpage>
        <pub-id pub-id-type="doi">10.1177/1745691611406920</pub-id>
        <?supplied-pmid 26168518?>
        <pub-id pub-id-type="pmid">26168518</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Gigerenzer</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Krauss</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Vitouch</surname>
            <given-names>O</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Kaplan</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>The Null Ritual: What You Always Wanted to Know about Significance Testing but Were Afraid to Ask</article-title>
        <source>The Sage Handbook of Quantitative Methodology for the Social Sciences</source>
        <year>2004</year>
        <publisher-loc>Thousand Oaks</publisher-loc>
        <publisher-name>Sage</publisher-name>
        <fpage>391</fpage>
        <lpage>408</lpage>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <mixed-citation publication-type="other">Goodman SN. Toward Evidence-based Medical Statistics. 1: The p Value Fallacy. Ann Intern Med. 1999;130(12):995–1004. 10.7326/0003-4819-130-12-199906150-00008.</mixed-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Goodman</surname>
            <given-names>SN</given-names>
          </name>
        </person-group>
        <article-title>A Dirty Dozen: Twelve <italic>p</italic>-value Misconceptions</article-title>
        <source>Semin Hematol.</source>
        <year>2008</year>
        <volume>45</volume>
        <issue>3</issue>
        <fpage>135</fpage>
        <lpage>140</lpage>
        <pub-id pub-id-type="doi">10.1053/j.seminhematol.2008.04.003</pub-id>
        <?supplied-pmid 18582619?>
        <pub-id pub-id-type="pmid">18582619</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Loftus</surname>
            <given-names>GR</given-names>
          </name>
        </person-group>
        <article-title>Psychology Will Be a Much Better Science When We Change the Way We Analyze Data</article-title>
        <source>Curr Dir Psychol Sci.</source>
        <year>1996</year>
        <volume>5</volume>
        <issue>6</issue>
        <fpage>161</fpage>
        <lpage>171</lpage>
        <pub-id pub-id-type="doi">10.1111/1467-8721.ep11512376</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <article-title>A Practical Solution to the Pervasive Problems of <italic>p</italic> values</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2007</year>
        <volume>14</volume>
        <issue>5</issue>
        <fpage>779</fpage>
        <lpage>804</lpage>
        <pub-id pub-id-type="doi">10.3758/BF03194105</pub-id>
        <?supplied-pmid 18087943?>
        <pub-id pub-id-type="pmid">18087943</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <mixed-citation publication-type="other">Wagenmakers EJ, Marsman M, Jamil T, Ly A, Verhagen J, Love J, et al. Bayesian Inference for Psychology. Part I: Theoretical Advantages and Practical Ramifications. Psychon Bull Rev. 2018;25(1):35–57. 10.3758/s13423-017-1343-3.</mixed-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wetzels</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Matzke</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Rouder</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Iverson</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <article-title>Statistical Evidence in Experimental Psychology: An Empirical Comparison Using 855 t Tests</article-title>
        <source>Perspect Psychol Sci.</source>
        <year>2011</year>
        <volume>6</volume>
        <issue>3</issue>
        <fpage>291</fpage>
        <lpage>298</lpage>
        <pub-id pub-id-type="doi">10.1177/1745691611406923</pub-id>
        <?supplied-pmid 26168519?>
        <pub-id pub-id-type="pmid">26168519</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <mixed-citation publication-type="other">Goodman SN. Toward Evidence-based Medical Statistics. 2: The Bayes Factor. Ann Intern Med. 1999;130(12):1005–1013. 10.7326/0003-4819-130-12-199906150-00019.</mixed-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van Ravenzwaaij</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ioannidis</surname>
            <given-names>JPA</given-names>
          </name>
        </person-group>
        <article-title>A Simulation Study of the Strength of Evidence in the Recommendation of Medications Based on Two Trials with Statistically Significant Results</article-title>
        <source>PLoS ONE.</source>
        <year>2017</year>
        <volume>12</volume>
        <issue>3</issue>
        <fpage>e0173184</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0173184</pub-id>
        <?supplied-pmid 28273140?>
        <pub-id pub-id-type="pmid">28273140</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wasserstein</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Lazar</surname>
            <given-names>NA</given-names>
          </name>
        </person-group>
        <article-title>The ASA’s Statement on p-values: Context, Process, and Purpose</article-title>
        <source>Am Stat.</source>
        <year>2016</year>
        <volume>70</volume>
        <issue>2</issue>
        <fpage>129</fpage>
        <lpage>133</lpage>
        <pub-id pub-id-type="doi">10.1080/00031305.2016.1154108</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berger</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Delampady</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Testing Precise Hypotheses</article-title>
        <source>Stat Sci.</source>
        <year>1987</year>
        <volume>2</volume>
        <issue>3</issue>
        <fpage>317</fpage>
        <lpage>335</lpage>
        <pub-id pub-id-type="doi">10.1214/ss/1177013238</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McShane</surname>
            <given-names>BB</given-names>
          </name>
          <name>
            <surname>Gal</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Gelman</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Robert</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Tackett</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>Abandon Statistical Significance</article-title>
        <source>Am Stat.</source>
        <year>2019</year>
        <volume>73</volume>
        <issue>sup1</issue>
        <fpage>235</fpage>
        <lpage>245</lpage>
        <pub-id pub-id-type="doi">10.1080/00031305.2018.1527253</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Kruschke</surname>
            <given-names>JK</given-names>
          </name>
        </person-group>
        <source>Doing Bayesian Data Analysis: A Tutorial with R, JAGS, and Stan</source>
        <year>2015</year>
        <edition>2</edition>
        <publisher-loc>Boston</publisher-loc>
        <publisher-name>Academic Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Gilks</surname>
            <given-names>WR</given-names>
          </name>
          <name>
            <surname>Richardson</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Spiegelhalter</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <source>Markov Chain Monte Carlo in Practice</source>
        <year>1995</year>
        <publisher-loc>Boca Raton</publisher-loc>
        <publisher-name>Chapman &amp; Hall/CRC</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van Ravenzwaaij</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Cassey</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>SD</given-names>
          </name>
        </person-group>
        <article-title>A Simple Introduction to Markov Chain Monte-Carlo Sampling</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2018</year>
        <volume>25</volume>
        <issue>1</issue>
        <fpage>143</fpage>
        <lpage>154</lpage>
        <pub-id pub-id-type="doi">10.3758/s13423-016-1015-8</pub-id>
        <?supplied-pmid 26968853?>
        <pub-id pub-id-type="pmid">26968853</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berry</surname>
            <given-names>DA</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Clinical Trials</article-title>
        <source>Nat Rev Drug Discov.</source>
        <year>2006</year>
        <volume>5</volume>
        <issue>1</issue>
        <fpage>27</fpage>
        <lpage>36</lpage>
        <pub-id pub-id-type="doi">10.1038/nrd1927</pub-id>
        <?supplied-pmid 16485344?>
        <pub-id pub-id-type="pmid">16485344</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van de Schoot</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Winter</surname>
            <given-names>SD</given-names>
          </name>
          <name>
            <surname>Ryan</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Zondervan-Zwijnenburg</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Depaoli</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>A Systematic Review of Bayesian Articles in Psychology: The Last 25 Years</article-title>
        <source>Psychol Methods.</source>
        <year>2017</year>
        <volume>22</volume>
        <issue>2</issue>
        <fpage>217</fpage>
        <lpage>239</lpage>
        <pub-id pub-id-type="doi">10.1037/met0000100.supp</pub-id>
        <?supplied-pmid 28594224?>
        <pub-id pub-id-type="pmid">28594224</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Chu</surname>
            <given-names>CT</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Clinical Trials in Action</article-title>
        <source>Stat Med.</source>
        <year>2012</year>
        <volume>31</volume>
        <issue>25</issue>
        <fpage>2937</fpage>
        <lpage>3072</lpage>
        <pub-id pub-id-type="doi">10.1002/sim.5404</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zaslavsky</surname>
            <given-names>BG</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Hypothesis Testing in Two-arm Trials with Dichotomous Outcomes</article-title>
        <source>Biometrics.</source>
        <year>2013</year>
        <volume>69</volume>
        <issue>1</issue>
        <fpage>157</fpage>
        <lpage>163</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1541-0420.2012.01806.x</pub-id>
        <?supplied-pmid 23002906?>
        <pub-id pub-id-type="pmid">23002906</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kruschke</surname>
            <given-names>JK</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Assessment of Null Values via Parameter Estimation and Model Comparison</article-title>
        <source>Perspect Psychol Sci.</source>
        <year>2011</year>
        <volume>6</volume>
        <issue>3</issue>
        <fpage>299</fpage>
        <lpage>312</lpage>
        <pub-id pub-id-type="doi">10.1177/1745691611406925</pub-id>
        <?supplied-pmid 26168520?>
        <pub-id pub-id-type="pmid">26168520</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kruschke</surname>
            <given-names>JK</given-names>
          </name>
        </person-group>
        <article-title>Rejecting or Accepting Parameter Values in Bayesian Estimation</article-title>
        <source>Adv Methods Pract Psychol Sci.</source>
        <year>2018</year>
        <volume>1</volume>
        <issue>2</issue>
        <fpage>270</fpage>
        <lpage>280</lpage>
        <pub-id pub-id-type="doi">10.1177/2515245918771304</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Jeffreys</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <source>Theory of Probability</source>
        <year>1939</year>
        <publisher-loc>Oxford</publisher-loc>
        <publisher-name>The Clarendon Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Jeffreys</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <source>Theory of Probability</source>
        <year>1948</year>
        <edition>2</edition>
        <publisher-loc>Oxford</publisher-loc>
        <publisher-name>The Clarendon Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Jeffreys</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <source>Theory of Probability</source>
        <year>1961</year>
        <edition>3</edition>
        <publisher-loc>Oxford</publisher-loc>
        <publisher-name>Oxford University Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kass</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Raftery</surname>
            <given-names>AE</given-names>
          </name>
        </person-group>
        <article-title>Bayes Factors</article-title>
        <source>J Am Stat Assoc.</source>
        <year>1995</year>
        <volume>90</volume>
        <issue>430</issue>
        <fpage>773</fpage>
        <lpage>795</lpage>
        <pub-id pub-id-type="doi">10.2307/2291091</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Winkler</surname>
            <given-names>RL</given-names>
          </name>
        </person-group>
        <article-title>Why Bayesian Analysis Hasn’t Caught on in Healthcare Decision Making</article-title>
        <source>Int J Technol Assess Health Care.</source>
        <year>2001</year>
        <volume>17</volume>
        <issue>1</issue>
        <fpage>56</fpage>
        <lpage>66</lpage>
        <pub-id pub-id-type="doi">10.1017/S026646230110406X</pub-id>
        <?supplied-pmid 11329845?>
        <pub-id pub-id-type="pmid">11329845</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gigerenzer</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Mindless Statistics</article-title>
        <source>J Socio-Econ.</source>
        <year>2004</year>
        <volume>33</volume>
        <issue>5</issue>
        <fpage>587</fpage>
        <lpage>606</lpage>
        <pub-id pub-id-type="doi">10.1016/j.socec.2004.09.033</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <mixed-citation publication-type="other">Morey RD, Rouder JN. BayesFactor: Computation of Bayes Factors for Common Designs. 2018. R package version 0.9.12-4.2. <ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=BayesFactor">https://CRAN.R-project.org/package=BayesFactor</ext-link>. Accessed 14 Sept 2022.</mixed-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <mixed-citation publication-type="other">R Core Team. R: A Language and Environment for Statistical Computing. Vienna. 2021. <ext-link ext-link-type="uri" xlink:href="https://www.R-project.org/">https://www.R-project.org/</ext-link>. Accessed 14 Sept 2022.</mixed-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <mixed-citation publication-type="other">JASP Team. JASP (Version 0.15)[Computer software]. 2021. <ext-link ext-link-type="uri" xlink:href="https://jasp-stats.org/">https://jasp-stats.org/</ext-link>. Accessed 14 Sept 2022.</mixed-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <mixed-citation publication-type="other">The jamovi project. jamovi (Version 1.6) [Computer Software]. 2021. <ext-link ext-link-type="uri" xlink:href="https://www.jamovi.org">https://www.jamovi.org</ext-link>. Accessed 14 Sept 2022.</mixed-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <mixed-citation publication-type="other">Linde M, van Ravenzwaaij D. baymedr: Computation of Bayes Factors for Common Biomedical Designs. 2021. R package version 0.1.1. <ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=baymedr">https://CRAN.R-project.org/package=baymedr</ext-link>. Accessed 14 Sept 2022.</mixed-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <mixed-citation publication-type="other">Linde M. baymedr. 2022. <ext-link ext-link-type="uri" xlink:href="https://maxlinde.shinyapps.io/baymedr/">https://maxlinde.shinyapps.io/baymedr/</ext-link>. Accessed 14 Sept 2022.</mixed-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Meyners</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Equivalence Tests - A Review</article-title>
        <source>Food Qual Prefer.</source>
        <year>2012</year>
        <volume>26</volume>
        <issue>2</issue>
        <fpage>231</fpage>
        <lpage>245</lpage>
        <pub-id pub-id-type="doi">10.1016/j.foodqual.2012.05.003</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hodges</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Lehmann</surname>
            <given-names>EL</given-names>
          </name>
        </person-group>
        <article-title>Testing the Approximate Validity of Statistical Hypotheses</article-title>
        <source>J R Stat Soc Ser B (Methodol).</source>
        <year>1954</year>
        <volume>16</volume>
        <issue>2</issue>
        <fpage>261</fpage>
        <lpage>268</lpage>
        <pub-id pub-id-type="doi">10.1007/978-1-4614-1412-4_15</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Westlake</surname>
            <given-names>WJ</given-names>
          </name>
        </person-group>
        <article-title>Symmetrical Confidence Intervals for Bioequivalence Trials</article-title>
        <source>Biometrics.</source>
        <year>1976</year>
        <volume>32</volume>
        <issue>4</issue>
        <fpage>741</fpage>
        <lpage>744</lpage>
        <pub-id pub-id-type="doi">10.2307/2529259</pub-id>
        <?supplied-pmid 1009222?>
        <pub-id pub-id-type="pmid">1009222</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schuirmann</surname>
            <given-names>DJ</given-names>
          </name>
        </person-group>
        <article-title>A Comparison of the Two One-sided Tests Procedure and the Power Approach for Assessing the Equivalence of Average Bioavailability</article-title>
        <source>J Pharmacokinet Biopharm.</source>
        <year>1987</year>
        <volume>15</volume>
        <issue>6</issue>
        <fpage>657</fpage>
        <lpage>680</lpage>
        <pub-id pub-id-type="doi">10.1007/BF01068419</pub-id>
        <?supplied-pmid 3450848?>
        <pub-id pub-id-type="pmid">3450848</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Senn</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <source>Statistical Issues in Drug Development</source>
        <year>2008</year>
        <edition>2</edition>
        <publisher-loc>Chichester</publisher-loc>
        <publisher-name>Wiley</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lakens</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Equivalence Tests: A Practical Primer for t Tests, Correlations, and Meta-analyses</article-title>
        <source>Soc Psychol Personal Sci.</source>
        <year>2017</year>
        <volume>8</volume>
        <issue>4</issue>
        <fpage>355</fpage>
        <lpage>362</lpage>
        <pub-id pub-id-type="doi">10.1177/1948550617697177</pub-id>
        <?supplied-pmid 28736600?>
        <pub-id pub-id-type="pmid">28736600</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lakens</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Scheel</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Isager</surname>
            <given-names>PM</given-names>
          </name>
        </person-group>
        <article-title>Equivalence Testing for Psychological Research: A Tutorial</article-title>
        <source>Adv Methods Pract Psychol Sci.</source>
        <year>2018</year>
        <volume>1</volume>
        <issue>2</issue>
        <fpage>259</fpage>
        <lpage>269</lpage>
        <pub-id pub-id-type="doi">10.1177/2515245918770963</pub-id>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Garrett</surname>
            <given-names>AD</given-names>
          </name>
        </person-group>
        <article-title>Therapeutic Equivalence: Fallacies and Falsification</article-title>
        <source>Stat Med.</source>
        <year>2003</year>
        <volume>22</volume>
        <issue>5</issue>
        <fpage>741</fpage>
        <lpage>762</lpage>
        <pub-id pub-id-type="doi">10.1002/sim.1360</pub-id>
        <?supplied-pmid 12587103?>
        <pub-id pub-id-type="pmid">12587103</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Walker</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Nowacki</surname>
            <given-names>AS</given-names>
          </name>
        </person-group>
        <article-title>Understanding Equivalence and Noninferiority Testing</article-title>
        <source>J Gen Intern Med.</source>
        <year>2011</year>
        <volume>26</volume>
        <issue>2</issue>
        <fpage>192</fpage>
        <lpage>196</lpage>
        <pub-id pub-id-type="doi">10.1007/s11606-010-1513-8</pub-id>
        <?supplied-pmid 20857339?>
        <pub-id pub-id-type="pmid">20857339</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <mixed-citation publication-type="other">Chadwick D, Vigabatrin European Monotherapy Study Group. Safety and Efficacy of Vigabatrin and Carbamazepine in Newly Diagnosed Epilepsy: A Multicentre Randomised Double-blind Study. Lancet. 1999;354(9172):13–19. 10.1016/S0140-6736(98)10531-7.</mixed-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kaul</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Diamond</surname>
            <given-names>GA</given-names>
          </name>
        </person-group>
        <article-title>Good Enough: A Primer on the Analysis and Interpretation of Noninferiority Trials</article-title>
        <source>Ann Intern Med.</source>
        <year>2006</year>
        <volume>145</volume>
        <issue>1</issue>
        <fpage>62</fpage>
        <lpage>69</lpage>
        <pub-id pub-id-type="doi">10.7326/0003-4819-145-1-200607040-00011</pub-id>
        <?supplied-pmid 16818930?>
        <pub-id pub-id-type="pmid">16818930</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Van de Werf</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Adgey</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ardissino</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Armstrong</surname>
            <given-names>PW</given-names>
          </name>
          <name>
            <surname>Aylward</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Barbash</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Single-bolus Tenecteplase Compared with Front-loaded Alteplase in Acute Myocardial Infarction: The ASSENT-2 Double-blind Randomised Trial</article-title>
        <source>Lancet.</source>
        <year>1999</year>
        <volume>354</volume>
        <issue>9180</issue>
        <fpage>716</fpage>
        <lpage>722</lpage>
        <pub-id pub-id-type="doi">10.1016/S0140-6736(99)07403-6</pub-id>
        <?supplied-pmid 10475182?>
        <pub-id pub-id-type="pmid">10475182</pub-id>
      </element-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hills</surname>
            <given-names>RK</given-names>
          </name>
        </person-group>
        <article-title>Non-inferiority Trials: No Better? No Worse? No Change? No Pain?</article-title>
        <source>Br J Haematol.</source>
        <year>2017</year>
        <volume>176</volume>
        <issue>6</issue>
        <fpage>883</fpage>
        <lpage>887</lpage>
        <pub-id pub-id-type="doi">10.1111/bjh.14504</pub-id>
        <?supplied-pmid 28106905?>
        <pub-id pub-id-type="pmid">28106905</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <mixed-citation publication-type="other">Rennie D. Vive La Différence (p<inline-formula id="IEq142"><alternatives><tex-math id="M299">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$&lt;$$\end{document}</tex-math><mml:math id="M300"><mml:mo>&lt;</mml:mo></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq142.gif"/></alternatives></inline-formula>0.05). N Engl J Med. 1978;299:828–829. 10.1056/NEJM197810122991509.</mixed-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <mixed-citation publication-type="other">International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Pathology. 1997;29:441–447. 10.1080/00313029700169515.</mixed-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rouder</surname>
            <given-names>JN</given-names>
          </name>
        </person-group>
        <article-title>Optional Stopping: No Problem for Bayesians</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2014</year>
        <volume>21</volume>
        <issue>2</issue>
        <fpage>301</fpage>
        <lpage>308</lpage>
        <pub-id pub-id-type="doi">10.3758/s13423-014-0595-4</pub-id>
        <?supplied-pmid 24659049?>
        <pub-id pub-id-type="pmid">24659049</pub-id>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schönbrodt</surname>
            <given-names>FD</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Zehetleitner</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Perugini</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Sequential Hypothesis Testing with Bayes Factors: Efficiently Testing Mean Differences</article-title>
        <source>Psychol Methods.</source>
        <year>2017</year>
        <volume>22</volume>
        <issue>2</issue>
        <fpage>322</fpage>
        <lpage>339</lpage>
        <pub-id pub-id-type="doi">10.1037/met0000061</pub-id>
        <?supplied-pmid 26651986?>
        <pub-id pub-id-type="pmid">26651986</pub-id>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schönbrodt</surname>
            <given-names>FD</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <article-title>Bayes Factor Design Analysis: Planning for Compelling Evidence</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2018</year>
        <volume>25</volume>
        <issue>1</issue>
        <fpage>128</fpage>
        <lpage>142</lpage>
        <pub-id pub-id-type="doi">10.3758/s13423-017-1230-y</pub-id>
        <?supplied-pmid 28251595?>
        <pub-id pub-id-type="pmid">28251595</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ranganathan</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Pramesh</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Buyse</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Common Pitfalls in Statistical Analysis: The Perils of Multiple Testing</article-title>
        <source>Perspect Clin Res.</source>
        <year>2016</year>
        <volume>7</volume>
        <issue>2</issue>
        <fpage>106</fpage>
        <lpage>107</lpage>
        <pub-id pub-id-type="doi">10.4103/2229-3485.179436</pub-id>
        <?supplied-pmid 27141478?>
        <pub-id pub-id-type="pmid">27141478</pub-id>
      </element-citation>
    </ref>
    <ref id="CR64">
      <label>64.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chalmers</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Glasziou</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Avoidable Waste in the Production and Reporting of Research Evidence</article-title>
        <source>Lancet.</source>
        <year>2009</year>
        <volume>374</volume>
        <issue>9683</issue>
        <fpage>86</fpage>
        <lpage>89</lpage>
        <pub-id pub-id-type="doi">10.1016/S0140-6736(09)60329-9</pub-id>
        <?supplied-pmid 19525005?>
        <pub-id pub-id-type="pmid">19525005</pub-id>
      </element-citation>
    </ref>
    <ref id="CR65">
      <label>65.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van Ravenzwaaij</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Monden</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Tendeiro</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Ioannidis</surname>
            <given-names>JPA</given-names>
          </name>
        </person-group>
        <article-title>Bayes Factors for Superiority, Non-inferiority, and Equivalence Designs</article-title>
        <source>BMC Med Res Methodol.</source>
        <year>2019</year>
        <volume>19</volume>
        <issue>1</issue>
        <fpage>71</fpage>
        <pub-id pub-id-type="doi">10.1186/s12874-019-0699-7</pub-id>
        <?supplied-pmid 30925900?>
        <pub-id pub-id-type="pmid">30925900</pub-id>
      </element-citation>
    </ref>
    <ref id="CR66">
      <label>66.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gallistel</surname>
            <given-names>CR</given-names>
          </name>
        </person-group>
        <article-title>The Importance of Proving the Null</article-title>
        <source>Psychol Rev.</source>
        <year>2009</year>
        <volume>116</volume>
        <issue>2</issue>
        <fpage>439</fpage>
        <lpage>453</lpage>
        <pub-id pub-id-type="doi">10.1037/a0015251</pub-id>
        <?supplied-pmid 19348549?>
        <pub-id pub-id-type="pmid">19348549</pub-id>
      </element-citation>
    </ref>
    <ref id="CR67">
      <label>67.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rouder</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Speckman</surname>
            <given-names>PL</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Morey</surname>
            <given-names>RD</given-names>
          </name>
          <name>
            <surname>Iverson</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Bayesian t Tests for Accepting and Rejecting the Null Hypothesis</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2009</year>
        <volume>16</volume>
        <issue>2</issue>
        <fpage>225</fpage>
        <lpage>237</lpage>
        <pub-id pub-id-type="doi">10.3758/PBR.16.2.225</pub-id>
        <?supplied-pmid 19293088?>
        <pub-id pub-id-type="pmid">19293088</pub-id>
      </element-citation>
    </ref>
    <ref id="CR68">
      <label>68.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gelman</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>p Values and Statistical Practice</article-title>
        <source>Epidemiology.</source>
        <year>2013</year>
        <volume>24</volume>
        <issue>1</issue>
        <fpage>69</fpage>
        <lpage>72</lpage>
        <pub-id pub-id-type="doi">10.1097/EDE.0b013e31827886f7</pub-id>
        <?supplied-pmid 23232612?>
        <pub-id pub-id-type="pmid">23232612</pub-id>
      </element-citation>
    </ref>
    <ref id="CR69">
      <label>69.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Haller</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Krauss</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Misinterpretation of Significance: A Problem Students Share with Their Teachers?</article-title>
        <source>Methods Psychol Res.</source>
        <year>2002</year>
        <volume>7</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>20</lpage>
      </element-citation>
    </ref>
    <ref id="CR70">
      <label>70.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bakan</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>The Test of Significance in Psychological Research</article-title>
        <source>Psychol Bull.</source>
        <year>1966</year>
        <volume>66</volume>
        <issue>6</issue>
        <fpage>423</fpage>
        <lpage>437</lpage>
        <pub-id pub-id-type="doi">10.1037/h0020412</pub-id>
        <?supplied-pmid 5974619?>
        <pub-id pub-id-type="pmid">5974619</pub-id>
      </element-citation>
    </ref>
    <ref id="CR71">
      <label>71.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Altman</surname>
            <given-names>DG</given-names>
          </name>
          <name>
            <surname>Bland</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>Absence of Evidence Is Not Evidence of Absence</article-title>
        <source>BMJ.</source>
        <year>1995</year>
        <volume>311</volume>
        <issue>7003</issue>
        <fpage>485</fpage>
        <pub-id pub-id-type="doi">10.1136/bmj.311.7003.485</pub-id>
        <?supplied-pmid 7647644?>
        <pub-id pub-id-type="pmid">7647644</pub-id>
      </element-citation>
    </ref>
    <ref id="CR72">
      <label>72.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Greene</surname>
            <given-names>WL</given-names>
          </name>
          <name>
            <surname>Concato</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Feinstein</surname>
            <given-names>AR</given-names>
          </name>
        </person-group>
        <article-title>Claims of Equivalence in Medical Research: Are They Supported by the Evidence?</article-title>
        <source>Ann Intern Med.</source>
        <year>2000</year>
        <volume>132</volume>
        <issue>9</issue>
        <fpage>715</fpage>
        <lpage>722</lpage>
        <pub-id pub-id-type="doi">10.7326/0003-4819-132-9-200005020-00006</pub-id>
        <?supplied-pmid 10787365?>
        <pub-id pub-id-type="pmid">10787365</pub-id>
      </element-citation>
    </ref>
    <ref id="CR73">
      <label>73.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Blackwelder</surname>
            <given-names>WC</given-names>
          </name>
        </person-group>
        <article-title>Proving the Null Hypothesis</article-title>
        <source>Clinical Trials. Controlled Clinical Trials.</source>
        <year>1982</year>
        <volume>3</volume>
        <issue>4</issue>
        <fpage>345</fpage>
        <lpage>353</lpage>
        <pub-id pub-id-type="doi">10.1016/0197-2456(82)90024-1</pub-id>
        <?supplied-pmid 7160191?>
        <pub-id pub-id-type="pmid">7160191</pub-id>
      </element-citation>
    </ref>
    <ref id="CR74">
      <label>74.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hoekstra</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Monden</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>van Ravenzwaaij</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Reanalysis of Null Results Reported in Medicine: Strong yet Variable Evidence for the Absence of Treatment Effects</article-title>
        <source>PLoS ONE.</source>
        <year>2018</year>
        <volume>13</volume>
        <issue>4</issue>
        <fpage>e0195474</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0195474</pub-id>
        <?supplied-pmid 29694370?>
        <pub-id pub-id-type="pmid">29694370</pub-id>
      </element-citation>
    </ref>
    <ref id="CR75">
      <label>75.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kruschke</surname>
            <given-names>JK</given-names>
          </name>
          <name>
            <surname>Liddell</surname>
            <given-names>TM</given-names>
          </name>
        </person-group>
        <article-title>The Bayesian New Statistics: Hypothesis Testing, Estimation, Meta-analysis, and Power Analysis from a Bayesian Perspective</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2018</year>
        <volume>25</volume>
        <issue>1</issue>
        <fpage>178</fpage>
        <lpage>206</lpage>
        <pub-id pub-id-type="doi">10.3758/s13423-016-1221-4</pub-id>
        <?supplied-pmid 28176294?>
        <pub-id pub-id-type="pmid">28176294</pub-id>
      </element-citation>
    </ref>
    <ref id="CR76">
      <label>76.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Lodewyckx</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kuriyal</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Grasman</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Hypothesis Testing for Psychologists: A Tutorial on the Savage-Dickey Method</article-title>
        <source>Cogn Psychol.</source>
        <year>2010</year>
        <volume>60</volume>
        <issue>3</issue>
        <fpage>158</fpage>
        <lpage>189</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cogpsych.2009.12.001</pub-id>
        <?supplied-pmid 20064637?>
        <pub-id pub-id-type="pmid">20064637</pub-id>
      </element-citation>
    </ref>
    <ref id="CR77">
      <label>77.</label>
      <mixed-citation publication-type="other">O’Hagan A, Forster J. Kendall’s Advanced Theory of Statistics: Vol. 2B. Bayesian Inference. 2nd ed. London: Arnold; 2004.</mixed-citation>
    </ref>
    <ref id="CR78">
      <label>78.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Etz</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Vandekerckhove</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Introduction to Bayesian Inference for Psychology</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2018</year>
        <volume>25</volume>
        <issue>1</issue>
        <fpage>5</fpage>
        <lpage>34</lpage>
        <pub-id pub-id-type="doi">10.3758/s13423-017-1262-3</pub-id>
        <?supplied-pmid 28378250?>
        <pub-id pub-id-type="pmid">28378250</pub-id>
      </element-citation>
    </ref>
    <ref id="CR79">
      <label>79.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gronau</surname>
            <given-names>QF</given-names>
          </name>
          <name>
            <surname>Ly</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <article-title>Informed Bayesian t-tests</article-title>
        <source>Am Stat.</source>
        <year>2020</year>
        <volume>74</volume>
        <issue>2</issue>
        <fpage>137</fpage>
        <lpage>143</lpage>
        <pub-id pub-id-type="doi">10.1080/00031305.2018.1562983</pub-id>
      </element-citation>
    </ref>
    <ref id="CR80">
      <label>80.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <source>Bayesian Cognitive Modeling: A Practical Course</source>
        <year>2013</year>
        <publisher-loc>Cambridge</publisher-loc>
        <publisher-name>Cambridge University Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR81">
      <label>81.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gönen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>WO</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Westfall</surname>
            <given-names>PH</given-names>
          </name>
        </person-group>
        <article-title>The Bayesian Two-sample t Test</article-title>
        <source>Am Stat.</source>
        <year>2005</year>
        <volume>59</volume>
        <issue>3</issue>
        <fpage>252</fpage>
        <lpage>257</lpage>
        <pub-id pub-id-type="doi">10.1198/000313005X55233</pub-id>
      </element-citation>
    </ref>
    <ref id="CR82">
      <label>82.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bayarri</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Berger</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Forte</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>García-Donato</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Criteria for Bayesian Model Choice with Application to Variable Selection</article-title>
        <source>Ann Stat.</source>
        <year>2012</year>
        <volume>40</volume>
        <issue>3</issue>
        <fpage>1550</fpage>
        <lpage>1577</lpage>
        <pub-id pub-id-type="doi">10.1214/12-AOS1013</pub-id>
      </element-citation>
    </ref>
    <ref id="CR83">
      <label>83.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berger</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Pericchi</surname>
            <given-names>LR</given-names>
          </name>
          <name>
            <surname>Varshavsky</surname>
            <given-names>JA</given-names>
          </name>
        </person-group>
        <article-title>Bayes Factors and Marginal Distributions in Invariant Situations</article-title>
        <source>Sankhyā Indian J Stat.</source>
        <year>1998</year>
        <volume>60</volume>
        <fpage>307</fpage>
        <lpage>321</lpage>
      </element-citation>
    </ref>
    <ref id="CR84">
      <label>84.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dickey</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Lientz</surname>
            <given-names>BP</given-names>
          </name>
        </person-group>
        <article-title>The Weighted Likelihood Ratio, Sharp Hypotheses about Chances, the Order of a Markov Chain</article-title>
        <source>Ann Math Stat.</source>
        <year>1970</year>
        <volume>41</volume>
        <issue>1</issue>
        <fpage>214</fpage>
        <lpage>226</lpage>
        <pub-id pub-id-type="doi">10.1214/aoms/1177697203</pub-id>
      </element-citation>
    </ref>
    <ref id="CR85">
      <label>85.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van Ravenzwaaij</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Etz</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Simulation Studies as a Tool to Understand Bayes Factors</article-title>
        <source>Adv Methods Pract Psychol Sci.</source>
        <year>2021</year>
        <volume>4</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>20</lpage>
        <pub-id pub-id-type="doi">10.1177/2515245920972624</pub-id>
      </element-citation>
    </ref>
    <ref id="CR86">
      <label>86.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vanpaemel</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Prior Sensitivity in Theory Testing: An Apologia for the Bayes Factor</article-title>
        <source>J Math Psychol.</source>
        <year>2010</year>
        <volume>54</volume>
        <issue>6</issue>
        <fpage>491</fpage>
        <lpage>498</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jmp.2010.07.003</pub-id>
      </element-citation>
    </ref>
    <ref id="CR87">
      <label>87.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Morey</surname>
            <given-names>RD</given-names>
          </name>
          <name>
            <surname>Romeijn</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>Rouder</surname>
            <given-names>JN</given-names>
          </name>
        </person-group>
        <article-title>The Philosophy of Bayes Factors and the Quantification of Statistical Evidence</article-title>
        <source>J Math Psychol.</source>
        <year>2016</year>
        <volume>72</volume>
        <fpage>6</fpage>
        <lpage>18</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jmp.2015.11.001</pub-id>
      </element-citation>
    </ref>
    <ref id="CR88">
      <label>88.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Consonni</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Fouskakis</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Liseo</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ntzoufras</surname>
            <given-names>I</given-names>
          </name>
        </person-group>
        <article-title>Prior Distributions for Objective Bayesian Analysis</article-title>
        <source>Bayesian Anal.</source>
        <year>2018</year>
        <volume>13</volume>
        <issue>2</issue>
        <fpage>627</fpage>
        <lpage>679</lpage>
        <pub-id pub-id-type="doi">10.1214/18-BA1103</pub-id>
      </element-citation>
    </ref>
    <ref id="CR89">
      <label>89.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Paulo</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Molina</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Clyde</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Berger</surname>
            <given-names>JO</given-names>
          </name>
        </person-group>
        <article-title>Mixtures of g Priors for Bayesian Variable Selection</article-title>
        <source>J Am Stat Assoc.</source>
        <year>2008</year>
        <volume>103</volume>
        <issue>481</issue>
        <fpage>410</fpage>
        <lpage>423</lpage>
        <pub-id pub-id-type="doi">10.1198/016214507000001337</pub-id>
      </element-citation>
    </ref>
    <ref id="CR90">
      <label>90.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tendeiro</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Kiers</surname>
            <given-names>HAL</given-names>
          </name>
        </person-group>
        <article-title>A Review of Issues about Null Hypothesis Bayesian Testing</article-title>
        <source>Psychol Methods.</source>
        <year>2019</year>
        <volume>24</volume>
        <issue>6</issue>
        <fpage>774</fpage>
        <lpage>795</lpage>
        <pub-id pub-id-type="doi">10.1037/met0000221</pub-id>
        <?supplied-pmid 31094544?>
        <pub-id pub-id-type="pmid">31094544</pub-id>
      </element-citation>
    </ref>
    <ref id="CR91">
      <label>91.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kruschke</surname>
            <given-names>JK</given-names>
          </name>
          <name>
            <surname>Liddell</surname>
            <given-names>TM</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Data Analysis for Newcomers</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2018</year>
        <volume>25</volume>
        <issue>1</issue>
        <fpage>155</fpage>
        <lpage>177</lpage>
        <pub-id pub-id-type="doi">10.3758/s13423-017-1272-1</pub-id>
        <?supplied-pmid 28405907?>
        <pub-id pub-id-type="pmid">28405907</pub-id>
      </element-citation>
    </ref>
    <ref id="CR92">
      <label>92.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Basner</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Asch</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Shea</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Bellini</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Carlin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ecker</surname>
            <given-names>AJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Sleep and Alertness in a Duty-hour Flexibility Trial in Internal Medicine</article-title>
        <source>N Engl J Med.</source>
        <year>2019</year>
        <volume>380</volume>
        <issue>10</issue>
        <fpage>915</fpage>
        <lpage>923</lpage>
        <pub-id pub-id-type="doi">10.1056/NEJMoa1810641</pub-id>
        <?supplied-pmid 30855741?>
        <pub-id pub-id-type="pmid">30855741</pub-id>
      </element-citation>
    </ref>
    <ref id="CR93">
      <label>93.</label>
      <mixed-citation publication-type="other">Wickham H, Hester J, Chang W. devtools: Tools to Make Developing R Packages Easier. 2019. R package version 2.2.0. <ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=devtools">https://CRAN.R-project.org/package=devtools</ext-link>. Accessed 14 Sept 2022.</mixed-citation>
    </ref>
    <ref id="CR94">
      <label>94.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Åkerstedt</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Gillberg</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Subjective and Objective Sleepiness in the Active Individual</article-title>
        <source>International Journal of Neuroscience.</source>
        <year>1990</year>
        <volume>52</volume>
        <issue>1–2</issue>
        <fpage>29</fpage>
        <lpage>37</lpage>
        <pub-id pub-id-type="doi">10.3109/00207459008994241</pub-id>
        <?supplied-pmid 2265922?>
        <pub-id pub-id-type="pmid">2265922</pub-id>
      </element-citation>
    </ref>
    <ref id="CR95">
      <label>95.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van Ravenzwaaij</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <article-title>Advantages Masquerading as “Issues” in Bayesian Hypothesis Testing: A Commentary on Tendeiro and Kiers (2019)</article-title>
        <source>Psychol Methods.</source>
        <year>2022</year>
        <volume>27</volume>
        <issue>3</issue>
        <fpage>451</fpage>
        <lpage>465</lpage>
        <pub-id pub-id-type="doi">10.1037/met0000415</pub-id>
        <?supplied-pmid 34881956?>
        <pub-id pub-id-type="pmid">34881956</pub-id>
      </element-citation>
    </ref>
    <ref id="CR96">
      <label>96.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tendeiro</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Kiers</surname>
            <given-names>HAL</given-names>
          </name>
        </person-group>
        <article-title>On the White, the Black, and the Many Shades of Gray in Between: Our Reply to van Ravenzwaaij and Wagenmakers (2021)</article-title>
        <source>Psychol Methods.</source>
        <year>2022</year>
        <volume>27</volume>
        <issue>3</issue>
        <fpage>466</fpage>
        <lpage>475</lpage>
        <pub-id pub-id-type="doi">10.1037/met0000505</pub-id>
        <?supplied-pmid 35901398?>
        <pub-id pub-id-type="pmid">35901398</pub-id>
      </element-citation>
    </ref>
    <ref id="CR97">
      <label>97.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sinharay</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Stern</surname>
            <given-names>HS</given-names>
          </name>
        </person-group>
        <article-title>On the Sensitivity of Bayes Factors to the Prior Distributions</article-title>
        <source>Am Stat.</source>
        <year>2002</year>
        <volume>56</volume>
        <issue>3</issue>
        <fpage>196</fpage>
        <lpage>201</lpage>
        <pub-id pub-id-type="doi">10.1198/000313002137</pub-id>
      </element-citation>
    </ref>
    <ref id="CR98">
      <label>98.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Aitkin</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Bayes Factors: Prior Sensitivity and Model Generalizability</article-title>
        <source>J Math Psychol.</source>
        <year>2008</year>
        <volume>52</volume>
        <issue>6</issue>
        <fpage>362</fpage>
        <lpage>375</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jmp.2008.03.002</pub-id>
      </element-citation>
    </ref>
    <ref id="CR99">
      <label>99.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lindley</surname>
            <given-names>DV</given-names>
          </name>
        </person-group>
        <article-title>A Statistical Paradox</article-title>
        <source>Biometrika.</source>
        <year>1957</year>
        <volume>44</volume>
        <issue>1/2</issue>
        <fpage>187</fpage>
        <lpage>192</lpage>
        <pub-id pub-id-type="doi">10.2307/2333251</pub-id>
      </element-citation>
    </ref>
    <ref id="CR100">
      <label>100.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wong</surname>
            <given-names>TK</given-names>
          </name>
          <name>
            <surname>Kiers</surname>
            <given-names>HAL</given-names>
          </name>
          <name>
            <surname>Tendeiro</surname>
            <given-names>JN</given-names>
          </name>
        </person-group>
        <article-title>On the Potential Mismatch Between the Function of the Bayes Factor and Researchers’ Expectations</article-title>
        <source>Collabra Psychol.</source>
        <year>2022</year>
        <volume>8</volume>
        <issue>1</issue>
        <fpage>36357</fpage>
        <pub-id pub-id-type="doi">10.1525/collabra.36357</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Med Res Methodol</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Med Res Methodol</journal-id>
    <journal-title-group>
      <journal-title>BMC Medical Research Methodology</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2288</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10668366</article-id>
    <article-id pub-id-type="publisher-id">2097</article-id>
    <article-id pub-id-type="doi">10.1186/s12874-023-02097-y</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Software</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>baymedr: an R package and web application for the calculation of Bayes factors for superiority, equivalence, and non-inferiority designs</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8421-090X</contrib-id>
        <name>
          <surname>Linde</surname>
          <given-names>Maximilian</given-names>
        </name>
        <address>
          <email>maximilian.linde@gesis.org</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5030-4091</contrib-id>
        <name>
          <surname>van Ravenzwaaij</surname>
          <given-names>Don</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/018afyw53</institution-id><institution-id institution-id-type="GRID">grid.425053.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 1013 1176</institution-id><institution>GESIS - Leibniz Institute for the Social Sciences, </institution></institution-wrap>Cologne, Germany </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/012p63287</institution-id><institution-id institution-id-type="GRID">grid.4830.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0407 1981</institution-id><institution>University of Groningen, </institution></institution-wrap>Groningen, The Netherlands </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>24</day>
      <month>11</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>24</day>
      <month>11</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <volume>23</volume>
    <elocation-id>279</elocation-id>
    <history>
      <date date-type="received">
        <day>14</day>
        <month>9</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>3</day>
        <month>11</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">Clinical trials often seek to determine the superiority, equivalence, or non-inferiority of an experimental condition (e.g., a new drug) compared to a control condition (e.g., a placebo or an already existing drug). The use of frequentist statistical methods to analyze data for these types of designs is ubiquitous even though they have several limitations. Bayesian inference remedies many of these shortcomings and allows for intuitive interpretations, but are currently difficult to implement for the applied researcher.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">We outline the frequentist conceptualization of superiority, equivalence, and non-inferiority designs and discuss its disadvantages. Subsequently, we explain how Bayes factors can be used to compare the relative plausibility of competing hypotheses. We present baymedr, an R package and web application, that provides user-friendly tools for the computation of Bayes factors for superiority, equivalence, and non-inferiority designs. Instructions on how to use baymedr are provided and an example illustrates how existing results can be reanalyzed with baymedr.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">Our baymedr R package and web application enable researchers to conduct Bayesian superiority, equivalence, and non-inferiority tests. baymedr is characterized by a user-friendly implementation, making it convenient for researchers who are not statistical experts. Using baymedr, it is possible to calculate Bayes factors based on raw data and summary statistics.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Bayes factor</kwd>
      <kwd>baymedr</kwd>
      <kwd>Equivalence</kwd>
      <kwd>Non-inferiority</kwd>
      <kwd>Superiority</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003246</institution-id>
            <institution>Nederlandse Organisatie voor Wetenschappelijk Onderzoek</institution>
          </institution-wrap>
        </funding-source>
        <award-id>016.Vidi.188.001</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>GESIS – Leibniz-Institut für Sozialwissenschaften e.V. (3447)</institution>
        </funding-source>
      </award-group>
      <open-access>
        <p>Open Access funding enabled and organized by Projekt DEAL.</p>
      </open-access>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© BioMed Central Ltd., part of Springer Nature 2023</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par9">Researchers generally agree that the clinical trial is the best method to determine and compare the effects of medications and treatments [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Although clinical trials are often similar in design, different statistical procedures need to be employed depending on the nature of the research question. Commonly, clinical trials seek to determine the superiority, equivalence, or non-inferiority of an experimental condition (e.g., subjects receiving a new medication) compared to a control condition (e.g., subjects receiving a placebo or an already existing medication; [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]). For these goals, statistical inference is often conducted in the form of testing.</p>
    <p id="Par10">Usually, the frequentist approach to statistical testing forms the framework in which data for these research designs are analyzed [<xref ref-type="bibr" rid="CR5">5</xref>]. In particular, researchers often rely on null hypothesis significance testing (NHST), which quantifies evidence through a <italic>p</italic>-value. This <italic>p</italic>-value represents the probability of obtaining a test statistic (e.g., a <italic>t</italic>-value) at least as extreme as the one observed, assuming that the null hypothesis is true. In other words, the <italic>p</italic>-value is an indicator of the unusualness of the obtained test statistic under the null hypothesis, forming a “proof by contradiction” ([<xref ref-type="bibr" rid="CR6">6</xref>], p. 123). If the <italic>p</italic>-value is smaller than a predefined Type I error rate (<inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\alpha$$\end{document}</tex-math><mml:math id="M2"><mml:mi>α</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq1.gif"/></alternatives></inline-formula>), typically set to <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\alpha =.05$$\end{document}</tex-math><mml:math id="M4"><mml:mrow><mml:mi>α</mml:mi><mml:mo>=</mml:mo><mml:mo>.</mml:mo><mml:mn>05</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq2.gif"/></alternatives></inline-formula> (but see, e.g., [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]), rejection of the null hypothesis is warranted; otherwise the obtained data do not justify rejection of the null hypothesis.</p>
    <p id="Par11">The NHST approach to inference has been criticized due to certain limitations and erroneous interpretations of <italic>p</italic>-values (e.g., [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR21">21</xref>]), which we briefly describe below. As a result, some methodologists have argued that <italic>p</italic>-values should be mostly abandoned from scientific practice (e.g., [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]).</p>
    <p id="Par12">An alternative to NHST is statistical testing within a Bayesian framework. Bayesian statistics is based on the idea that the credibilities of well-defined parameter values (e.g., effect size) or models (e.g., null and alternative hypotheses) are updated based on new observations [<xref ref-type="bibr" rid="CR24">24</xref>]. With exploding computational power and the rise of Markov chain Monte Carlo methods (e.g., [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]) that are used to estimate probability distributions that cannot be determined analytically, applications of Bayesian inference have recently become tractable. Indeed, Bayesian methods are seeing more and more use in the biomedical field [<xref ref-type="bibr" rid="CR27">27</xref>] and other disciplines [<xref ref-type="bibr" rid="CR28">28</xref>].</p>
    <p id="Par13">Lee and Chu [<xref ref-type="bibr" rid="CR29">29</xref>] have conducted a literature search to investigate how Bayesian inference is typically used in biomedicine. They found that the number of studies using Bayesian inference has been steadily increasing over the last decades, with a majority of studies testing treatment efficacy and with most applications in fields such as oncology, cardiovascular system research, and central nervous system research. Further, most of the studies that used Bayesian methods complemented frequentist results with Bayesian results, and a majority of studies had a continuous or binary endpoint. The results indicated that many studies used Bayesian methods for the purpose of estimation or hypothesis testing, both with informative and non-informative priors, and had two conditions.</p>
    <p id="Par14">There are multiple ways that Bayesian hypothesis testing specifically is done in biomedicine. For instance, the posterior probabilities of the null and alternative hypotheses could be consulted, such that the alternative hypothesis is accepted if its posterior probability is close to 1 or if the posterior probability of the null hypothesis is lower than a predefined threshold (e.g., [<xref ref-type="bibr" rid="CR30">30</xref>]). Alternatively, the highest density interval of the posterior distribution could be compared to a predefined region of practical equivalence: If the highest density interval does not overlap with the region of equivalence, the alternative hypothesis can be accepted [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. Another possibility is the use of Bayes factors [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR36">36</xref>], which quantify the evidence for the alternative hypothesis relative to the evidence for the null hypothesis.</p>
    <p id="Par15">It can be argued that the Bayes factor should be preferred among those options. For example, a Bayes factor is an updating factor that enables researchers to update their individual prior beliefs about the two hypotheses. In other words, in contrast to posterior probabilities for the hypotheses, the Bayes factor is independent of any prior beliefs a researcher might have. Furthermore, a Bayes factor provides the relative evidence for the considered hypotheses. Conducting hypothesis testing with posterior probabilities does not necessarily have this property: evidence against one hypothesis need not be in favor of the other (although for complementary hypotheses this would be true). For these reasons, we only consider Bayes factors in the remainder of this manuscript.</p>
    <p id="Par16">Despite the fact that statistical inference is slowly changing from frequentist methods towards Bayesian methods [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR29">29</xref>], a majority of biomedical research still employs frequentist statistical techniques [<xref ref-type="bibr" rid="CR5">5</xref>]. To some extent, this might be due to a biased statistical education in favor of frequentist inference. Moreover, researchers might perceive statistical inference through NHST and reporting of <italic>p</italic>-values as prescriptive and, hence, adhere to this convention [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. We believe that one of the most crucial factors is the unavailability of easy-to-use Bayesian tools and software, leaving Bayesian hypothesis testing largely to statistical experts. Fortunately, important advances have been made towards user-friendly interfaces for Bayesian analyses with the release of the BayesFactor software [<xref ref-type="bibr" rid="CR39">39</xref>], written in R [<xref ref-type="bibr" rid="CR40">40</xref>], and point-and-click software like JASP [<xref ref-type="bibr" rid="CR41">41</xref>] and Jamovi [<xref ref-type="bibr" rid="CR42">42</xref>], the latter two of which are based to some extent on the BayesFactor software. However, these tools are mainly tailored towards research designs in the social sciences. Easy-to-use Bayesian tools and corresponding accessible software for the analysis of biomedical research designs specifically (e.g., superiority, equivalence, and non-inferiority) are still missing and, thus, urgently needed.</p>
    <p id="Par17">In this article, we provide an R package and a web application for conducting Bayesian hypothesis tests for superiority, equivalence, and non-inferiority designs, which is particularly relevant for the biomedical sciences. Although implementations for the superiority and equivalence test exist elsewhere, the implementation of the non-inferiority test is novel. The main objective of this manuscript is twofold: (1) to provide an easy-to-use software for the calculation of Bayes factors for common biomedical designs that can be used both by researchers who are comfortable programming and those who are not; (2) to provide a tutorial on how to use this software, using an applied example related to biomedicine. First, we outline the traditional frequentist approach to statistical testing for each of these designs. Second, we discuss the key disadvantages and potential pitfalls of this approach and motivate why Bayesian inferential techniques are better suited for these research designs. Third, we explain the conceptual background of Bayes factors [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR36">36</xref>]. Fourth, we provide and introduce baymedr [<xref ref-type="bibr" rid="CR43">43</xref>], an open-source software written in R [<xref ref-type="bibr" rid="CR40">40</xref>] that comes together with a web application (available at [<xref ref-type="bibr" rid="CR44">44</xref>]), for the computation of Bayes factors for common biomedical designs. We provide step-by-step instructions on how to use baymedr. Finally, we present a reanalysis of an existing empirical study to illustrate the most important features of the baymedr R package and the accompanying web application.</p>
    <sec id="Sec2">
      <title>Frequentist inference for superiority, equivalence and non-inferiority designs</title>
      <p id="Par18">The superiority, equivalence, and non-inferiority tests are concerned with research settings in which two conditions (e.g., control and experimental) are compared on some outcome measure [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. For instance, researchers might want to investigate whether a new antidepressant medication is superior, equivalent, or non-inferior compared to a well-established antidepressant. For a continuous outcome variable, the between-group comparison is typically made with one or two <italic>t</italic>-tests. The three designs differ, however, in the precise specification of the <italic>t</italic>-tests (see Fig. <xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Schematic depiction of the superiority, equivalence, and non-inferiority designs. The <italic>x</italic>-axis represents the true population effect size (<inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M6"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq3.gif"/></alternatives></inline-formula>), where <italic>c</italic> is the standardized equivalence margin in case of the equivalence test and the standardized non-inferiority margin in case of the non-inferiority test. Gray regions mark the null hypotheses and white regions the alternative hypotheses. The region with the diagonal black lines is not used for the one-sided superiority design. Note that the diagram assumes that high values on the measure of interest represent superior or non-inferior values and that a one-sided test is used for the superiority design</p></caption><graphic xlink:href="12874_2023_2097_Fig1_HTML" id="MO1"/></fig></p>
      <p id="Par19">In the following, we will assume that higher scores on the outcome measure of interest represent a more favorable outcome (i.e., superiority or non-inferiority) than lower scores. For example, high scores are favorable when the measure of interest represents the number of social interactions in patients with social anxiety, whereas low scores are favorable when the outcome variable is the number of depressive symptoms in patients with major depressive disorder. We will also assume that the outcome variable is continuous and that the residuals within both conditions are Normal distributed in the population, sharing a common population variance. Throughout this article, the true population effect size (<inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M8"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq4.gif"/></alternatives></inline-formula>) reflects the true standardized difference in the outcome between the experimental condition (i.e., <inline-formula id="IEq5"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {e}$$\end{document}</tex-math><mml:math id="M10"><mml:mtext>e</mml:mtext></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq5.gif"/></alternatives></inline-formula>) and the control condition (i.e., <inline-formula id="IEq6"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {c}$$\end{document}</tex-math><mml:math id="M12"><mml:mtext>c</mml:mtext></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq6.gif"/></alternatives></inline-formula>):<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \delta = \frac{\mu _{\text {e}}- \mu _{\text {c}}}{\sigma } \text {.} \end{aligned}$$\end{document}</tex-math><mml:math id="M14" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>μ</mml:mi><mml:mtext>e</mml:mtext></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mtext>c</mml:mtext></mml:msub></mml:mrow><mml:mi>σ</mml:mi></mml:mfrac><mml:mtext>.</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula></p>
      <sec id="Sec3">
        <title>The superiority design</title>
        <p id="Par20">The superiority design tests whether the experimental condition is superior to the control condition (see the first row of Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Conceptually, the superiority design consists of a one-sided test due to its inherent directionality. The null hypothesis <inline-formula id="IEq7"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M16"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq7.gif"/></alternatives></inline-formula> states that the true population effect size is zero, whereas the alternative hypotheses <inline-formula id="IEq8"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M18"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq8.gif"/></alternatives></inline-formula> states that the true population effect size is larger than zero:<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \mathcal {H} _0 {:}\ \, \delta =0\qquad \qquad \mathcal {H} _1 {:}\ \, \delta &gt;0 \text {.} \end{aligned}$$\end{document}</tex-math><mml:math id="M20" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mspace width="0.166667em"/><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mspace width="2em"/><mml:mspace width="2em"/><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mspace width="0.166667em"/><mml:mi>δ</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn><mml:mtext>.</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par21">To test these hypotheses, a one-sided <italic>t</italic>-test is conducted.<xref ref-type="fn" rid="Fn1">1</xref></p>
      </sec>
      <sec id="Sec4">
        <title>The equivalence design</title>
        <p id="Par22">The equivalence design tests whether the experimental and control conditions are practically equivalent (see the second row of Fig. <xref rid="Fig1" ref-type="fig">1</xref>). There are multiple approaches to equivalence testing (see, e.g., [<xref ref-type="bibr" rid="CR45">45</xref>]). A comprehensive treatment of all approaches is beyond the scope of this article. Here, we focus on one popular alternative: the two one-sided tests procedure (TOST; [<xref ref-type="bibr" rid="CR45">45</xref>–<xref ref-type="bibr" rid="CR49">49</xref>]). An equivalence interval must be defined, which can be based, for example, on the smallest effect size of interest [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]. The specification of the equivalence interval is not a statistical question; thus, it should be set by experts in the respective fields [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR48">48</xref>] or comply with regulatory guidelines [<xref ref-type="bibr" rid="CR52">52</xref>]. Importantly, however, the equivalence interval should be determined independent of the obtained data.</p>
        <p id="Par23">TOST involves conducting two one-sided <italic>t</italic>-tests, each one with its own null and alternative hypotheses. For the first test, the null hypothesis states that the true population effect size is smaller than the lower boundary of the equivalence interval, whereas the alternative hypothesis states that the true population effect size is larger than the lower boundary of the equivalence interval. For the second test, the null hypothesis states that the true population effect size is larger than the upper boundary of the equivalence interval, whereas the alternative hypothesis states that the true population effect size is smaller than the upper boundary of the equivalence interval. Assuming that the equivalence interval is symmetric around the null value, these hypotheses can be summarized as follows:<disp-formula id="Equ3"><label>3</label><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \mathcal {H} _0 {:}\ \delta \le -c ~ \text {OR} ~ \delta \ge c \qquad \qquad \mathcal {H} _1 {:}\ \delta &gt; -c\ \text {AND}\ \delta &lt; c \text {,} \end{aligned}$$\end{document}</tex-math><mml:math id="M22" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>≤</mml:mo><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mspace width="3.33333pt"/><mml:mtext>OR</mml:mtext><mml:mspace width="3.33333pt"/><mml:mi>δ</mml:mi><mml:mo>≥</mml:mo><mml:mi>c</mml:mi><mml:mspace width="2em"/><mml:mspace width="2em"/><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&gt;</mml:mo><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mspace width="4pt"/><mml:mtext>AND</mml:mtext><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>c</mml:mi><mml:mtext>,</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula>where <italic>c</italic> represents the margin of the standardized equivalence interval. Two <italic>p</italic>-values (<inline-formula id="IEq9"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p_{-c}$$\end{document}</tex-math><mml:math id="M24"><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq9.gif"/></alternatives></inline-formula> and <inline-formula id="IEq10"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p_{c}$$\end{document}</tex-math><mml:math id="M26"><mml:msub><mml:mi>p</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq10.gif"/></alternatives></inline-formula>) result from the application of the TOST procedure. We reject the null hypothesis of non-equivalence and, thus, establish equivalence if <inline-formula id="IEq11"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\max \left( p_{-c}, ~ p_{c} \right) &lt; \alpha$$\end{document}</tex-math><mml:math id="M28"><mml:mrow><mml:mo movablelimits="true">max</mml:mo><mml:mfenced close=")" open="("><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mspace width="3.33333pt"/><mml:msub><mml:mi>p</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mfenced><mml:mo>&lt;</mml:mo><mml:mi>α</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq11.gif"/></alternatives></inline-formula> (cf. [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]). In other words, both tests need to reach statistical significance.</p>
      </sec>
      <sec id="Sec5">
        <title>The non-inferiority design</title>
        <p id="Par24">In some situations, researchers are interested in testing whether the experimental condition is non-inferior or not worse than the control condition by a certain amount. This is the goal of the non-inferiority design, which consists of a one-tailed test (see the third row of Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Realistic applications might include testing the effectiveness of a new medication that has fewer undesirable adverse effects [<xref ref-type="bibr" rid="CR54">54</xref>], is cheaper [<xref ref-type="bibr" rid="CR55">55</xref>], or is easier to administer than the current medication [<xref ref-type="bibr" rid="CR56">56</xref>]. In these cases, we need to ponder the cost of a somewhat lower or equal effectiveness of the new treatment with the value of the just mentioned benefits [<xref ref-type="bibr" rid="CR57">57</xref>]. The null hypothesis states that the true population effect size is equal to a predetermined threshold, whereas the alternative hypothesis states that the true population effect size is higher than this threshold:<disp-formula id="Equ4"><label>4</label><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \mathcal {H} _0 {:}\ \delta =-c \qquad \qquad \mathcal {H} _1 {:}\ \delta &gt;-c \text {,} \end{aligned}$$\end{document}</tex-math><mml:math id="M30" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mspace width="2em"/><mml:mspace width="2em"/><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&gt;</mml:mo><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mtext>,</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ4.gif" position="anchor"/></alternatives></disp-formula>where <italic>c</italic> represents the standardized non-inferiority margin. As with the equivalence interval, the non-inferiority margin should be defined independent of the obtained data.</p>
      </sec>
      <sec id="Sec6">
        <title>Limitations of frequentist inference</title>
        <p id="Par25">Tests of superiority, equivalence, and non-inferiority have great value in biomedical research. It is the way researchers conduct their statistical analyses that, we argue, should be critically reconsidered. There are several disadvantages associated with the application of NHST to superiority, equivalence, and non-inferiority designs. Here, we limit our discussion to two disadvantages; for a more comprehensive exposition we refer the reader to other sources (e.g., [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>]).</p>
        <p id="Par26">First, researchers need to stick to a predetermined sampling plan [<xref ref-type="bibr" rid="CR60">60</xref>–<xref ref-type="bibr" rid="CR62">62</xref>]. That is, it is not legitimate to decide based on interim results to stop data collection (e.g., because the <italic>p</italic>-value is already smaller than <inline-formula id="IEq12"><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\alpha$$\end{document}</tex-math><mml:math id="M32"><mml:mi>α</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq12.gif"/></alternatives></inline-formula>) or to continue data collection beyond the predetermined sample size (e.g., because the <italic>p</italic>-value almost reaches statistical significance). In principle, researchers can correct for the fact that they inspected the data by reducing the required significance threshold through one of several techniques [<xref ref-type="bibr" rid="CR63">63</xref>]. However, such correction methods are rarely applied. Especially in biomedical research, the possibility of optional stopping could reduce the waste of resources for expensive and time-consuming trials [<xref ref-type="bibr" rid="CR64">64</xref>].</p>
        <p id="Par27">Second, with the traditional frequentist framework it is impossible to quantify evidence in favor of the null hypothesis [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR65">65</xref>–<xref ref-type="bibr" rid="CR67">67</xref>]. Oftentimes, the <italic>p</italic>-value is erroneously interpreted as a posterior probability, in the sense that it represents the probability of the null hypothesis [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. However, a non-significant <italic>p</italic>-value does not only occur when the null hypothesis is in fact true but also when the alternative hypothesis is true, yet there was not enough power to detect an effect [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]. As ([<xref ref-type="bibr" rid="CR71">71</xref>], p.485) put it: “Absence of evidence is not evidence of absence”. Still, a large proportion of biomedical studies falsely claim equivalence based on statistically non-significant <italic>t</italic>-tests [<xref ref-type="bibr" rid="CR72">72</xref>]. Yet, estimating evidence in favor of the null hypothesis is essential for certain designs like the equivalence test [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>].</p>
        <p id="Par28">The TOST procedure for equivalence testing provides a workaround for the problem that evidence for the null hypothesis cannot be quantified with traditional frequentist techniques by defining an equivalence interval around <inline-formula id="IEq13"><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta =0$$\end{document}</tex-math><mml:math id="M34"><mml:mrow><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq13.gif"/></alternatives></inline-formula> and conducting two tests. Without this interval the TOST procedure would inevitably fail (see [<xref ref-type="bibr" rid="CR45">45</xref>] for an explanation of why this is the case). As we will see, the Bayesian equivalence test does not have this restriction; it allows for the specification of interval as well as point null hypotheses.</p>
      </sec>
    </sec>
    <sec id="Sec7">
      <title>Bayesian tests for superiority, equivalence and non-inferiority designs</title>
      <p id="Par29">The Bayesian statistical framework provides a logically sound method to update beliefs about parameters based on new data [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. Bayesian inference can be divided into parameter estimation (e.g., estimating a population correlation) and model comparison (e.g., comparing the relative probabilities of the data under the null and alternative hypotheses) procedures (see, e.g., [<xref ref-type="bibr" rid="CR75">75</xref>], for an overview). Here, we will focus on the latter approach, which is usually accomplished with Bayes factors [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR36">36</xref>]. In our exposition of Bayes factors in general and specifically for superiority, equivalence, and non-inferiority designs, we mostly refrain from complex equations and derivations. Formulas are only provided when we think that they help to communicate the ideas and concepts. We refer readers interested in the mathematics of Bayes factors to other sources (e.g., [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR76">76</xref>–<xref ref-type="bibr" rid="CR78">78</xref>]). The precise derivation of Bayes factors for superiority, equivalence, and non-inferiority designs in particular is treated elsewhere [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR79">79</xref>].</p>
      <sec id="Sec8">
        <title>The Bayes factor</title>
        <p id="Par30">Let us suppose that we have two hypotheses, <inline-formula id="IEq14"><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M36"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq14.gif"/></alternatives></inline-formula> and <inline-formula id="IEq15"><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M38"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq15.gif"/></alternatives></inline-formula>, that we want to contrast. Without considering any data, we have initial beliefs about the probabilities of <inline-formula id="IEq16"><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M40"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq16.gif"/></alternatives></inline-formula> and <inline-formula id="IEq17"><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M42"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq17.gif"/></alternatives></inline-formula>, which are given by the prior probabilities <inline-formula id="IEq18"><alternatives><tex-math id="M43">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _0 \right)$$\end{document}</tex-math><mml:math id="M44"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq18.gif"/></alternatives></inline-formula> and <inline-formula id="IEq19"><alternatives><tex-math id="M45">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _1 \right) =1-p \left( \mathcal {H} _0 \right)$$\end{document}</tex-math><mml:math id="M46"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq19.gif"/></alternatives></inline-formula>. Now, we collect some data <italic>D</italic>. After having seen the data, we have new and refined beliefs about the probabilities that <inline-formula id="IEq20"><alternatives><tex-math id="M47">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M48"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq20.gif"/></alternatives></inline-formula> and <inline-formula id="IEq21"><alternatives><tex-math id="M49">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M50"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq21.gif"/></alternatives></inline-formula> are true, which are given by the posterior probabilities <inline-formula id="IEq22"><alternatives><tex-math id="M51">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _0 \mid D \right)$$\end{document}</tex-math><mml:math id="M52"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq22.gif"/></alternatives></inline-formula> and <inline-formula id="IEq23"><alternatives><tex-math id="M53">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _1 \mid D \right) =1-p \left( \mathcal {H} _0 \mid D \right)$$\end{document}</tex-math><mml:math id="M54"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq23.gif"/></alternatives></inline-formula>. In other words, we update our prior beliefs about the probabilities of <inline-formula id="IEq24"><alternatives><tex-math id="M55">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M56"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq24.gif"/></alternatives></inline-formula> and <inline-formula id="IEq25"><alternatives><tex-math id="M57">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M58"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq25.gif"/></alternatives></inline-formula> by incorporating what the data dictates we should believe and arrive at our posterior beliefs. This relation is expressed in Bayes’ rule:<disp-formula id="Equ5"><label>5</label><alternatives><tex-math id="M59">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \underbrace{p \left( \mathcal {H} _i \mid D \right) }_{\text {Posterior}} = \frac{\overbrace{p \left( D \mid \mathcal {H} _i \right) }^{\text {Likelihood}} \overbrace{p \left( \mathcal {H} _i \right) }^{\text {Prior}}}{\underbrace{p \left( D \mid \mathcal {H} _0 \right) p \left( \mathcal {H} _0 \right) +p \left( D \mid \mathcal {H} _1 \right) p \left( \mathcal {H} _1 \right) }_{\text {Marginal Likelihood}}} \text {,} \end{aligned}$$\end{document}</tex-math><mml:math id="M60" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:munder><mml:munder accentunder="true"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mo>⏟</mml:mo></mml:munder><mml:mtext>Posterior</mml:mtext></mml:munder><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mover><mml:mover accent="true"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow><mml:mo>⏞</mml:mo></mml:mover><mml:mtext>Likelihood</mml:mtext></mml:mover><mml:mover><mml:mover accent="true"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow><mml:mo>⏞</mml:mo></mml:mover><mml:mtext>Prior</mml:mtext></mml:mover></mml:mrow><mml:munder><mml:munder accentunder="true"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mo>+</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mo>⏟</mml:mo></mml:munder><mml:mrow><mml:mtext>Marginal Likelihood</mml:mtext></mml:mrow></mml:munder></mml:mfrac><mml:mtext>,</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ5.gif" position="anchor"/></alternatives></disp-formula>with <inline-formula id="IEq26"><alternatives><tex-math id="M61">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$i= \{0, ~ 1 \}$$\end{document}</tex-math><mml:math id="M62"><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mo stretchy="false">{</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mspace width="3.33333pt"/><mml:mn>1</mml:mn><mml:mo stretchy="false">}</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq26.gif"/></alternatives></inline-formula>, and where <inline-formula id="IEq27"><alternatives><tex-math id="M63">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _i \right)$$\end{document}</tex-math><mml:math id="M64"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq27.gif"/></alternatives></inline-formula> represents the prior probability of <inline-formula id="IEq28"><alternatives><tex-math id="M65">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _i$$\end{document}</tex-math><mml:math id="M66"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq28.gif"/></alternatives></inline-formula>, <inline-formula id="IEq29"><alternatives><tex-math id="M67">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( D \mid \mathcal {H} _i \right)$$\end{document}</tex-math><mml:math id="M68"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq29.gif"/></alternatives></inline-formula> denotes the likelihood of the data under <inline-formula id="IEq30"><alternatives><tex-math id="M69">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _i$$\end{document}</tex-math><mml:math id="M70"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq30.gif"/></alternatives></inline-formula>, <inline-formula id="IEq31"><alternatives><tex-math id="M71">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( D \mid \mathcal {H} _0 \right) p \left( \mathcal {H} _0 \right) +p \left( D \mid \mathcal {H} _1 \right) p \left( \mathcal {H} _1 \right)$$\end{document}</tex-math><mml:math id="M72"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mo>+</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq31.gif"/></alternatives></inline-formula> is the marginal likelihood (also called evidence; [<xref ref-type="bibr" rid="CR24">24</xref>]), and <inline-formula id="IEq32"><alternatives><tex-math id="M73">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _i \mid D \right)$$\end{document}</tex-math><mml:math id="M74"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq32.gif"/></alternatives></inline-formula> is the posterior probability of <inline-formula id="IEq33"><alternatives><tex-math id="M75">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _i$$\end{document}</tex-math><mml:math id="M76"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq33.gif"/></alternatives></inline-formula>.</p>
        <p id="Par31">As we will see, the likelihood in Eq. <xref rid="Equ5" ref-type="disp-formula">5</xref> is actually a marginal likelihood because each model (i.e., <inline-formula id="IEq34"><alternatives><tex-math id="M77">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M78"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq34.gif"/></alternatives></inline-formula> and <inline-formula id="IEq35"><alternatives><tex-math id="M79">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M80"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq35.gif"/></alternatives></inline-formula>) contains certain parameters that are integrated out. The denominator in Eq. <xref rid="Equ5" ref-type="disp-formula">5</xref> (labeled marginal likelihood) serves as a normalization constant, ensuring that the sum of the posterior probabilities is 1. Without this normalization constant, the posterior is still proportional to the product of the likelihood and the prior. Therefore, for <inline-formula id="IEq36"><alternatives><tex-math id="M81">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M82"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq36.gif"/></alternatives></inline-formula> and <inline-formula id="IEq37"><alternatives><tex-math id="M83">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M84"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq37.gif"/></alternatives></inline-formula> we can also write:<disp-formula id="Equ6"><label>6</label><alternatives><tex-math id="M85">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} p \left( \mathcal {H} _i \mid D \right) \propto p \left( D \mid \mathcal {H} _i \right) p \left( \mathcal {H} _i \right) \text {,} \end{aligned}$$\end{document}</tex-math><mml:math id="M86" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced><mml:mo>∝</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mtext>,</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ6.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq38"><alternatives><tex-math id="M87">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\propto$$\end{document}</tex-math><mml:math id="M88"><mml:mo>∝</mml:mo></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq38.gif"/></alternatives></inline-formula> means “is proportional to”.</p>
        <p id="Par32">Rather than using posterior probabilities for each hypothesis, let the ratio of the posterior probabilities for <inline-formula id="IEq39"><alternatives><tex-math id="M89">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M90"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq39.gif"/></alternatives></inline-formula> and <inline-formula id="IEq40"><alternatives><tex-math id="M91">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M92"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq40.gif"/></alternatives></inline-formula> be:<disp-formula id="Equ7"><label>7</label><alternatives><tex-math id="M93">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \underbrace{\frac{p \left( \mathcal {H} _0 \mid D \right) }{p \left( \mathcal {H} _1 \mid D \right) }}_{\text {Posterior odds}} = \underbrace{\frac{p \left( D \mid \mathcal {H} _0 \right) }{p \left( D \mid \mathcal {H} _1 \right) }}_{\text {Bayes factor,} ~ \text {BF}_{01}} \underbrace{\frac{p \left( \mathcal {H} _0 \right) }{p \left( \mathcal {H} _1 \right) }}_{\text {Prior odds}} \text {.} \end{aligned}$$\end{document}</tex-math><mml:math id="M94" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:munder><mml:munder accentunder="true"><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>⏟</mml:mo></mml:munder><mml:mrow><mml:mtext>Posterior odds</mml:mtext></mml:mrow></mml:munder><mml:mo>=</mml:mo><mml:munder><mml:munder accentunder="true"><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>⏟</mml:mo></mml:munder><mml:mrow><mml:mtext>Bayes factor,</mml:mtext><mml:mspace width="3.33333pt"/><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub></mml:mrow></mml:munder><mml:munder><mml:munder accentunder="true"><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>⏟</mml:mo></mml:munder><mml:mrow><mml:mtext>Prior odds</mml:mtext></mml:mrow></mml:munder><mml:mtext>.</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ7.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par33">The quantity <inline-formula id="IEq41"><alternatives><tex-math id="M95">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _0 \mid D \right) /p \left( \mathcal {H} _1 \mid D \right)$$\end{document}</tex-math><mml:math id="M96"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced><mml:mo stretchy="false">/</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq41.gif"/></alternatives></inline-formula> represents the posterior odds and the quantity <inline-formula id="IEq42"><alternatives><tex-math id="M97">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \mathcal {H} _0 \right) /p \left( \mathcal {H} _1 \right)$$\end{document}</tex-math><mml:math id="M98"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mo stretchy="false">/</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq42.gif"/></alternatives></inline-formula> is called the prior odds. To get the posterior odds, we have to multiply the prior odds with <inline-formula id="IEq43"><alternatives><tex-math id="M99">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( D \mid \mathcal {H} _0 \right) /p \left( D \mid \mathcal {H} _1 \right)$$\end{document}</tex-math><mml:math id="M100"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mo stretchy="false">/</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq43.gif"/></alternatives></inline-formula>, a quantity known as the Bayes factor [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR36">36</xref>], which is a ratio of marginal likelihoods:<disp-formula id="Equ8"><label>8</label><alternatives><tex-math id="M101">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \text {BF}_{01}= \frac{\int _{\varvec{\theta } _0} p \left( D \mid \varvec{\theta } _0, \mathcal {H} _0 \right) p \left( \varvec{\theta } _0 \mid \mathcal {H} _0 \right) d \varvec{\theta } _0}{\int _{\varvec{\theta } _1} p \left( D \mid \varvec{\theta } _1, \mathcal {H} _1 \right) p \left( \varvec{\theta } _1 \mid \mathcal {H} _1 \right) d \varvec{\theta } _1} \text {,} \end{aligned}$$\end{document}</tex-math><mml:math id="M102" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mo>∫</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>0</mml:mn></mml:msub></mml:msub><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>0</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mo>∫</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub></mml:msub><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>D</mml:mi><mml:mo>∣</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mtext>,</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ8.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq44"><alternatives><tex-math id="M103">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\varvec{\theta } _0$$\end{document}</tex-math><mml:math id="M104"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq44.gif"/></alternatives></inline-formula> and <inline-formula id="IEq45"><alternatives><tex-math id="M105">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\varvec{\theta } _1$$\end{document}</tex-math><mml:math id="M106"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq45.gif"/></alternatives></inline-formula> are vectors of parameters under <inline-formula id="IEq46"><alternatives><tex-math id="M107">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M108"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq46.gif"/></alternatives></inline-formula> and <inline-formula id="IEq47"><alternatives><tex-math id="M109">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M110"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq47.gif"/></alternatives></inline-formula>, respectively. In other words, the marginal likelihoods in the numerator and denominator of Eq. <xref rid="Equ8" ref-type="disp-formula">8</xref> are weighted averages of the likelihoods, for which the weights are determined by the corresponding prior. In the case where one hypothesis has fixed values for the parameter vector <inline-formula id="IEq48"><alternatives><tex-math id="M111">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\varvec{\theta } _i$$\end{document}</tex-math><mml:math id="M112"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq48.gif"/></alternatives></inline-formula> (e.g., a point null hypothesis), integration over the parameter space and the specification of a prior is not required. In that case, the marginal likelihood becomes a likelihood.</p>
        <p id="Par34">The Bayes factor is the amount by which we would update our prior odds to obtain the posterior odds, after taking into consideration the data. For example, if we had prior odds of 2 and the Bayes factor is 24, then the posterior odds would be 48. In the special case where the prior odds is 1, the Bayes factor is equal to the posterior odds. A major advantage of the Bayes factor is its ease of interpretation. For example, if the Bayes factor (<inline-formula id="IEq49"><alternatives><tex-math id="M113">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{01}$$\end{document}</tex-math><mml:math id="M114"><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq49.gif"/></alternatives></inline-formula>, denoting the fact that <inline-formula id="IEq50"><alternatives><tex-math id="M115">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M116"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq50.gif"/></alternatives></inline-formula> is in the numerator and <inline-formula id="IEq51"><alternatives><tex-math id="M117">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M118"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq51.gif"/></alternatives></inline-formula> in the denominator) equals 10, the data are ten times more likely to have occurred under <inline-formula id="IEq52"><alternatives><tex-math id="M119">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M120"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq52.gif"/></alternatives></inline-formula> compared to <inline-formula id="IEq53"><alternatives><tex-math id="M121">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M122"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq53.gif"/></alternatives></inline-formula>. With <inline-formula id="IEq54"><alternatives><tex-math id="M123">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{01}=0.2$$\end{document}</tex-math><mml:math id="M124"><mml:mrow><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.2</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq54.gif"/></alternatives></inline-formula>, we can say that the data are five times more likely under <inline-formula id="IEq55"><alternatives><tex-math id="M125">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M126"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq55.gif"/></alternatives></inline-formula> compared to <inline-formula id="IEq56"><alternatives><tex-math id="M127">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M128"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq56.gif"/></alternatives></inline-formula> because we can simply take the reciprocal of <inline-formula id="IEq57"><alternatives><tex-math id="M129">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{01}$$\end{document}</tex-math><mml:math id="M130"><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq57.gif"/></alternatives></inline-formula> (i.e., <inline-formula id="IEq58"><alternatives><tex-math id="M131">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{10}=1/\text {BF}_{01}$$\end{document}</tex-math><mml:math id="M132"><mml:mrow><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>10</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq58.gif"/></alternatives></inline-formula>). What constitutes enough evidence is subjective and certainly depends on the context. Nevertheless, rules of thumb for evidence thresholds have been proposed. For instance, [<xref ref-type="bibr" rid="CR36">36</xref>] labeled Bayes factors between 1 and 3 as “not worth more than a bare mention”, Bayes factors between 3 and 20 as “positive”, those between 20 and 150 as “strong”, and anything above 150 as “very strong”, with corresponding thresholds for the reciprocals of the Bayes factors. An alternative classification scheme was already proposed before, with thresholds at 3, 10, 30, and 100 and similar labels [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR80">80</xref>].</p>
        <p id="Par35">Of course, we need to define <inline-formula id="IEq59"><alternatives><tex-math id="M133">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M134"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq59.gif"/></alternatives></inline-formula> and <inline-formula id="IEq60"><alternatives><tex-math id="M135">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M136"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq60.gif"/></alternatives></inline-formula>. In other words, both models contain certain parameters for which we need to determine a prior distribution. Here, we will assume that the residuals of the two groups are Normal distributed in the population with a common population variance. The shape of a Normal distribution is fully determined with the location (mean; <inline-formula id="IEq61"><alternatives><tex-math id="M137">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mu$$\end{document}</tex-math><mml:math id="M138"><mml:mi>μ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq61.gif"/></alternatives></inline-formula>) and the scale (variance; <inline-formula id="IEq62"><alternatives><tex-math id="M139">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma ^2$$\end{document}</tex-math><mml:math id="M140"><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq62.gif"/></alternatives></inline-formula>) parameters. Thus, in principle, both models contain two parameters. Now, we make two important changes.</p>
        <p id="Par36">First, in the case where we have a point null hypothesis, <inline-formula id="IEq63"><alternatives><tex-math id="M141">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mu$$\end{document}</tex-math><mml:math id="M142"><mml:mi>μ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq63.gif"/></alternatives></inline-formula> under <inline-formula id="IEq64"><alternatives><tex-math id="M143">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M144"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq64.gif"/></alternatives></inline-formula> is fixed at <inline-formula id="IEq65"><alternatives><tex-math id="M145">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta = 0$$\end{document}</tex-math><mml:math id="M146"><mml:mrow><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq65.gif"/></alternatives></inline-formula>, leaving <inline-formula id="IEq66"><alternatives><tex-math id="M147">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma ^2$$\end{document}</tex-math><mml:math id="M148"><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq66.gif"/></alternatives></inline-formula> for <inline-formula id="IEq67"><alternatives><tex-math id="M149">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0$$\end{document}</tex-math><mml:math id="M150"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq67.gif"/></alternatives></inline-formula> and <inline-formula id="IEq68"><alternatives><tex-math id="M151">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mu$$\end{document}</tex-math><mml:math id="M152"><mml:mi>μ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq68.gif"/></alternatives></inline-formula> and <inline-formula id="IEq69"><alternatives><tex-math id="M153">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma ^2$$\end{document}</tex-math><mml:math id="M154"><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq69.gif"/></alternatives></inline-formula> for <inline-formula id="IEq70"><alternatives><tex-math id="M155">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M156"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq70.gif"/></alternatives></inline-formula>. Parameter <inline-formula id="IEq71"><alternatives><tex-math id="M157">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma ^2$$\end{document}</tex-math><mml:math id="M158"><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq71.gif"/></alternatives></inline-formula> is a nuisance parameter because it is common to both models. Placing a Jeffreys prior (also called right Haar prior), <inline-formula id="IEq72"><alternatives><tex-math id="M159">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p \left( \sigma ^2 \right) \propto 1/ \sigma ^2$$\end{document}</tex-math><mml:math id="M160"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mfenced><mml:mo>∝</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq72.gif"/></alternatives></inline-formula>, on this nuisance parameter [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR81">81</xref>] has several desirable properties that are explained elsewhere (e.g., [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>]).</p>
        <p id="Par37">Second, <inline-formula id="IEq73"><alternatives><tex-math id="M161">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mu$$\end{document}</tex-math><mml:math id="M162"><mml:mi>μ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq73.gif"/></alternatives></inline-formula> under <inline-formula id="IEq74"><alternatives><tex-math id="M163">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M164"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq74.gif"/></alternatives></inline-formula> can be expressed in terms of a population effect size <inline-formula id="IEq75"><alternatives><tex-math id="M165">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M166"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq75.gif"/></alternatives></inline-formula> [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR81">81</xref>]. This establishes a common and comparable scale across experiments and populations [<xref ref-type="bibr" rid="CR67">67</xref>]. The prior on <inline-formula id="IEq76"><alternatives><tex-math id="M167">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M168"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq76.gif"/></alternatives></inline-formula> could reflect certain hypotheses that we want to test. For instance, we could compare the null hypothesis (<inline-formula id="IEq77"><alternatives><tex-math id="M169">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0 {:}\ \delta = 0$$\end{document}</tex-math><mml:math id="M170"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq77.gif"/></alternatives></inline-formula>) to a two-sided alternative hypotheses (<inline-formula id="IEq78"><alternatives><tex-math id="M171">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1 {:}\ \delta \ne 0$$\end{document}</tex-math><mml:math id="M172"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>≠</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq78.gif"/></alternatives></inline-formula>) or to one of two one-sided alternative hypotheses (<inline-formula id="IEq79"><alternatives><tex-math id="M173">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1 {:}\ \delta &lt; 0$$\end{document}</tex-math><mml:math id="M174"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq79.gif"/></alternatives></inline-formula> or <inline-formula id="IEq80"><alternatives><tex-math id="M175">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1 {:}\ \delta &gt; 0$$\end{document}</tex-math><mml:math id="M176"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq80.gif"/></alternatives></inline-formula>). Alternatively, we could compare an interval hypothesis for the null hypothesis (<inline-formula id="IEq81"><alternatives><tex-math id="M177">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _0 {:}\ -c&lt; \delta &lt; c$$\end{document}</tex-math><mml:math id="M178"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>δ</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq81.gif"/></alternatives></inline-formula>) with a corresponding alternative hypothesis (<inline-formula id="IEq82"><alternatives><tex-math id="M179">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1 {:}\ \delta &lt; -c ~ \text {OR} ~ \delta &gt; c$$\end{document}</tex-math><mml:math id="M180"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&lt;</mml:mo><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mspace width="3.33333pt"/><mml:mtext>OR</mml:mtext><mml:mspace width="3.33333pt"/><mml:mi>δ</mml:mi><mml:mo>&gt;</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq82.gif"/></alternatives></inline-formula>).<xref ref-type="fn" rid="Fn2">2</xref> The choice of the specific prior for <inline-formula id="IEq88"><alternatives><tex-math id="M181">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M182"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq88.gif"/></alternatives></inline-formula> is a delicate matter, which is discussed in the next section.</p>
        <p id="Par38">In the most general case, the Bayes factor (i.e., <inline-formula id="IEq89"><alternatives><tex-math id="M183">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{01}$$\end{document}</tex-math><mml:math id="M184"><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq89.gif"/></alternatives></inline-formula>) can be calculated through division of the posterior odds by the prior odds (i.e., rearranging Eq. <xref rid="Equ7" ref-type="disp-formula">7</xref>):<disp-formula id="Equ9"><label>9</label><alternatives><tex-math id="M185">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \text {BF}_{01}= \frac{\left( \frac{p \left( \mathcal {H} _0 \mid D \right) }{p \left( \mathcal {H} _1 \mid D \right) } \right) }{\left( \frac{p \left( \mathcal {H} _0 \right) }{p \left( \mathcal {H} _1 \right) } \right) } = \frac{\left( \frac{p \left( \mathcal {H} _0 \mid D \right) }{p \left( \mathcal {H} _0 \right) } \right) }{\left( \frac{p \left( \mathcal {H} _1 \mid D \right) }{p \left( \mathcal {H} _1 \right) } \right) } \text {;} \end{aligned}$$\end{document}</tex-math><mml:math id="M186" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced></mml:mfrac><mml:mtext>;</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ9.gif" position="anchor"/></alternatives></disp-formula>accordingly, we can also calculate <inline-formula id="IEq90"><alternatives><tex-math id="M187">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{10}$$\end{document}</tex-math><mml:math id="M188"><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>10</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq90.gif"/></alternatives></inline-formula>:<disp-formula id="Equ10"><label>10</label><alternatives><tex-math id="M189">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} \text {BF}_{10}= \frac{\left( \frac{p \left( \mathcal {H} _1 \mid D \right) }{p \left( \mathcal {H} _0 \mid D \right) } \right) }{\left( \frac{p \left( \mathcal {H} _1 \right) }{p \left( \mathcal {H} _0 \right) } \right) } = \frac{\left( \frac{p \left( \mathcal {H} _1 \mid D \right) }{p \left( \mathcal {H} _1 \right) } \right) }{\left( \frac{p \left( \mathcal {H} _0 \mid D \right) }{p \left( \mathcal {H} _0 \right) } \right) } \text {.} \end{aligned}$$\end{document}</tex-math><mml:math id="M190" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>10</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>∣</mml:mo><mml:mi>D</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced></mml:mfrac><mml:mtext>.</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12874_2023_2097_Article_Equ10.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par39">Calculating Bayes factors this way often involves solving complex integrals (see, e.g., Eq. <xref rid="Equ8" ref-type="disp-formula">8</xref>; also cf. [<xref ref-type="bibr" rid="CR76">76</xref>]). Fortunately, there is a computational shortcut for the specific but very common scenario where we have a point null hypothesis and a complementary interval alternative hypothesis. This shortcut, which is called the Savage-Dickey density ratio, takes the ratio of the density of the prior and posterior at the null value under the alternative hypothesis to calculate the Bayes factor; this is explained in more detail elsewhere [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR85">85</xref>].</p>
      </sec>
      <sec id="Sec9">
        <title>Default priors</title>
        <p id="Par40">Until this point in our exposition, we were quite vague about the form of the prior for <inline-formula id="IEq91"><alternatives><tex-math id="M191">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M192"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq91.gif"/></alternatives></inline-formula> under <inline-formula id="IEq92"><alternatives><tex-math id="M193">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M194"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq92.gif"/></alternatives></inline-formula>. In principle, the prior for <inline-formula id="IEq93"><alternatives><tex-math id="M195">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M196"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq93.gif"/></alternatives></inline-formula> within <inline-formula id="IEq94"><alternatives><tex-math id="M197">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M198"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq94.gif"/></alternatives></inline-formula> can be defined as desired, conforming to the beliefs of the researcher. In fact, this is a fundamental part of Bayesian inference because various priors allow for the expression of a theory or prior beliefs [<xref ref-type="bibr" rid="CR86">86</xref>, <xref ref-type="bibr" rid="CR87">87</xref>]. Most commonly, however, default or objective priors are employed that aim to increase the objectivity in specifying the prior or serve as a default when no specific prior information is available [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR88">88</xref>]. We employ objective priors in baymedr.</p>
        <p id="Par41">In the situation where we have a point null hypothesis and an alternative hypothesis that involves a range of values, [<xref ref-type="bibr" rid="CR35">35</xref>] proposed to use a Cauchy prior with a scale parameter of <inline-formula id="IEq95"><alternatives><tex-math id="M199">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$r=1$$\end{document}</tex-math><mml:math id="M200"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq95.gif"/></alternatives></inline-formula> for <inline-formula id="IEq96"><alternatives><tex-math id="M201">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M202"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq96.gif"/></alternatives></inline-formula> under <inline-formula id="IEq97"><alternatives><tex-math id="M203">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H} _1$$\end{document}</tex-math><mml:math id="M204"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq97.gif"/></alternatives></inline-formula>. This Cauchy distribution is equivalent to a Student’s <italic>t</italic> distribution with 1 degree of freedom and resembles a standard Normal distribution, except that the Cauchy distribution has less mass at the center but instead heavier tails (see Fig. <xref rid="Fig2" ref-type="fig">2</xref>; [<xref ref-type="bibr" rid="CR67">67</xref>]). Mathematically, the Cauchy distribution corresponds to the combined specification of (1) a Normal prior with mean <inline-formula id="IEq98"><alternatives><tex-math id="M205">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mu _ \delta$$\end{document}</tex-math><mml:math id="M206"><mml:msub><mml:mi>μ</mml:mi><mml:mi>δ</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq98.gif"/></alternatives></inline-formula> and variance <inline-formula id="IEq99"><alternatives><tex-math id="M207">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma ^2_ \delta$$\end{document}</tex-math><mml:math id="M208"><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>δ</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq99.gif"/></alternatives></inline-formula> on <inline-formula id="IEq100"><alternatives><tex-math id="M209">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M210"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq100.gif"/></alternatives></inline-formula>; and (2) an inverse Chi-square distribution with 1 degree of freedom on <inline-formula id="IEq101"><alternatives><tex-math id="M211">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma ^2_ \delta$$\end{document}</tex-math><mml:math id="M212"><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>δ</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq101.gif"/></alternatives></inline-formula>. Integrating out <inline-formula id="IEq102"><alternatives><tex-math id="M213">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sigma ^2_ \delta$$\end{document}</tex-math><mml:math id="M214"><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>δ</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq102.gif"/></alternatives></inline-formula> yields the Cauchy distribution [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR89">89</xref>]. The scale parameter <italic>r</italic> defines the width of the Cauchy distribution; that is, half of the mass lies between –<italic>r</italic> and <italic>r</italic>.<fig id="Fig2"><label>Fig. 2</label><caption><p>Comparison of the standard Normal probability density function (solid line) and the standard Cauchy probability density function (dashed line)</p></caption><graphic xlink:href="12874_2023_2097_Fig2_HTML" id="MO2"/></fig></p>
        <p id="Par42">Choosing a Cauchy prior with a location parameter of 0 and a scale parameter of <inline-formula id="IEq103"><alternatives><tex-math id="M215">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$r=1$$\end{document}</tex-math><mml:math id="M216"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq103.gif"/></alternatives></inline-formula> has the advantage that the resulting Bayes factor is 1 in case of completely uninformative data. In turn, the Bayes factor approaches infinity (or 0) for decisive data [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR82">82</xref>]. Still, by varying the Cauchy scale parameter, we can set a different emphasis on the prior credibility of a range of effect sizes. More recently, a Cauchy prior scale of <inline-formula id="IEq104"><alternatives><tex-math id="M217">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$r=1/ \sqrt{2}$$\end{document}</tex-math><mml:math id="M218"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:msqrt><mml:mn>2</mml:mn></mml:msqrt></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq104.gif"/></alternatives></inline-formula> is used as a default setting in the BayesFactor software [<xref ref-type="bibr" rid="CR39">39</xref>], the point-and-click software JASP [<xref ref-type="bibr" rid="CR41">41</xref>], and Jamovi [<xref ref-type="bibr" rid="CR42">42</xref>]. We have adopted this value in baymedr as a default setting. Nevertheless, objective priors are often criticized (see, e.g., [<xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR91">91</xref>]); researchers are encouraged to use more informed priors if relevant knowledge is available [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR79">79</xref>].</p>
      </sec>
    </sec>
  </sec>
  <sec id="Sec10">
    <title>Implementation</title>
    <p id="Par43">With the baymedr software (BAYesian inference for MEDical designs in R; [<xref ref-type="bibr" rid="CR43">43</xref>]), written in R [<xref ref-type="bibr" rid="CR40">40</xref>], and the corresponding web application (accessible at [<xref ref-type="bibr" rid="CR44">44</xref>]) one can easily calculate Bayes factors for superiority, equivalence, and non-inferiority designs. The R package can be used by researchers who have only rudimentary knowledge of R; if that is not the case, researchers can use the web application, which does not require any knowledge of programming. In the following, we will demonstrate how Bayes factors for superiority, equivalence, and non-inferiority designs can be calculated with the baymedr R package; a thorough explanation of the web application is not necessary as it strongly overlaps with the R package. Subsequently, we will showcase (1) the baymedr R package and (2) the corresponding web application by reanalyzing data of an empirical study by [<xref ref-type="bibr" rid="CR92">92</xref>].</p>
    <sec id="Sec11">
      <title>The R package</title>
      <sec id="Sec12">
        <title>Install and load baymedr</title>
        <p id="Par44">To install the latest release of the baymedr R package from The Comprehensive R Archive Network (CRAN), use the following command: <graphic position="anchor" xlink:href="12874_2023_2097_Figa_HTML" id="MO3"/></p>
        <p id="Par45">The most recent version of the R package can be obtained from GitHub with the help of the devtools package [<xref ref-type="bibr" rid="CR93">93</xref>]: <graphic position="anchor" xlink:href="12874_2023_2097_Figb_HTML" id="MO4"/></p>
        <p id="Par46">Once baymedr is installed, it needs to be loaded into memory, after which it is ready for usage: <graphic position="anchor" xlink:href="12874_2023_2097_Figc_HTML" id="MO5"/></p>
      </sec>
      <sec id="Sec13">
        <title>Commonalities across designs</title>
        <p id="Par47">For all three research designs, the user has three options for data input (function arguments that have “x” as a name or suffix refer to the control condition and those with “y” as a name or suffix to the experimental condition): (1) provide the raw data; the relevant arguments are x and y; (2) provide the sample sizes, sample means, and sample standard deviations; the relevant arguments are n_x and n_y for sample sizes, mean_x and mean_y for sample means, and sd_x and sd_y for sample standard deviations; (3) provide the sample sizes, sample means, and the confidence interval for the difference in group means; the relevant arguments are n_x and n_y for sample sizes, mean_x and mean_y for sample means, and ci_margin for the confidence interval margin and ci_level for the confidence level.</p>
        <p id="Par48">The Cauchy distribution is used as the prior for <inline-formula id="IEq105"><alternatives><tex-math id="M219">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta$$\end{document}</tex-math><mml:math id="M220"><mml:mi>δ</mml:mi></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq105.gif"/></alternatives></inline-formula> under the alternative hypothesis for all three tests. The user can set the width of the Cauchy prior with the prior_scale argument, thus, allowing the specification of different ranges of plausible effect sizes. In all three cases, the Cauchy prior is centered on <inline-formula id="IEq106"><alternatives><tex-math id="M221">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta =0$$\end{document}</tex-math><mml:math id="M222"><mml:mrow><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq106.gif"/></alternatives></inline-formula>. Further, baymedr uses a default Cauchy prior scale of <inline-formula id="IEq107"><alternatives><tex-math id="M223">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$r=1/ \sqrt{2}$$\end{document}</tex-math><mml:math id="M224"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:msqrt><mml:mn>2</mml:mn></mml:msqrt></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq107.gif"/></alternatives></inline-formula>, complying with the standard settings of the BayesFactor software [<xref ref-type="bibr" rid="CR39">39</xref>], JASP [<xref ref-type="bibr" rid="CR41">41</xref>], and Jamovi [<xref ref-type="bibr" rid="CR42">42</xref>].</p>
        <p id="Par49">Once a superiority, equivalence, or non-inferiority test is conducted, an informative and accessible output message is printed in the console. For all three designs, this output states the type of test that was conducted and whether raw or summary data were used. Moreover, the corresponding null and alternative hypotheses are restated and the specified Cauchy prior scale is shown. In addition, the lower and upper bounds of the equivalence interval are presented in case an equivalence test was employed; similarly, the non-inferiority margin is printed when the non-inferiority design was chosen. Lastly, the resulting Bayes factor is shown. To avoid any confusion, it is declared in brackets whether the Bayes factor quantifies evidence towards the null (e.g., equivalence) or alternative (e.g., non-inferiority or superiority) hypothesis.</p>
      </sec>
      <sec id="Sec14">
        <title>Conducting superiority, equivalence and non-inferiority tests</title>
        <p id="Par50">The Bayesian superiority test is performed with the super_bf() function. Depending on the research setting, low or high scores on the measure of interest represent “superiority”, which is specified by the argument direction. Since we seek to find evidence for the alternative hypothesis (superiority), the Bayes factor quantifies evidence for <inline-formula id="IEq108"><alternatives><tex-math id="M225">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M226"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq108.gif"/></alternatives></inline-formula> relative to <inline-formula id="IEq109"><alternatives><tex-math id="M227">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M228"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq109.gif"/></alternatives></inline-formula> (i.e., <inline-formula id="IEq110"><alternatives><tex-math id="M229">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{10}$$\end{document}</tex-math><mml:math id="M230"><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>10</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq110.gif"/></alternatives></inline-formula>).</p>
        <p id="Par51">The Bayesian equivalence test is done with the equiv_bf() function. The desired equivalence interval is specified with the interval argument. Several options are possible: A symmetric equivalence interval around <inline-formula id="IEq111"><alternatives><tex-math id="M231">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta =0$$\end{document}</tex-math><mml:math id="M232"><mml:mrow><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq111.gif"/></alternatives></inline-formula> can be indicated by providing one value (e.g., interval = 0.2) or by providing a vector with the negative and the positive values (e.g., interval = c(-0.2, 0.2)). An asymmetric equivalence interval can be specified by providing a vector with the negative and the positive values (e.g., interval = c(-0.3, 0.2)). The implementation of a point null hypothesis is achieved by using either interval = 0 or interval = c(0, 0), which also serves as the default specification. The argument interval_std can be used to declare whether the equivalence interval was specified in standardized or unstandardized units. Since we seek to quantify evidence towards equivalence, we contrast the evidence for <inline-formula id="IEq112"><alternatives><tex-math id="M233">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M234"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq112.gif"/></alternatives></inline-formula> relative to <inline-formula id="IEq113"><alternatives><tex-math id="M235">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M236"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq113.gif"/></alternatives></inline-formula> (i.e., <inline-formula id="IEq114"><alternatives><tex-math id="M237">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{01}$$\end{document}</tex-math><mml:math id="M238"><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>01</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq114.gif"/></alternatives></inline-formula>).</p>
        <p id="Par52">The Bayes factor for the non-inferiority design is calculated with the infer_bf() function. The value for the non-inferiority margin can be specified with the ni_margin argument. The argument ni_margin_std can be used to declare whether the non-inferiority margin was given in standardized or unstandardized units. Lastly, depending on whether high or low values on the measure of interest represent “non-inferiority”, one of the options “high” or “low” should be set for the argument direction. We wish to determine the evidence in favor of <inline-formula id="IEq115"><alternatives><tex-math id="M239">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M240"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq115.gif"/></alternatives></inline-formula>; therefore, the evidence is expressed for <inline-formula id="IEq116"><alternatives><tex-math id="M241">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M242"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq116.gif"/></alternatives></inline-formula> relative to <inline-formula id="IEq117"><alternatives><tex-math id="M243">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M244"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq117.gif"/></alternatives></inline-formula> (i.e., <inline-formula id="IEq118"><alternatives><tex-math id="M245">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text {BF}_{10}$$\end{document}</tex-math><mml:math id="M246"><mml:msub><mml:mtext>BF</mml:mtext><mml:mn>10</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq118.gif"/></alternatives></inline-formula>).</p>
      </sec>
    </sec>
  </sec>
  <sec id="Sec15">
    <title>Results</title>
    <p id="Par53">To illustrate how the R package and the web application can be used, we provide one example of an empirical study that employed non-inferiority tests to investigate differences in the amount of sleep, sleepiness, and alertness among medical trainees following either standard or flexible duty-hour programs [<xref ref-type="bibr" rid="CR92">92</xref>]. The authors list several disadvantages of restricted duty-hour programs, such as: (1) “[t]ransitions [as a result of restricted duty hours] into and out of night shifts can result in fatigue from shift-work-related sleep loss and circadian misalignment”; (2) “[p]reventing interns from participating in extended shifts may reduce educational opportunities”; (3) “increase[d] handoffs”; (4) “reduce[d] continuity of care”; and (5) “[r]estricting duty hours may increase the necessity of cross-coverage, contributing to work compression for both interns and more senior residents” ([<xref ref-type="bibr" rid="CR92">92</xref>], p.916). As outlined above, the calculation of Bayes factors for equivalence and superiority tests is done quite similarly to the non-inferiority test, so we do not provide specific examples for those tests. For the purpose of this demonstration, we will only consider the outcome variable sleepiness. Participants were monitored over a period of 14 days and were asked to indicate each morning how sleepy they were by completing the Karolinska sleepiness scale [<xref ref-type="bibr" rid="CR94">94</xref>], a 9-point Likert scale ranging from 1 (extremely alert) to 9 (extremely sleepy, fighting sleep). The dependent variable consisted of the average sleepiness score over the whole observation period of 14 days. The research question was whether the flexible duty-hour program was non-inferior to the standard program in terms of sleepiness.</p>
    <p id="Par54">The null hypothesis was that medical trainees in the flexible program are sleepier by more than a non-inferiority margin than trainees in the standard program. Conversely, the alternative hypothesis was that trainees in the flexible program are not sleepier by more than a non-inferiority margin than trainees in the standard program. The non-inferiority margin was defined as 1 point on the 9-point Likert scale. All relevant summary statistics can be obtained or calculated from Table 1 of [<xref ref-type="bibr" rid="CR92">92</xref>] and the Results section of [<xref ref-type="bibr" rid="CR92">92</xref>]. Table 1 of [<xref ref-type="bibr" rid="CR92">92</xref>] indicates that the flexible program had a mean of <inline-formula id="IEq119"><alternatives><tex-math id="M247">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$M_e=4.8$$\end{document}</tex-math><mml:math id="M248"><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>4.8</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq119.gif"/></alternatives></inline-formula> and the standard program had a mean of <inline-formula id="IEq120"><alternatives><tex-math id="M249">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$M_c=4.7$$\end{document}</tex-math><mml:math id="M250"><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>4.7</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq120.gif"/></alternatives></inline-formula>. From the Results section of [<xref ref-type="bibr" rid="CR92">92</xref>], we can extract that sample sizes were <inline-formula id="IEq121"><alternatives><tex-math id="M251">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n_e=205$$\end{document}</tex-math><mml:math id="M252"><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>205</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq121.gif"/></alternatives></inline-formula> and <inline-formula id="IEq122"><alternatives><tex-math id="M253">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n_c=193$$\end{document}</tex-math><mml:math id="M254"><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>193</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq122.gif"/></alternatives></inline-formula> in the flexible and standard programs, respectively. Further, the margin of the <inline-formula id="IEq123"><alternatives><tex-math id="M255">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$95 \%$$\end{document}</tex-math><mml:math id="M256"><mml:mrow><mml:mn>95</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq123.gif"/></alternatives></inline-formula> CI of the difference between the two conditions was <inline-formula id="IEq124"><alternatives><tex-math id="M257">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$0.31-0.12=0.19$$\end{document}</tex-math><mml:math id="M258"><mml:mrow><mml:mn>0.31</mml:mn><mml:mo>-</mml:mo><mml:mn>0.12</mml:mn><mml:mo>=</mml:mo><mml:mn>0.19</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq124.gif"/></alternatives></inline-formula>. Finally, lower scores on the sleepiness scale constitute favorable (non-inferior) outcomes.</p>
    <sec id="Sec16">
      <title>The R package</title>
      <p id="Par55">Using this information, we can use the baymedr R package to calculate the Bayes factor as follows: <graphic position="anchor" xlink:href="12874_2023_2097_Figd_HTML" id="MO6"/></p>
      <p id="Par56">Note that we decided to use a Cauchy prior scale of <inline-formula id="IEq125"><alternatives><tex-math id="M259">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$r=1/ \sqrt{2}$$\end{document}</tex-math><mml:math id="M260"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:msqrt><mml:mn>2</mml:mn></mml:msqrt></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq125.gif"/></alternatives></inline-formula> for this reanalysis. Since our Cauchy prior scale of choice represents the default value in baymedr, it would not have been necessary to provide this argument; however, for purposes of illustration, we mentioned it explicitly in the function call.</p>
      <p id="Par57">The output provides a user-friendly summary of the analysis: <graphic position="anchor" xlink:href="12874_2023_2097_Fige_HTML" id="MO7"/></p>
      <p id="Par58">This large Bayes factor supports the conclusion from [<xref ref-type="bibr" rid="CR92">92</xref>] that medical trainees in the flexible duty-hour program are non-inferior in terms of sleepiness compared to medical trainees in the standard program (<inline-formula id="IEq126"><alternatives><tex-math id="M261">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p&lt;.001$$\end{document}</tex-math><mml:math id="M262"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mo>.</mml:mo><mml:mn>001</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq126.gif"/></alternatives></inline-formula>). In other words, the data are <inline-formula id="IEq127"><alternatives><tex-math id="M263">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$8.56 \times {10}^{10}$$\end{document}</tex-math><mml:math id="M264"><mml:mrow><mml:mn>8.56</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>10</mml:mn></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq127.gif"/></alternatives></inline-formula> more likely to have occurred under <inline-formula id="IEq128"><alternatives><tex-math id="M265">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M266"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq128.gif"/></alternatives></inline-formula> than <inline-formula id="IEq129"><alternatives><tex-math id="M267">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M268"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq129.gif"/></alternatives></inline-formula>.</p>
    </sec>
    <sec id="Sec17">
      <title>The web application</title>
      <p id="Par59">Similarly, we can use the web application to calculate the Bayes factor. For this, the web application should first be opened in a web browser (available at [<xref ref-type="bibr" rid="CR44">44</xref>]). The just-opened welcome page offers a brief description of the three research designs and Bayes factors and lists several further useful resources for the interested user. Since we want to conduct a non-inferiority test with summary data, we click on “Non-inferiority” and then “Summary data” on the navigation bar at the top (see Fig. <xref rid="Fig3" ref-type="fig">3</xref>). The summary statistics for the example reanalysis of [<xref ref-type="bibr" rid="CR92">92</xref>] can be inserted in the corresponding fields, as shown in Fig. <xref rid="Fig3" ref-type="fig">3</xref>. For some fields a small green question mark is shown, which provides more details and help when the user clicks on them. Furthermore, the scale of the prior distribution can be specified, which by default is set to 1 / sqrt(2). A small dynamic plot accompanies the field for the Cauchy prior scale. That is, once the prior scale is changed, the plot updates automatically, so that users obtain an impression of what the distribution looks like and what effect sizes are included. Once the “Calculate Bayes factor” button is clicked, the output is displayed.<fig id="Fig3"><label>Fig. 3</label><caption><p>Shown is part of the baymedr web application demonstrating how summary statistics can be inserted and further parameters specified for a Bayesian non-inferiority test. In this specific case, the summary statistics correspond to the ones obtained from [<xref ref-type="bibr" rid="CR92">92</xref>]. See text for details</p></caption><graphic xlink:href="12874_2023_2097_Fig3_HTML" id="MO8"/></fig></p>
      <p id="Par60">Figure <xref rid="Fig4" ref-type="fig">4</xref> shows the output of the calculations. The top of the left column displays the same output that is given with the R package. Further, upon clicking on “Show frequentist results”, the results of the frequentist non-inferiority test are shown and clicking on “Hide frequentist results” in turn hides those results. Below that output is the formula for the Bayes factor, with different elements printed in colors that correspond to dots in matching colors in the plots on the right column of the results output. The upper plot shows the prior and posterior for contrasting <inline-formula id="IEq130"><alternatives><tex-math id="M269">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0{:}\ \delta = c$$\end{document}</tex-math><mml:math id="M270"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq130.gif"/></alternatives></inline-formula> with <inline-formula id="IEq131"><alternatives><tex-math id="M271">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1{:}\ \delta &lt; c$$\end{document}</tex-math><mml:math id="M272"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq131.gif"/></alternatives></inline-formula>. The two distributions are truncated, meaning that they are cut off at <inline-formula id="IEq132"><alternatives><tex-math id="M273">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta = c$$\end{document}</tex-math><mml:math id="M274"><mml:mrow><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq132.gif"/></alternatives></inline-formula>. Similarly, the lower plot shows the truncated prior and posterior for contrasting <inline-formula id="IEq133"><alternatives><tex-math id="M275">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0{:}\ \delta = c$$\end{document}</tex-math><mml:math id="M276"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq133.gif"/></alternatives></inline-formula> with <inline-formula id="IEq134"><alternatives><tex-math id="M277">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1{:}\ \delta &gt; c$$\end{document}</tex-math><mml:math id="M278"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&gt;</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq134.gif"/></alternatives></inline-formula>. Through a heuristic called the Savage-Dickey density ratio [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR85">85</xref>], the ratio of the heights of the colored dots gives us the Bayes factor (see the colored expressions in the formula on the right side of the results output). The text above the two plots explains the plots as well.<fig id="Fig4"><label>Fig. 4</label><caption><p>Shown is part of the baymedr web application showing the results of a Bayesian non-inferiority test. In this specific case, the results correspond to a reanalysis using summary statistics obtained from [<xref ref-type="bibr" rid="CR92">92</xref>]. See text for details</p></caption><graphic xlink:href="12874_2023_2097_Fig4_HTML" id="MO9"/></fig></p>
    </sec>
  </sec>
  <sec id="Sec18">
    <title>Conclusions</title>
    <p id="Par61">Tests of superiority, equivalence, and non-inferiority are important means to compare the effectiveness of medications and treatments in biomedical research. Despite several limitations, researchers overwhelmingly rely on traditional frequentist inference to analyze the corresponding data for these research designs [<xref ref-type="bibr" rid="CR5">5</xref>]. Bayes factors [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR36">36</xref>] are an attractive alternative to NHST and <italic>p</italic>-values because they allow researchers to quantify evidence in favor of the null hypothesis [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>] and permit sequential testing and optional stopping [<xref ref-type="bibr" rid="CR60">60</xref>–<xref ref-type="bibr" rid="CR62">62</xref>]. In fact, the possibility for optional stopping and sequential testing has the potential to largely reduce the waste of scarce resources. This is especially important in the field of biomedicine, where clinical trials might be expensive or even harmful for participants.</p>
    <p id="Par62">Although Bayes factors have many advantages over NHST, they bring along their own challenges (for a discussion, see [<xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR96">96</xref>]). For instance, the choice of the prior distribution can have a large impact on the resulting Bayes factor [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR86">86</xref>, <xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR91">91</xref>, <xref ref-type="bibr" rid="CR97">97</xref>, <xref ref-type="bibr" rid="CR98">98</xref>]. In the extreme case, the Bayes factor and results from frequentist analyses can lead to diverging conclusions, something known as Lindley’s paradox [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR99">99</xref>]. Thus, the choice of prior distribution is important but subjective and often difficult to make. Most of the time, however, Bayes factors and results from NHST are in agreement [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. Related to that, misspecification of the model might lead to erroneous and misleading conclusions. That is, a Bayes factor only makes a comparison of the models under investigation (i.e., <inline-formula id="IEq135"><alternatives><tex-math id="M279">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M280"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq135.gif"/></alternatives></inline-formula> and <inline-formula id="IEq136"><alternatives><tex-math id="M281">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M282"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq136.gif"/></alternatives></inline-formula>). If these models are inadequate or do not fulfill certain assumptions (e.g., Normality of residuals), the Bayes factor might not be trustworthy. Moreover, the Bayes factor is not immune to misinterpretations: [<xref ref-type="bibr" rid="CR100">100</xref>] have shown that among the most common false interpretations of Bayes factors are the interpretation of a Bayes factor as posterior odds (i.e., a ratio of probabilities in favor of or against <inline-formula id="IEq137"><alternatives><tex-math id="M283">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M284"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq137.gif"/></alternatives></inline-formula> and <inline-formula id="IEq138"><alternatives><tex-math id="M285">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M286"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq138.gif"/></alternatives></inline-formula>) and ignoring that Bayes factors only provide relative instead of absolute evidence (see also [<xref ref-type="bibr" rid="CR90">90</xref>]). Lastly, the computation of Bayes factors is complex and involves solving integrals [<xref ref-type="bibr" rid="CR90">90</xref>]. For this reason, easy-to-use software is needed.</p>
    <p id="Par63">Our baymedr R package and web application [<xref ref-type="bibr" rid="CR43">43</xref>] enable researchers to conduct Bayesian superiority, equivalence, and non-inferiority tests. baymedr is characterized by a user-friendly implementation, making it convenient for researchers who are not statistical experts. Furthermore, using baymedr, it is possible to calculate Bayes factors based on raw data and summary statistics, allowing for the reanalysis of published studies, for which the full data set is not available. To further promote the use of Bayesian statistics in biomedical research, more easy-to-use software and tutorial papers are urgently needed.</p>
  </sec>
  <sec id="Sec19">
    <title>Availability and requirements</title>
    <p id="Par64">Project name: baymedr</p>
    <p id="Par65">Project home page: <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/baymedr/index.html">https://cran.r-project.org/web/packages/baymedr/index.html</ext-link></p>
    <p id="Par66">Operating system(s): Platform independent</p>
    <p id="Par67">Programming language: R</p>
    <p id="Par68">Other requirements: Not applicable.</p>
    <p id="Par69">License: GPL-3</p>
    <p id="Par70">Any restrictions to use by non-academics: Not applicable.</p>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>NHST</term>
        <def>
          <p id="Par4">Null hypothesis significance testing</p>
        </def>
      </def-item>
      <def-item>
        <term>TOST</term>
        <def>
          <p id="Par5">Two one-sided tests</p>
        </def>
      </def-item>
      <def-item>
        <term>CRAN</term>
        <def>
          <p id="Par6">Comprehensive R Archive Network</p>
        </def>
      </def-item>
      <def-item>
        <term>CI</term>
        <def>
          <p id="Par7">Confidence interval</p>
        </def>
      </def-item>
      <def-item>
        <term>Fig</term>
        <def>
          <p id="Par8">Figure</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn id="Fn1">
      <label>1</label>
      <p id="Par74">Researchers often conduct a two-sided <italic>t</italic>-test and then confirm that the observed effect goes in the expected direction. We do not describe this approach because we have the opinion that a one-sided <italic>t</italic>-test should be conducted for the superiority test, whose name already implies a uni-directional alternative hypothesis.</p>
    </fn>
    <fn id="Fn2">
      <label>2</label>
      <p id="Par75">Note that the hypotheses represent exactly the opposite of the hypotheses in TOST (i.e., <inline-formula id="IEq83"><alternatives><tex-math id="M287">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0$$\end{document}</tex-math><mml:math id="M288"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq83.gif"/></alternatives></inline-formula> of equivalence corresponds to <inline-formula id="IEq84"><alternatives><tex-math id="M289">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_1$$\end{document}</tex-math><mml:math id="M290"><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq84.gif"/></alternatives></inline-formula> of equivalence in TOST, and vice versa). Evidence in favor of equivalence in TOST can only be obtained by rejecting two null hypotheses: <inline-formula id="IEq85"><alternatives><tex-math id="M291">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0 {:}\ \delta &lt; -c$$\end{document}</tex-math><mml:math id="M292"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&lt;</mml:mo><mml:mo>-</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq85.gif"/></alternatives></inline-formula> and <inline-formula id="IEq86"><alternatives><tex-math id="M293">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0 {:}\ \delta &gt; c$$\end{document}</tex-math><mml:math id="M294"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mi>δ</mml:mi><mml:mo>&gt;</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq86.gif"/></alternatives></inline-formula>. For the Bayesian equivalence test we use the more intuitive null hypothesis of equivalence (i.e., <inline-formula id="IEq87"><alternatives><tex-math id="M295">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal {H}_0 {:}\ -c&lt; \delta &lt; c$$\end{document}</tex-math><mml:math id="M296"><mml:mrow><mml:msub><mml:mi mathvariant="script">H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>:</mml:mo><mml:mspace width="4pt"/><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>δ</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq87.gif"/></alternatives></inline-formula>).</p>
    </fn>
    <fn>
      <p>
        <bold>Publisher’s Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>Not applicable.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>ML and DvR jointly conceptualized the project. ML wrote the first draft of the manuscript, implemented the software, and conducted the analyses. DvR edited the manuscript and tested the software. All authors have read and approved the manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>Open Access funding enabled and organized by Projekt DEAL. This research was supported by a Dutch scientific organization VIDI fellowship grant awarded to Don van Ravenzwaaij (016.Vidi.188.001). The funder was not involved in the design of the study, collection, analysis, and interpretation of data, or writing.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>Not applicable.</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar1">
      <title>Ethics approval and consent to participate</title>
      <p id="Par71">Not applicable.</p>
    </notes>
    <notes id="FPar2">
      <title>Consent for publication</title>
      <p id="Par72">Not applicable.</p>
    </notes>
    <notes id="FPar3" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par73">The authors declare that they have no competing interests.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Christensen</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Methodology of Superiority vs. Equivalence Trials and Non-Inferiority Trials</article-title>
        <source>J Hepatol.</source>
        <year>2007</year>
        <volume>46</volume>
        <issue>5</issue>
        <fpage>947</fpage>
        <lpage>954</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jhep.2007.02.015</pub-id>
        <?supplied-pmid 17412447?>
        <pub-id pub-id-type="pmid">17412447</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Friedman</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Furberg</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>DeMets</surname>
            <given-names>DL</given-names>
          </name>
          <name>
            <surname>Reboussin</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Granger</surname>
            <given-names>CB</given-names>
          </name>
        </person-group>
        <source>Fundamentals of Clinical Trials</source>
        <year>2010</year>
        <edition>4</edition>
        <publisher-loc>New York</publisher-loc>
        <publisher-name>Springer</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lesaffre</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Superiority, Equivalence, and Non-inferiority Trials</article-title>
        <source>Bull NYU Hosp Joint Dis.</source>
        <year>2008</year>
        <volume>66</volume>
        <issue>2</issue>
        <fpage>150</fpage>
        <lpage>154</lpage>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Piaggio</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Elbourne</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Pocock</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Evans</surname>
            <given-names>SJW</given-names>
          </name>
          <name>
            <surname>Altman</surname>
            <given-names>DG</given-names>
          </name>
        </person-group>
        <article-title>Reporting of Noninferiority and Equivalence Randomized Trials</article-title>
        <source>J Am Med Assoc.</source>
        <year>2012</year>
        <volume>308</volume>
        <issue>24</issue>
        <fpage>2594</fpage>
        <lpage>2604</lpage>
        <pub-id pub-id-type="doi">10.1001/jama.2012.87802</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chavalarias</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Wallach</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>AHT</given-names>
          </name>
          <name>
            <surname>Ioannidis</surname>
            <given-names>JPA</given-names>
          </name>
        </person-group>
        <article-title>Evolution of Reporting p Values in the Biomedical Literature, 1990–2015</article-title>
        <source>J Am Med Assoc.</source>
        <year>2016</year>
        <volume>315</volume>
        <issue>11</issue>
        <fpage>1141</fpage>
        <lpage>1148</lpage>
        <pub-id pub-id-type="doi">10.1001/jama.2016.1952</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Christensen</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Testing Fisher, Neyman, Pearson, and Bayes</article-title>
        <source>Am Stat.</source>
        <year>2005</year>
        <volume>59</volume>
        <issue>2</issue>
        <fpage>121</fpage>
        <lpage>126</lpage>
        <pub-id pub-id-type="doi">10.1198/000313005X20871</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Benjamin</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Berger</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Johannesson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nosek</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Berk</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Redefine Statistical Significance</article-title>
        <source>Nat Hum Behav.</source>
        <year>2018</year>
        <volume>2</volume>
        <issue>1</issue>
        <fpage>6</fpage>
        <lpage>10</lpage>
        <pub-id pub-id-type="doi">10.1038/s41562-017-0189-z</pub-id>
        <?supplied-pmid 30980045?>
        <pub-id pub-id-type="pmid">30980045</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lakens</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Adolfi</surname>
            <given-names>FG</given-names>
          </name>
          <name>
            <surname>Albers</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Anvari</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Apps</surname>
            <given-names>MAJ</given-names>
          </name>
          <name>
            <surname>Argamon</surname>
            <given-names>SE</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Justify Your Alpha</article-title>
        <source>Nat Hum Behav.</source>
        <year>2018</year>
        <volume>2</volume>
        <issue>3</issue>
        <fpage>168</fpage>
        <lpage>171</lpage>
        <pub-id pub-id-type="doi">10.1038/s41562-018-0311-x</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berger</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Sellke</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Testing a Point Null Hypothesis: The Irreconcilability of p Values and Evidence</article-title>
        <source>J Am Stat Assoc.</source>
        <year>1987</year>
        <volume>82</volume>
        <issue>397</issue>
        <fpage>112</fpage>
        <lpage>122</lpage>
        <pub-id pub-id-type="doi">10.2307/2289131</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <mixed-citation publication-type="other">Cohen J. The Earth Is Round (p <inline-formula id="IEq141"><alternatives><tex-math id="M297">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$&lt;$$\end{document}</tex-math><mml:math id="M298"><mml:mo>&lt;</mml:mo></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq141.gif"/></alternatives></inline-formula> .05). Am Psychol. 1994;49(12):997–1003. 10.1037/0003-066X.49.12.997.</mixed-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dienes</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Versus Orthodox Statistics: Which Side Are You on?</article-title>
        <source>Perspect Psychol Sci.</source>
        <year>2011</year>
        <volume>6</volume>
        <issue>3</issue>
        <fpage>274</fpage>
        <lpage>290</lpage>
        <pub-id pub-id-type="doi">10.1177/1745691611406920</pub-id>
        <?supplied-pmid 26168518?>
        <pub-id pub-id-type="pmid">26168518</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Gigerenzer</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Krauss</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Vitouch</surname>
            <given-names>O</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Kaplan</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>The Null Ritual: What You Always Wanted to Know about Significance Testing but Were Afraid to Ask</article-title>
        <source>The Sage Handbook of Quantitative Methodology for the Social Sciences</source>
        <year>2004</year>
        <publisher-loc>Thousand Oaks</publisher-loc>
        <publisher-name>Sage</publisher-name>
        <fpage>391</fpage>
        <lpage>408</lpage>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <mixed-citation publication-type="other">Goodman SN. Toward Evidence-based Medical Statistics. 1: The p Value Fallacy. Ann Intern Med. 1999;130(12):995–1004. 10.7326/0003-4819-130-12-199906150-00008.</mixed-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Goodman</surname>
            <given-names>SN</given-names>
          </name>
        </person-group>
        <article-title>A Dirty Dozen: Twelve <italic>p</italic>-value Misconceptions</article-title>
        <source>Semin Hematol.</source>
        <year>2008</year>
        <volume>45</volume>
        <issue>3</issue>
        <fpage>135</fpage>
        <lpage>140</lpage>
        <pub-id pub-id-type="doi">10.1053/j.seminhematol.2008.04.003</pub-id>
        <?supplied-pmid 18582619?>
        <pub-id pub-id-type="pmid">18582619</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Loftus</surname>
            <given-names>GR</given-names>
          </name>
        </person-group>
        <article-title>Psychology Will Be a Much Better Science When We Change the Way We Analyze Data</article-title>
        <source>Curr Dir Psychol Sci.</source>
        <year>1996</year>
        <volume>5</volume>
        <issue>6</issue>
        <fpage>161</fpage>
        <lpage>171</lpage>
        <pub-id pub-id-type="doi">10.1111/1467-8721.ep11512376</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <article-title>A Practical Solution to the Pervasive Problems of <italic>p</italic> values</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2007</year>
        <volume>14</volume>
        <issue>5</issue>
        <fpage>779</fpage>
        <lpage>804</lpage>
        <pub-id pub-id-type="doi">10.3758/BF03194105</pub-id>
        <?supplied-pmid 18087943?>
        <pub-id pub-id-type="pmid">18087943</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <mixed-citation publication-type="other">Wagenmakers EJ, Marsman M, Jamil T, Ly A, Verhagen J, Love J, et al. Bayesian Inference for Psychology. Part I: Theoretical Advantages and Practical Ramifications. Psychon Bull Rev. 2018;25(1):35–57. 10.3758/s13423-017-1343-3.</mixed-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wetzels</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Matzke</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Rouder</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Iverson</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <article-title>Statistical Evidence in Experimental Psychology: An Empirical Comparison Using 855 t Tests</article-title>
        <source>Perspect Psychol Sci.</source>
        <year>2011</year>
        <volume>6</volume>
        <issue>3</issue>
        <fpage>291</fpage>
        <lpage>298</lpage>
        <pub-id pub-id-type="doi">10.1177/1745691611406923</pub-id>
        <?supplied-pmid 26168519?>
        <pub-id pub-id-type="pmid">26168519</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <mixed-citation publication-type="other">Goodman SN. Toward Evidence-based Medical Statistics. 2: The Bayes Factor. Ann Intern Med. 1999;130(12):1005–1013. 10.7326/0003-4819-130-12-199906150-00019.</mixed-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van Ravenzwaaij</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ioannidis</surname>
            <given-names>JPA</given-names>
          </name>
        </person-group>
        <article-title>A Simulation Study of the Strength of Evidence in the Recommendation of Medications Based on Two Trials with Statistically Significant Results</article-title>
        <source>PLoS ONE.</source>
        <year>2017</year>
        <volume>12</volume>
        <issue>3</issue>
        <fpage>e0173184</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0173184</pub-id>
        <?supplied-pmid 28273140?>
        <pub-id pub-id-type="pmid">28273140</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wasserstein</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Lazar</surname>
            <given-names>NA</given-names>
          </name>
        </person-group>
        <article-title>The ASA’s Statement on p-values: Context, Process, and Purpose</article-title>
        <source>Am Stat.</source>
        <year>2016</year>
        <volume>70</volume>
        <issue>2</issue>
        <fpage>129</fpage>
        <lpage>133</lpage>
        <pub-id pub-id-type="doi">10.1080/00031305.2016.1154108</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berger</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Delampady</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Testing Precise Hypotheses</article-title>
        <source>Stat Sci.</source>
        <year>1987</year>
        <volume>2</volume>
        <issue>3</issue>
        <fpage>317</fpage>
        <lpage>335</lpage>
        <pub-id pub-id-type="doi">10.1214/ss/1177013238</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McShane</surname>
            <given-names>BB</given-names>
          </name>
          <name>
            <surname>Gal</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Gelman</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Robert</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Tackett</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>Abandon Statistical Significance</article-title>
        <source>Am Stat.</source>
        <year>2019</year>
        <volume>73</volume>
        <issue>sup1</issue>
        <fpage>235</fpage>
        <lpage>245</lpage>
        <pub-id pub-id-type="doi">10.1080/00031305.2018.1527253</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Kruschke</surname>
            <given-names>JK</given-names>
          </name>
        </person-group>
        <source>Doing Bayesian Data Analysis: A Tutorial with R, JAGS, and Stan</source>
        <year>2015</year>
        <edition>2</edition>
        <publisher-loc>Boston</publisher-loc>
        <publisher-name>Academic Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Gilks</surname>
            <given-names>WR</given-names>
          </name>
          <name>
            <surname>Richardson</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Spiegelhalter</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <source>Markov Chain Monte Carlo in Practice</source>
        <year>1995</year>
        <publisher-loc>Boca Raton</publisher-loc>
        <publisher-name>Chapman &amp; Hall/CRC</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van Ravenzwaaij</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Cassey</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>SD</given-names>
          </name>
        </person-group>
        <article-title>A Simple Introduction to Markov Chain Monte-Carlo Sampling</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2018</year>
        <volume>25</volume>
        <issue>1</issue>
        <fpage>143</fpage>
        <lpage>154</lpage>
        <pub-id pub-id-type="doi">10.3758/s13423-016-1015-8</pub-id>
        <?supplied-pmid 26968853?>
        <pub-id pub-id-type="pmid">26968853</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berry</surname>
            <given-names>DA</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Clinical Trials</article-title>
        <source>Nat Rev Drug Discov.</source>
        <year>2006</year>
        <volume>5</volume>
        <issue>1</issue>
        <fpage>27</fpage>
        <lpage>36</lpage>
        <pub-id pub-id-type="doi">10.1038/nrd1927</pub-id>
        <?supplied-pmid 16485344?>
        <pub-id pub-id-type="pmid">16485344</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van de Schoot</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Winter</surname>
            <given-names>SD</given-names>
          </name>
          <name>
            <surname>Ryan</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Zondervan-Zwijnenburg</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Depaoli</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>A Systematic Review of Bayesian Articles in Psychology: The Last 25 Years</article-title>
        <source>Psychol Methods.</source>
        <year>2017</year>
        <volume>22</volume>
        <issue>2</issue>
        <fpage>217</fpage>
        <lpage>239</lpage>
        <pub-id pub-id-type="doi">10.1037/met0000100.supp</pub-id>
        <?supplied-pmid 28594224?>
        <pub-id pub-id-type="pmid">28594224</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Chu</surname>
            <given-names>CT</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Clinical Trials in Action</article-title>
        <source>Stat Med.</source>
        <year>2012</year>
        <volume>31</volume>
        <issue>25</issue>
        <fpage>2937</fpage>
        <lpage>3072</lpage>
        <pub-id pub-id-type="doi">10.1002/sim.5404</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zaslavsky</surname>
            <given-names>BG</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Hypothesis Testing in Two-arm Trials with Dichotomous Outcomes</article-title>
        <source>Biometrics.</source>
        <year>2013</year>
        <volume>69</volume>
        <issue>1</issue>
        <fpage>157</fpage>
        <lpage>163</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1541-0420.2012.01806.x</pub-id>
        <?supplied-pmid 23002906?>
        <pub-id pub-id-type="pmid">23002906</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kruschke</surname>
            <given-names>JK</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Assessment of Null Values via Parameter Estimation and Model Comparison</article-title>
        <source>Perspect Psychol Sci.</source>
        <year>2011</year>
        <volume>6</volume>
        <issue>3</issue>
        <fpage>299</fpage>
        <lpage>312</lpage>
        <pub-id pub-id-type="doi">10.1177/1745691611406925</pub-id>
        <?supplied-pmid 26168520?>
        <pub-id pub-id-type="pmid">26168520</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kruschke</surname>
            <given-names>JK</given-names>
          </name>
        </person-group>
        <article-title>Rejecting or Accepting Parameter Values in Bayesian Estimation</article-title>
        <source>Adv Methods Pract Psychol Sci.</source>
        <year>2018</year>
        <volume>1</volume>
        <issue>2</issue>
        <fpage>270</fpage>
        <lpage>280</lpage>
        <pub-id pub-id-type="doi">10.1177/2515245918771304</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Jeffreys</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <source>Theory of Probability</source>
        <year>1939</year>
        <publisher-loc>Oxford</publisher-loc>
        <publisher-name>The Clarendon Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Jeffreys</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <source>Theory of Probability</source>
        <year>1948</year>
        <edition>2</edition>
        <publisher-loc>Oxford</publisher-loc>
        <publisher-name>The Clarendon Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Jeffreys</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <source>Theory of Probability</source>
        <year>1961</year>
        <edition>3</edition>
        <publisher-loc>Oxford</publisher-loc>
        <publisher-name>Oxford University Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kass</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Raftery</surname>
            <given-names>AE</given-names>
          </name>
        </person-group>
        <article-title>Bayes Factors</article-title>
        <source>J Am Stat Assoc.</source>
        <year>1995</year>
        <volume>90</volume>
        <issue>430</issue>
        <fpage>773</fpage>
        <lpage>795</lpage>
        <pub-id pub-id-type="doi">10.2307/2291091</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Winkler</surname>
            <given-names>RL</given-names>
          </name>
        </person-group>
        <article-title>Why Bayesian Analysis Hasn’t Caught on in Healthcare Decision Making</article-title>
        <source>Int J Technol Assess Health Care.</source>
        <year>2001</year>
        <volume>17</volume>
        <issue>1</issue>
        <fpage>56</fpage>
        <lpage>66</lpage>
        <pub-id pub-id-type="doi">10.1017/S026646230110406X</pub-id>
        <?supplied-pmid 11329845?>
        <pub-id pub-id-type="pmid">11329845</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gigerenzer</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Mindless Statistics</article-title>
        <source>J Socio-Econ.</source>
        <year>2004</year>
        <volume>33</volume>
        <issue>5</issue>
        <fpage>587</fpage>
        <lpage>606</lpage>
        <pub-id pub-id-type="doi">10.1016/j.socec.2004.09.033</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <mixed-citation publication-type="other">Morey RD, Rouder JN. BayesFactor: Computation of Bayes Factors for Common Designs. 2018. R package version 0.9.12-4.2. <ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=BayesFactor">https://CRAN.R-project.org/package=BayesFactor</ext-link>. Accessed 14 Sept 2022.</mixed-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <mixed-citation publication-type="other">R Core Team. R: A Language and Environment for Statistical Computing. Vienna. 2021. <ext-link ext-link-type="uri" xlink:href="https://www.R-project.org/">https://www.R-project.org/</ext-link>. Accessed 14 Sept 2022.</mixed-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <mixed-citation publication-type="other">JASP Team. JASP (Version 0.15)[Computer software]. 2021. <ext-link ext-link-type="uri" xlink:href="https://jasp-stats.org/">https://jasp-stats.org/</ext-link>. Accessed 14 Sept 2022.</mixed-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <mixed-citation publication-type="other">The jamovi project. jamovi (Version 1.6) [Computer Software]. 2021. <ext-link ext-link-type="uri" xlink:href="https://www.jamovi.org">https://www.jamovi.org</ext-link>. Accessed 14 Sept 2022.</mixed-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <mixed-citation publication-type="other">Linde M, van Ravenzwaaij D. baymedr: Computation of Bayes Factors for Common Biomedical Designs. 2021. R package version 0.1.1. <ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=baymedr">https://CRAN.R-project.org/package=baymedr</ext-link>. Accessed 14 Sept 2022.</mixed-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <mixed-citation publication-type="other">Linde M. baymedr. 2022. <ext-link ext-link-type="uri" xlink:href="https://maxlinde.shinyapps.io/baymedr/">https://maxlinde.shinyapps.io/baymedr/</ext-link>. Accessed 14 Sept 2022.</mixed-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Meyners</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Equivalence Tests - A Review</article-title>
        <source>Food Qual Prefer.</source>
        <year>2012</year>
        <volume>26</volume>
        <issue>2</issue>
        <fpage>231</fpage>
        <lpage>245</lpage>
        <pub-id pub-id-type="doi">10.1016/j.foodqual.2012.05.003</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hodges</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Lehmann</surname>
            <given-names>EL</given-names>
          </name>
        </person-group>
        <article-title>Testing the Approximate Validity of Statistical Hypotheses</article-title>
        <source>J R Stat Soc Ser B (Methodol).</source>
        <year>1954</year>
        <volume>16</volume>
        <issue>2</issue>
        <fpage>261</fpage>
        <lpage>268</lpage>
        <pub-id pub-id-type="doi">10.1007/978-1-4614-1412-4_15</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Westlake</surname>
            <given-names>WJ</given-names>
          </name>
        </person-group>
        <article-title>Symmetrical Confidence Intervals for Bioequivalence Trials</article-title>
        <source>Biometrics.</source>
        <year>1976</year>
        <volume>32</volume>
        <issue>4</issue>
        <fpage>741</fpage>
        <lpage>744</lpage>
        <pub-id pub-id-type="doi">10.2307/2529259</pub-id>
        <?supplied-pmid 1009222?>
        <pub-id pub-id-type="pmid">1009222</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schuirmann</surname>
            <given-names>DJ</given-names>
          </name>
        </person-group>
        <article-title>A Comparison of the Two One-sided Tests Procedure and the Power Approach for Assessing the Equivalence of Average Bioavailability</article-title>
        <source>J Pharmacokinet Biopharm.</source>
        <year>1987</year>
        <volume>15</volume>
        <issue>6</issue>
        <fpage>657</fpage>
        <lpage>680</lpage>
        <pub-id pub-id-type="doi">10.1007/BF01068419</pub-id>
        <?supplied-pmid 3450848?>
        <pub-id pub-id-type="pmid">3450848</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Senn</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <source>Statistical Issues in Drug Development</source>
        <year>2008</year>
        <edition>2</edition>
        <publisher-loc>Chichester</publisher-loc>
        <publisher-name>Wiley</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lakens</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Equivalence Tests: A Practical Primer for t Tests, Correlations, and Meta-analyses</article-title>
        <source>Soc Psychol Personal Sci.</source>
        <year>2017</year>
        <volume>8</volume>
        <issue>4</issue>
        <fpage>355</fpage>
        <lpage>362</lpage>
        <pub-id pub-id-type="doi">10.1177/1948550617697177</pub-id>
        <?supplied-pmid 28736600?>
        <pub-id pub-id-type="pmid">28736600</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lakens</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Scheel</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Isager</surname>
            <given-names>PM</given-names>
          </name>
        </person-group>
        <article-title>Equivalence Testing for Psychological Research: A Tutorial</article-title>
        <source>Adv Methods Pract Psychol Sci.</source>
        <year>2018</year>
        <volume>1</volume>
        <issue>2</issue>
        <fpage>259</fpage>
        <lpage>269</lpage>
        <pub-id pub-id-type="doi">10.1177/2515245918770963</pub-id>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Garrett</surname>
            <given-names>AD</given-names>
          </name>
        </person-group>
        <article-title>Therapeutic Equivalence: Fallacies and Falsification</article-title>
        <source>Stat Med.</source>
        <year>2003</year>
        <volume>22</volume>
        <issue>5</issue>
        <fpage>741</fpage>
        <lpage>762</lpage>
        <pub-id pub-id-type="doi">10.1002/sim.1360</pub-id>
        <?supplied-pmid 12587103?>
        <pub-id pub-id-type="pmid">12587103</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Walker</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Nowacki</surname>
            <given-names>AS</given-names>
          </name>
        </person-group>
        <article-title>Understanding Equivalence and Noninferiority Testing</article-title>
        <source>J Gen Intern Med.</source>
        <year>2011</year>
        <volume>26</volume>
        <issue>2</issue>
        <fpage>192</fpage>
        <lpage>196</lpage>
        <pub-id pub-id-type="doi">10.1007/s11606-010-1513-8</pub-id>
        <?supplied-pmid 20857339?>
        <pub-id pub-id-type="pmid">20857339</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <mixed-citation publication-type="other">Chadwick D, Vigabatrin European Monotherapy Study Group. Safety and Efficacy of Vigabatrin and Carbamazepine in Newly Diagnosed Epilepsy: A Multicentre Randomised Double-blind Study. Lancet. 1999;354(9172):13–19. 10.1016/S0140-6736(98)10531-7.</mixed-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kaul</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Diamond</surname>
            <given-names>GA</given-names>
          </name>
        </person-group>
        <article-title>Good Enough: A Primer on the Analysis and Interpretation of Noninferiority Trials</article-title>
        <source>Ann Intern Med.</source>
        <year>2006</year>
        <volume>145</volume>
        <issue>1</issue>
        <fpage>62</fpage>
        <lpage>69</lpage>
        <pub-id pub-id-type="doi">10.7326/0003-4819-145-1-200607040-00011</pub-id>
        <?supplied-pmid 16818930?>
        <pub-id pub-id-type="pmid">16818930</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Van de Werf</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Adgey</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ardissino</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Armstrong</surname>
            <given-names>PW</given-names>
          </name>
          <name>
            <surname>Aylward</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Barbash</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Single-bolus Tenecteplase Compared with Front-loaded Alteplase in Acute Myocardial Infarction: The ASSENT-2 Double-blind Randomised Trial</article-title>
        <source>Lancet.</source>
        <year>1999</year>
        <volume>354</volume>
        <issue>9180</issue>
        <fpage>716</fpage>
        <lpage>722</lpage>
        <pub-id pub-id-type="doi">10.1016/S0140-6736(99)07403-6</pub-id>
        <?supplied-pmid 10475182?>
        <pub-id pub-id-type="pmid">10475182</pub-id>
      </element-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hills</surname>
            <given-names>RK</given-names>
          </name>
        </person-group>
        <article-title>Non-inferiority Trials: No Better? No Worse? No Change? No Pain?</article-title>
        <source>Br J Haematol.</source>
        <year>2017</year>
        <volume>176</volume>
        <issue>6</issue>
        <fpage>883</fpage>
        <lpage>887</lpage>
        <pub-id pub-id-type="doi">10.1111/bjh.14504</pub-id>
        <?supplied-pmid 28106905?>
        <pub-id pub-id-type="pmid">28106905</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <mixed-citation publication-type="other">Rennie D. Vive La Différence (p<inline-formula id="IEq142"><alternatives><tex-math id="M299">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$&lt;$$\end{document}</tex-math><mml:math id="M300"><mml:mo>&lt;</mml:mo></mml:math><inline-graphic xlink:href="12874_2023_2097_Article_IEq142.gif"/></alternatives></inline-formula>0.05). N Engl J Med. 1978;299:828–829. 10.1056/NEJM197810122991509.</mixed-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <mixed-citation publication-type="other">International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Pathology. 1997;29:441–447. 10.1080/00313029700169515.</mixed-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rouder</surname>
            <given-names>JN</given-names>
          </name>
        </person-group>
        <article-title>Optional Stopping: No Problem for Bayesians</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2014</year>
        <volume>21</volume>
        <issue>2</issue>
        <fpage>301</fpage>
        <lpage>308</lpage>
        <pub-id pub-id-type="doi">10.3758/s13423-014-0595-4</pub-id>
        <?supplied-pmid 24659049?>
        <pub-id pub-id-type="pmid">24659049</pub-id>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schönbrodt</surname>
            <given-names>FD</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Zehetleitner</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Perugini</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Sequential Hypothesis Testing with Bayes Factors: Efficiently Testing Mean Differences</article-title>
        <source>Psychol Methods.</source>
        <year>2017</year>
        <volume>22</volume>
        <issue>2</issue>
        <fpage>322</fpage>
        <lpage>339</lpage>
        <pub-id pub-id-type="doi">10.1037/met0000061</pub-id>
        <?supplied-pmid 26651986?>
        <pub-id pub-id-type="pmid">26651986</pub-id>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schönbrodt</surname>
            <given-names>FD</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <article-title>Bayes Factor Design Analysis: Planning for Compelling Evidence</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2018</year>
        <volume>25</volume>
        <issue>1</issue>
        <fpage>128</fpage>
        <lpage>142</lpage>
        <pub-id pub-id-type="doi">10.3758/s13423-017-1230-y</pub-id>
        <?supplied-pmid 28251595?>
        <pub-id pub-id-type="pmid">28251595</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ranganathan</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Pramesh</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Buyse</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Common Pitfalls in Statistical Analysis: The Perils of Multiple Testing</article-title>
        <source>Perspect Clin Res.</source>
        <year>2016</year>
        <volume>7</volume>
        <issue>2</issue>
        <fpage>106</fpage>
        <lpage>107</lpage>
        <pub-id pub-id-type="doi">10.4103/2229-3485.179436</pub-id>
        <?supplied-pmid 27141478?>
        <pub-id pub-id-type="pmid">27141478</pub-id>
      </element-citation>
    </ref>
    <ref id="CR64">
      <label>64.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chalmers</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Glasziou</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Avoidable Waste in the Production and Reporting of Research Evidence</article-title>
        <source>Lancet.</source>
        <year>2009</year>
        <volume>374</volume>
        <issue>9683</issue>
        <fpage>86</fpage>
        <lpage>89</lpage>
        <pub-id pub-id-type="doi">10.1016/S0140-6736(09)60329-9</pub-id>
        <?supplied-pmid 19525005?>
        <pub-id pub-id-type="pmid">19525005</pub-id>
      </element-citation>
    </ref>
    <ref id="CR65">
      <label>65.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van Ravenzwaaij</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Monden</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Tendeiro</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Ioannidis</surname>
            <given-names>JPA</given-names>
          </name>
        </person-group>
        <article-title>Bayes Factors for Superiority, Non-inferiority, and Equivalence Designs</article-title>
        <source>BMC Med Res Methodol.</source>
        <year>2019</year>
        <volume>19</volume>
        <issue>1</issue>
        <fpage>71</fpage>
        <pub-id pub-id-type="doi">10.1186/s12874-019-0699-7</pub-id>
        <?supplied-pmid 30925900?>
        <pub-id pub-id-type="pmid">30925900</pub-id>
      </element-citation>
    </ref>
    <ref id="CR66">
      <label>66.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gallistel</surname>
            <given-names>CR</given-names>
          </name>
        </person-group>
        <article-title>The Importance of Proving the Null</article-title>
        <source>Psychol Rev.</source>
        <year>2009</year>
        <volume>116</volume>
        <issue>2</issue>
        <fpage>439</fpage>
        <lpage>453</lpage>
        <pub-id pub-id-type="doi">10.1037/a0015251</pub-id>
        <?supplied-pmid 19348549?>
        <pub-id pub-id-type="pmid">19348549</pub-id>
      </element-citation>
    </ref>
    <ref id="CR67">
      <label>67.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rouder</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Speckman</surname>
            <given-names>PL</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Morey</surname>
            <given-names>RD</given-names>
          </name>
          <name>
            <surname>Iverson</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Bayesian t Tests for Accepting and Rejecting the Null Hypothesis</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2009</year>
        <volume>16</volume>
        <issue>2</issue>
        <fpage>225</fpage>
        <lpage>237</lpage>
        <pub-id pub-id-type="doi">10.3758/PBR.16.2.225</pub-id>
        <?supplied-pmid 19293088?>
        <pub-id pub-id-type="pmid">19293088</pub-id>
      </element-citation>
    </ref>
    <ref id="CR68">
      <label>68.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gelman</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>p Values and Statistical Practice</article-title>
        <source>Epidemiology.</source>
        <year>2013</year>
        <volume>24</volume>
        <issue>1</issue>
        <fpage>69</fpage>
        <lpage>72</lpage>
        <pub-id pub-id-type="doi">10.1097/EDE.0b013e31827886f7</pub-id>
        <?supplied-pmid 23232612?>
        <pub-id pub-id-type="pmid">23232612</pub-id>
      </element-citation>
    </ref>
    <ref id="CR69">
      <label>69.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Haller</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Krauss</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Misinterpretation of Significance: A Problem Students Share with Their Teachers?</article-title>
        <source>Methods Psychol Res.</source>
        <year>2002</year>
        <volume>7</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>20</lpage>
      </element-citation>
    </ref>
    <ref id="CR70">
      <label>70.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bakan</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>The Test of Significance in Psychological Research</article-title>
        <source>Psychol Bull.</source>
        <year>1966</year>
        <volume>66</volume>
        <issue>6</issue>
        <fpage>423</fpage>
        <lpage>437</lpage>
        <pub-id pub-id-type="doi">10.1037/h0020412</pub-id>
        <?supplied-pmid 5974619?>
        <pub-id pub-id-type="pmid">5974619</pub-id>
      </element-citation>
    </ref>
    <ref id="CR71">
      <label>71.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Altman</surname>
            <given-names>DG</given-names>
          </name>
          <name>
            <surname>Bland</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>Absence of Evidence Is Not Evidence of Absence</article-title>
        <source>BMJ.</source>
        <year>1995</year>
        <volume>311</volume>
        <issue>7003</issue>
        <fpage>485</fpage>
        <pub-id pub-id-type="doi">10.1136/bmj.311.7003.485</pub-id>
        <?supplied-pmid 7647644?>
        <pub-id pub-id-type="pmid">7647644</pub-id>
      </element-citation>
    </ref>
    <ref id="CR72">
      <label>72.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Greene</surname>
            <given-names>WL</given-names>
          </name>
          <name>
            <surname>Concato</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Feinstein</surname>
            <given-names>AR</given-names>
          </name>
        </person-group>
        <article-title>Claims of Equivalence in Medical Research: Are They Supported by the Evidence?</article-title>
        <source>Ann Intern Med.</source>
        <year>2000</year>
        <volume>132</volume>
        <issue>9</issue>
        <fpage>715</fpage>
        <lpage>722</lpage>
        <pub-id pub-id-type="doi">10.7326/0003-4819-132-9-200005020-00006</pub-id>
        <?supplied-pmid 10787365?>
        <pub-id pub-id-type="pmid">10787365</pub-id>
      </element-citation>
    </ref>
    <ref id="CR73">
      <label>73.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Blackwelder</surname>
            <given-names>WC</given-names>
          </name>
        </person-group>
        <article-title>Proving the Null Hypothesis</article-title>
        <source>Clinical Trials. Controlled Clinical Trials.</source>
        <year>1982</year>
        <volume>3</volume>
        <issue>4</issue>
        <fpage>345</fpage>
        <lpage>353</lpage>
        <pub-id pub-id-type="doi">10.1016/0197-2456(82)90024-1</pub-id>
        <?supplied-pmid 7160191?>
        <pub-id pub-id-type="pmid">7160191</pub-id>
      </element-citation>
    </ref>
    <ref id="CR74">
      <label>74.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hoekstra</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Monden</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>van Ravenzwaaij</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Reanalysis of Null Results Reported in Medicine: Strong yet Variable Evidence for the Absence of Treatment Effects</article-title>
        <source>PLoS ONE.</source>
        <year>2018</year>
        <volume>13</volume>
        <issue>4</issue>
        <fpage>e0195474</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0195474</pub-id>
        <?supplied-pmid 29694370?>
        <pub-id pub-id-type="pmid">29694370</pub-id>
      </element-citation>
    </ref>
    <ref id="CR75">
      <label>75.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kruschke</surname>
            <given-names>JK</given-names>
          </name>
          <name>
            <surname>Liddell</surname>
            <given-names>TM</given-names>
          </name>
        </person-group>
        <article-title>The Bayesian New Statistics: Hypothesis Testing, Estimation, Meta-analysis, and Power Analysis from a Bayesian Perspective</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2018</year>
        <volume>25</volume>
        <issue>1</issue>
        <fpage>178</fpage>
        <lpage>206</lpage>
        <pub-id pub-id-type="doi">10.3758/s13423-016-1221-4</pub-id>
        <?supplied-pmid 28176294?>
        <pub-id pub-id-type="pmid">28176294</pub-id>
      </element-citation>
    </ref>
    <ref id="CR76">
      <label>76.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Lodewyckx</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kuriyal</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Grasman</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Hypothesis Testing for Psychologists: A Tutorial on the Savage-Dickey Method</article-title>
        <source>Cogn Psychol.</source>
        <year>2010</year>
        <volume>60</volume>
        <issue>3</issue>
        <fpage>158</fpage>
        <lpage>189</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cogpsych.2009.12.001</pub-id>
        <?supplied-pmid 20064637?>
        <pub-id pub-id-type="pmid">20064637</pub-id>
      </element-citation>
    </ref>
    <ref id="CR77">
      <label>77.</label>
      <mixed-citation publication-type="other">O’Hagan A, Forster J. Kendall’s Advanced Theory of Statistics: Vol. 2B. Bayesian Inference. 2nd ed. London: Arnold; 2004.</mixed-citation>
    </ref>
    <ref id="CR78">
      <label>78.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Etz</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Vandekerckhove</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Introduction to Bayesian Inference for Psychology</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2018</year>
        <volume>25</volume>
        <issue>1</issue>
        <fpage>5</fpage>
        <lpage>34</lpage>
        <pub-id pub-id-type="doi">10.3758/s13423-017-1262-3</pub-id>
        <?supplied-pmid 28378250?>
        <pub-id pub-id-type="pmid">28378250</pub-id>
      </element-citation>
    </ref>
    <ref id="CR79">
      <label>79.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gronau</surname>
            <given-names>QF</given-names>
          </name>
          <name>
            <surname>Ly</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <article-title>Informed Bayesian t-tests</article-title>
        <source>Am Stat.</source>
        <year>2020</year>
        <volume>74</volume>
        <issue>2</issue>
        <fpage>137</fpage>
        <lpage>143</lpage>
        <pub-id pub-id-type="doi">10.1080/00031305.2018.1562983</pub-id>
      </element-citation>
    </ref>
    <ref id="CR80">
      <label>80.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <source>Bayesian Cognitive Modeling: A Practical Course</source>
        <year>2013</year>
        <publisher-loc>Cambridge</publisher-loc>
        <publisher-name>Cambridge University Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR81">
      <label>81.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gönen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>WO</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Westfall</surname>
            <given-names>PH</given-names>
          </name>
        </person-group>
        <article-title>The Bayesian Two-sample t Test</article-title>
        <source>Am Stat.</source>
        <year>2005</year>
        <volume>59</volume>
        <issue>3</issue>
        <fpage>252</fpage>
        <lpage>257</lpage>
        <pub-id pub-id-type="doi">10.1198/000313005X55233</pub-id>
      </element-citation>
    </ref>
    <ref id="CR82">
      <label>82.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bayarri</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Berger</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Forte</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>García-Donato</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Criteria for Bayesian Model Choice with Application to Variable Selection</article-title>
        <source>Ann Stat.</source>
        <year>2012</year>
        <volume>40</volume>
        <issue>3</issue>
        <fpage>1550</fpage>
        <lpage>1577</lpage>
        <pub-id pub-id-type="doi">10.1214/12-AOS1013</pub-id>
      </element-citation>
    </ref>
    <ref id="CR83">
      <label>83.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berger</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Pericchi</surname>
            <given-names>LR</given-names>
          </name>
          <name>
            <surname>Varshavsky</surname>
            <given-names>JA</given-names>
          </name>
        </person-group>
        <article-title>Bayes Factors and Marginal Distributions in Invariant Situations</article-title>
        <source>Sankhyā Indian J Stat.</source>
        <year>1998</year>
        <volume>60</volume>
        <fpage>307</fpage>
        <lpage>321</lpage>
      </element-citation>
    </ref>
    <ref id="CR84">
      <label>84.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dickey</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Lientz</surname>
            <given-names>BP</given-names>
          </name>
        </person-group>
        <article-title>The Weighted Likelihood Ratio, Sharp Hypotheses about Chances, the Order of a Markov Chain</article-title>
        <source>Ann Math Stat.</source>
        <year>1970</year>
        <volume>41</volume>
        <issue>1</issue>
        <fpage>214</fpage>
        <lpage>226</lpage>
        <pub-id pub-id-type="doi">10.1214/aoms/1177697203</pub-id>
      </element-citation>
    </ref>
    <ref id="CR85">
      <label>85.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van Ravenzwaaij</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Etz</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Simulation Studies as a Tool to Understand Bayes Factors</article-title>
        <source>Adv Methods Pract Psychol Sci.</source>
        <year>2021</year>
        <volume>4</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>20</lpage>
        <pub-id pub-id-type="doi">10.1177/2515245920972624</pub-id>
      </element-citation>
    </ref>
    <ref id="CR86">
      <label>86.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vanpaemel</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Prior Sensitivity in Theory Testing: An Apologia for the Bayes Factor</article-title>
        <source>J Math Psychol.</source>
        <year>2010</year>
        <volume>54</volume>
        <issue>6</issue>
        <fpage>491</fpage>
        <lpage>498</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jmp.2010.07.003</pub-id>
      </element-citation>
    </ref>
    <ref id="CR87">
      <label>87.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Morey</surname>
            <given-names>RD</given-names>
          </name>
          <name>
            <surname>Romeijn</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>Rouder</surname>
            <given-names>JN</given-names>
          </name>
        </person-group>
        <article-title>The Philosophy of Bayes Factors and the Quantification of Statistical Evidence</article-title>
        <source>J Math Psychol.</source>
        <year>2016</year>
        <volume>72</volume>
        <fpage>6</fpage>
        <lpage>18</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jmp.2015.11.001</pub-id>
      </element-citation>
    </ref>
    <ref id="CR88">
      <label>88.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Consonni</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Fouskakis</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Liseo</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ntzoufras</surname>
            <given-names>I</given-names>
          </name>
        </person-group>
        <article-title>Prior Distributions for Objective Bayesian Analysis</article-title>
        <source>Bayesian Anal.</source>
        <year>2018</year>
        <volume>13</volume>
        <issue>2</issue>
        <fpage>627</fpage>
        <lpage>679</lpage>
        <pub-id pub-id-type="doi">10.1214/18-BA1103</pub-id>
      </element-citation>
    </ref>
    <ref id="CR89">
      <label>89.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Paulo</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Molina</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Clyde</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Berger</surname>
            <given-names>JO</given-names>
          </name>
        </person-group>
        <article-title>Mixtures of g Priors for Bayesian Variable Selection</article-title>
        <source>J Am Stat Assoc.</source>
        <year>2008</year>
        <volume>103</volume>
        <issue>481</issue>
        <fpage>410</fpage>
        <lpage>423</lpage>
        <pub-id pub-id-type="doi">10.1198/016214507000001337</pub-id>
      </element-citation>
    </ref>
    <ref id="CR90">
      <label>90.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tendeiro</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Kiers</surname>
            <given-names>HAL</given-names>
          </name>
        </person-group>
        <article-title>A Review of Issues about Null Hypothesis Bayesian Testing</article-title>
        <source>Psychol Methods.</source>
        <year>2019</year>
        <volume>24</volume>
        <issue>6</issue>
        <fpage>774</fpage>
        <lpage>795</lpage>
        <pub-id pub-id-type="doi">10.1037/met0000221</pub-id>
        <?supplied-pmid 31094544?>
        <pub-id pub-id-type="pmid">31094544</pub-id>
      </element-citation>
    </ref>
    <ref id="CR91">
      <label>91.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kruschke</surname>
            <given-names>JK</given-names>
          </name>
          <name>
            <surname>Liddell</surname>
            <given-names>TM</given-names>
          </name>
        </person-group>
        <article-title>Bayesian Data Analysis for Newcomers</article-title>
        <source>Psychon Bull Rev.</source>
        <year>2018</year>
        <volume>25</volume>
        <issue>1</issue>
        <fpage>155</fpage>
        <lpage>177</lpage>
        <pub-id pub-id-type="doi">10.3758/s13423-017-1272-1</pub-id>
        <?supplied-pmid 28405907?>
        <pub-id pub-id-type="pmid">28405907</pub-id>
      </element-citation>
    </ref>
    <ref id="CR92">
      <label>92.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Basner</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Asch</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Shea</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Bellini</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Carlin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ecker</surname>
            <given-names>AJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Sleep and Alertness in a Duty-hour Flexibility Trial in Internal Medicine</article-title>
        <source>N Engl J Med.</source>
        <year>2019</year>
        <volume>380</volume>
        <issue>10</issue>
        <fpage>915</fpage>
        <lpage>923</lpage>
        <pub-id pub-id-type="doi">10.1056/NEJMoa1810641</pub-id>
        <?supplied-pmid 30855741?>
        <pub-id pub-id-type="pmid">30855741</pub-id>
      </element-citation>
    </ref>
    <ref id="CR93">
      <label>93.</label>
      <mixed-citation publication-type="other">Wickham H, Hester J, Chang W. devtools: Tools to Make Developing R Packages Easier. 2019. R package version 2.2.0. <ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=devtools">https://CRAN.R-project.org/package=devtools</ext-link>. Accessed 14 Sept 2022.</mixed-citation>
    </ref>
    <ref id="CR94">
      <label>94.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Åkerstedt</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Gillberg</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Subjective and Objective Sleepiness in the Active Individual</article-title>
        <source>International Journal of Neuroscience.</source>
        <year>1990</year>
        <volume>52</volume>
        <issue>1–2</issue>
        <fpage>29</fpage>
        <lpage>37</lpage>
        <pub-id pub-id-type="doi">10.3109/00207459008994241</pub-id>
        <?supplied-pmid 2265922?>
        <pub-id pub-id-type="pmid">2265922</pub-id>
      </element-citation>
    </ref>
    <ref id="CR95">
      <label>95.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van Ravenzwaaij</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Wagenmakers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <article-title>Advantages Masquerading as “Issues” in Bayesian Hypothesis Testing: A Commentary on Tendeiro and Kiers (2019)</article-title>
        <source>Psychol Methods.</source>
        <year>2022</year>
        <volume>27</volume>
        <issue>3</issue>
        <fpage>451</fpage>
        <lpage>465</lpage>
        <pub-id pub-id-type="doi">10.1037/met0000415</pub-id>
        <?supplied-pmid 34881956?>
        <pub-id pub-id-type="pmid">34881956</pub-id>
      </element-citation>
    </ref>
    <ref id="CR96">
      <label>96.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tendeiro</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Kiers</surname>
            <given-names>HAL</given-names>
          </name>
        </person-group>
        <article-title>On the White, the Black, and the Many Shades of Gray in Between: Our Reply to van Ravenzwaaij and Wagenmakers (2021)</article-title>
        <source>Psychol Methods.</source>
        <year>2022</year>
        <volume>27</volume>
        <issue>3</issue>
        <fpage>466</fpage>
        <lpage>475</lpage>
        <pub-id pub-id-type="doi">10.1037/met0000505</pub-id>
        <?supplied-pmid 35901398?>
        <pub-id pub-id-type="pmid">35901398</pub-id>
      </element-citation>
    </ref>
    <ref id="CR97">
      <label>97.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sinharay</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Stern</surname>
            <given-names>HS</given-names>
          </name>
        </person-group>
        <article-title>On the Sensitivity of Bayes Factors to the Prior Distributions</article-title>
        <source>Am Stat.</source>
        <year>2002</year>
        <volume>56</volume>
        <issue>3</issue>
        <fpage>196</fpage>
        <lpage>201</lpage>
        <pub-id pub-id-type="doi">10.1198/000313002137</pub-id>
      </element-citation>
    </ref>
    <ref id="CR98">
      <label>98.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Aitkin</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Bayes Factors: Prior Sensitivity and Model Generalizability</article-title>
        <source>J Math Psychol.</source>
        <year>2008</year>
        <volume>52</volume>
        <issue>6</issue>
        <fpage>362</fpage>
        <lpage>375</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jmp.2008.03.002</pub-id>
      </element-citation>
    </ref>
    <ref id="CR99">
      <label>99.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lindley</surname>
            <given-names>DV</given-names>
          </name>
        </person-group>
        <article-title>A Statistical Paradox</article-title>
        <source>Biometrika.</source>
        <year>1957</year>
        <volume>44</volume>
        <issue>1/2</issue>
        <fpage>187</fpage>
        <lpage>192</lpage>
        <pub-id pub-id-type="doi">10.2307/2333251</pub-id>
      </element-citation>
    </ref>
    <ref id="CR100">
      <label>100.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wong</surname>
            <given-names>TK</given-names>
          </name>
          <name>
            <surname>Kiers</surname>
            <given-names>HAL</given-names>
          </name>
          <name>
            <surname>Tendeiro</surname>
            <given-names>JN</given-names>
          </name>
        </person-group>
        <article-title>On the Potential Mismatch Between the Function of the Bayes Factor and Researchers’ Expectations</article-title>
        <source>Collabra Psychol.</source>
        <year>2022</year>
        <volume>8</volume>
        <issue>1</issue>
        <fpage>36357</fpage>
        <pub-id pub-id-type="doi">10.1525/collabra.36357</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
